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ABSTRACT 
 
The anti-cancer agent 4,4-dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A007) 
forms complexes with  π-delocalized lymphangitic dyes that allow its penetration through the 
skin effectively delivering it to a meta-stable type cancerous site. Previous in vitro studies, 
combined with gas phase mass spectrometry studies, have shown that a stronger binding affinity 
equates to a greater efficacy of the drug.  For the determination of drug:dye complex binding 
strength coefficients in solution, two methods have been developed by affinity capillary 
electrophoresis (ACE), and cation exchange liquid chromatography (CELC). The methods 
demonstrated that A007 non-covalent binding strength was greatest for methylene green, 
followed by methylene blue, and lastly toluidine blue. 
Bond dissociation energies and apparent reaction enthalpies for the fragmentation 
pathways of lithiated acylglycerols were experimentally determined by collision activation in a 
triple quadrupole mass spectrometer.  A developed novel derived effective path length approach 
for predicting bond dissociation energies (BDE) for electrostatic complex’s alkali metal adducts 
(Li+), and halide adducts (Cl-) of acylglycerols was applied to the major fragmentation product 
ions of a lithiated mono-acylglycerol, a 1,2-diacylglycerol, and a 1,3-diacylglycerol, to predict 
the covalent bond dissociation energies involved in fragmentation pathways.  The model’s 
calculated apparent reaction enthalpies are used in conjunction with the energy-resolved mass 
spectrometry method of breakdown graphs to give a more complete quantitative aspect to the 
interpretation of the fragmentation processes. 
The dry eye condition affects millions of individuals world wide. The symptoms can be a 
result of simple irritation to the eye or a serious disease state. A dry eye model was developed 
 xx
  
using rabbits in order to study the compositional makeup of the tear components in hopes of 
identifying an underlying cause, or expressed effect of the dry eye condition. The major non-
polar lipids of the tear were identified by mass spectrometry as mono and diacylglycerols, with a 
smaller extent of triacylglycerols. The major polar phosphorylated lipids were identified in the 
tear extract revealing that sphingomyelin based species were being expressed in the dry eye 
condition. The major proteins were determined to be the lower molecular weight lipid binding 
proteins where two specific species were found to increase in expression for the dry eye 
condition. 
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 CHAPTER I: INTRODUCTION 
 
1.1 Objectives and Aims 
 
Previous work in measuring and identifying biological compounds from complicated 
extracts has had difficulty in the ability to achieve detection, identification and quantitation of 
the low nano to picogram levels that are found in tears. Also, specialized mass spectrometers that 
are not readily available to most laboratories are typically used for complex biological compound 
interactions. Therefore, the main objective of my work was to develop new and improved mass 
spectrometric methods for the measurement of biological compounds and their complex 
interactions using common mass spectrometer instrumentation.  The specific aims of my work 
were to develop advanced mass spectrometric methodology for: a) the measurement of complex 
biological interactions in the solution-phase, b) the measurement of complex biological 
interactions in the gas-phase c) the identity and comparison of nonpolar and polar lipids in a 
rabbit dry eye tear model, and d) the identity and comparison of the major proteins in a rabbit dry 
eye tear model. 
 
1.2 Significance and Impact 
The use of mass spectrometry has become a powerful analytical tool for gas phase 
thermochemistry studies, for structural elucidation of organic compounds, and for composition 
studies of complex biological samples. The high sensitivity of mass spectrometers has also 
allowed the measurement of biological extracts that contain very low levels of the analytes of 
interest such as tear film extracts. Previous investigations into molecular changes in tear film 
structure have been hampered by the need to pool tears to make up a sample large enough to 
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 undergo analytical methods such as one- or two-dimensional electrophoresis. Another problem is 
the requirement that the tear components be derivatized before they are subjected to gas 
chromatography, mass spectrometry, or both. Finally, the total chloroform extract of the tear 
layer constitutes a complex mixture of biological compounds that includes non-polar and polar 
lipids and some lipoproteins. The polar lipid components make up a very small fraction of the 
total extract, rendering their analysis difficult by mass spectrometry alone. Therefore, there is a 
need to develop new methodology that combines optimized sample pretreatment in conjunction 
with mass spectral instrumental analysis.  In response to this, we have developed methodologies 
for enhanced lipid and protein analysis that includes sample pretreatment such as clean-up 
chromatography, cationizing agents, washing solutions, wax plating MALDI Voyager plates, and 
enhanced MALDI matrices. The methodologies that have been developed have generated 
significant improvements such as increased sensitivities, enhanced signal responses, and lower 
detection limits. 
 The study of noncovalent bond dissociation energies by mass spectrometry has been 
investigated for well over 25 years, generating very accurate and reliable values. However, the 
type of mass spectrometer used is highly specialized and not readily accessible to most research 
laboratories, and is primarily limited to small molecular weight systems such as solvent/metal 
adducts. In response to this, we have developed a mass spectrometric method for the 
measurement of bond dissociation energies for both small molecular weight systems such as 
solvent/metal adducts, and larger molecular weight systems such as lipid/metal adducts. We have 
also extended the method to calculate “covalent” bond dissociation energies as well as 
noncovalent using a mass spectrometer that is fairly common in many research laboratories. This 
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 methodology in effect enables a broader scope to the measurement of dissociation energies by 
mass spectrometry that is more accessible to researchers.  
The analysis of the components of tears has been reported upon for more than 40 years 
primarily using methods that required compositing samples, special pretreatment of samples, and 
were not as sensitive as that needed for very low levels of analytes. With the advancements in 
mass spectrometric instrumentation, ionization sources, and preparation techniques, there has 
been a tremendous growth in applications towards the analysis of complex biological samples. 
However, there are still many obstacles that are encountered when analyzing these complex 
biological samples. For the tear composition studies, these included very low levels of lipids in 
the nano to picogram levels that were suffering from suppression from other analytes present, 
and proteins that have been challenging to compare a normal to a diseased state expression. The 
developed methodology presented here shows for the first time the observance of single lipid 
species in the tear thus allowing the observance of an expression differential. The developed 
methodology has also allowed an expression study differential to be observed with the tear 
proteins. These studies may be able to identify causes to, or signaling agents of the dry eye 
diseased state. 
In order to fully understand the results presented in Chapters III through VIII, it is 
necessary to be familiar with some of the basic concepts of the applied methodologies used in 
each study. Therefore, the following sections provide a brief introduction and overview of the 
instrumental methods used in the research studies reported upon in this dissertation.  
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 1.3 Overview of High Performance Liquid Chromatography (HPLC) and Capillary Zone 
Electrophoresis (CZE) 
High performance liquid chromatography (HPLC), and capillary zone electrophoresis 
(CZE) are two analytical separation techniques that have been used as individual approaches for 
compound separations, and as complimentary approaches. HPLC is a separation technique that 
utilizes a compound’s affinities for either a stationary phase, or a mobile phase, in order to 
perform a chromatographic separation. In reverse phase HPLC (RP-HPLC), typically the 
stationary phase is composed of a long chain non-aromatic, aliphatic hydrocarbon (e.g. C18, for 
an 18-carbon chain) that is covalently bound to silica or polymer beads packed into a cylinder 
stainless steel tube. The mobile phase typically consists of mixtures of H2O, methanol (MeOH), 
and acetonitrile (ACN) that are all three completely miscible in all molar fraction ratios. The 
sample is loaded onto the C18 column with a high H2O ratio in the mobile phase where the 
affinity of organic compounds are greatest for the C18 stationary phase.  The mobile phase is 
changed in a gradient fashion where the organic solvent (MeOH or ACN) is gradually increased. 
The affinity for the organic molecules now increases in the mobile phase which helps to carry 
them along through the column. The separation of the individual organic constituents now takes 
place due to their different affinities for the stationary and mobile phases. 
Strong ion exchange high performance liquid chromatography works upon similar 
principles as RP-HPLC, except that the compound of interest now has a strong ionic, 
electrostatic, non-covalent affinity for the stationary phase. This approach works well for 
compound that posses a permanent charge such as an acid in basic solution, or a base in acidic 
solution. Strong cation exchange high performance liquid chromatography (SCEX-HPLC) uses 
an organically bound sulfonic acid group that has a high affinity for compounds that contain 
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 permanent positive charges.  Due to the aromatic backbone of strong cation exchange stationary 
phases, there is also a slight reverse phase interaction that can also take place. For the 
chromatographic elution of the compound of interest from the strong cation exchange column, 
typically a salt gradient is used which displaces the analyte from the poly-sulfonic acid stationary 
phase.  
Capillary zone electrophoresis (CZE) is another very useful separation technique which 
has traditionally been applied primarily to analytes of interest which also posses a permanent 
charge, just as is the case with strong ion exchange chromatography. Unlike liquid 
chromatography, capillary zone electrophoresis does not separate analytes according to their 
respective affinities for mobile and stationary phases, rather the separation is achieved based off 
of analytes electrophoretic mobilities in an electric field. In positive mode electrophoresis, 
positively charged analytes move from the anodic (positive electrode) region of the separation 
phase, to a cathodic (negative electrode) region of the separation phase, through a narrow bore, 
short fused silica tube. In general, small highly charged analytes have the greatest mobilities, 
followed by higher molecular weight similarly charged analytes, followed by neutrals, which 
travel through the separation capillary due to a phenomenon known as electroosmotic flow 
(EOF), and lastly, oppositely charged ions. The forces acting upon the analytes are vectors, 
therefore they are additive, and result in the separation of analytes based upon their mass to 
charge ratios. Electroosmotic flow results from bulk movement of the separation phase through 
the fused silica capillary due to the charged silano groups of the fused silica wall. EOF can be 
influenced through pH changes (high pH produces deprotonated, charged silano groups resulting 
in higher EOF, while low pH results in protonated silano groups thus decreasing EOF), organic 
modifiers in the separation phase (a higher organic modifier such as MeOH reduces EOF), and 
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 also through neutral coating of the fused silica wall such as with polymers, which can reduce or 
eliminate EOF. 
Since its early introduction(1-4), capillary zone electrophoresis is an analytical technique 
that has become an indispensable tool in many modern laboratories, especially in the 
pharmaceutical industry(5).  The application of capillary electrophoresis to the study of 
complexes, known as affinity capillary electrophoresis (ACE), has recently experienced a large 
growth.  This methodology has been used to study the electrophoretic mobility and separation of 
various complexes(6), complex electrostatic interactions(7), complex binding and disassociation 
constants(8,9), and complex stoichiometry(10).  In most studies, affinity CE ideally involves the 
measurement of a complex that stays bound throughout the electrophoretic separation(11).  The 
complexes that were evaluated by this study involve a purely electrostatic binding between the 
dye carrier compound, and the anti-cancer agent A007, which have estimated high disassociation 
constants.   
 
1.4 Overview of Electrospray Triple Quadrupole Mass Spectrometry 
Electrospray ionization (ESI) is a process that enables the transfer of compounds in 
solution phase to the gas phase in an ionized state thus allowing their measurement by mass 
spectrometry.  The use of ESI coupled to mass spectrometry was pioneered by Fenn et al.(12,13), 
in 1985, by extending the work of Dole et al.(14) who demonstrated the production of gas phase 
ions by spraying macromolecules through a steel capillary that was electrically charged, and 
subsequently monitoring the ions with an ion-drift spectrometer.  The process by which ESI 
works has received much theorization, study, and debate(15-21), in the scientific community, 
especially the formation of the ions from the Taylor(22) cone droplets and offspring droplets. The 
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 electrospray process is achieved by placing a potential difference between the capillary and a flat 
counter electrode. The generated electric field will penetrate into the liquid meniscus and create 
an excess abundance of charge at the surface.  The meniscus becomes unstable and protrudes out 
forming a Taylor cone.  At the end of the Taylor cone a jet of emitting droplets (number of drops 
estimated at 51,250 with radius of 1.5 µm) will form that contain an excess of charge. As the 
droplets move towards the counter electrode, a few processes take place.  The drop shrinks due 
to evaporation thus increasing the surface charge until columbic repulsion is great enough that 
offspring droplets are produced. This is known as the Rayleigh limit producing a columbic 
explosion. The produced offspring droplets have 2% of the parent droplets mass and 15% of the 
parent droplets charge.  This process will continue until the drop contains one molecule of 
analyte and charges that are associated with basic sites (positive mode). This is referred to as the 
“charged residue model” that is most important for large molecules such as proteins. As the 
droplets move towards the counter electrode a second process also take place known as the “ion 
evaporation model.”  In this process the offspring droplet will allow evaporation of an analyte 
molecule from its surface along with charge when the charge repulsion of the analyte with the 
solution is great enough to allow it to leave the surface of the drop. This usually takes place for 
droplets with a radius that is less than 10 nm. This type of ion formation is most important for 
small molecules. 
In the ensuring years since its introduction, electrospray mass spectrometry has been used 
for structural elucidation and fragment information(23-25), and non-covalent complex studies(26,27), 
just to name a few recent examples of its overwhelmingly wide range of applications.   
Electrospray(28-31) is an ionization method that is now well known to produce intact gas 
phase ions with very minimal, if any, fragmentation being produced during the ionization 
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 process.  In the transfer process of the ions from the condensed phase to the gas phase, several 
types of “cooling” processes of the ions are taking place in the source: (1) cooling during the 
desolvation process through vibrational energy transfer from the ion to the departing solvent 
molecules, (2) adiabatic expansion of the electrospray as it enters the first vacuum stage, (3) 
evaporative cooling, and (4) cooling due to low energy dampening collisions with ambient gas 
molecules.  The combination of these effects, and the fact that electrospray can effectively 
transfer a solution phase complex to the gas phase with minimal interruption of the complex, 
makes the study of non-covalent complexes from solution by electrospray ionization mass 
spectrometry attractive.   
The ESI source is coupled to a triple quadrupole mass spectrometer for detection of the 
ions produced from the electrospray process.  The triple quadrupole mass spectrometer is a 
versatile tool in structural analysis of components of complex matrices.  The instrument is 
comprised of three quadrupoles, in tandem, which two (the first and third) have individual 
detectors, while the middle quadrupole (actually a hexapole), known as the collision gas cell, is 
RF only with no detector. Figure 1.2.4 shows the arrangement in space of the quadrupoles. 
Having the quadrupoles aligned in tandem allows approaches to compound isolation, and 
subsequent identification by using the quadrupoles as mass filters(32).  A quadrupole is made up 
of four rods that are placed precisely parallel to each other. One set of opposite poles have a DC 
voltage (U) supply connected while the other two have a radio frequency (rf) voltage (V) 
connected(33). Ions are accelerated into the quadrupole by a small voltage of 5 V, and under the 
influence of the combination of electric fields, the ions follow a complicated trajectory path. If 
the oscillation of the ions in the quadrupole have finite amplitude it will be stable and pass 
through. If they are infinite, they will be unstable and the ion will collide with the rods. At a 
 8
 certain range of DC voltage U and radio frequency potential V, the ion of interest will have a 
stable region. A plot of U versus V is used to scan mass to charge ratios (m/z) with the 
quadrupoles allowing the measurement of a range of masses, typically up to 4000 Da. The slope 
of the line is a fixed ratio of U to V. As U and V are varied, the scan follows the scan line and 
subsequent m/z values are recorded. Due to this functionality the quadrupoles are called mass 
filters, however, they are still dependent upon a mass to charge ratio. The mass spectrometry 
methods used in the lipid analyses included single stage analysis (ESI-MS) where the first 
quadrupole is scanned and the first detector is used. This is used for compound molecular mass. 
A second method used was neutral loss scanning (NL). This is used to determine the initial 
molecule that losses a certain neutral mass upon fragmentation induced in the central hexapole 
collision cell. In this procedure the first and third quadrupoles are scanned at a differential equal 
to the neutral loss value. For example, if the NL value is 50 then when Q1 is at 200 m/z, Q3 is 
scanning at 150 m/z. When 150 m/z is registered by detector 2, the Q1 value is recorded along 
with the intensity recorded with detector 2. A third method used was precursor ion scanning. 
This is used to determine the initial molecule that produces a specific product ion. Here Q3 is 
held static at the ion fragment m/z of interest and Q1 is scanned over an m/z range. When the ion 
is detected by Q3 the m/z value in Q1 is recorded in conjunction with the intensity recorded by 
detector 2. Finally, a fourth method used was product ion scanning(33). This is a scan for product 
ions produced from a single precursor ion which is allowed to pass through Q1. This is used for 
structural elucidation. 
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 1.5 Overview of Matrix Assisted Laser Desorption Ionization (MALDI) Time-of-Flight 
(TOF) Mass Spectrometry 
Matrix assisted laser desorption ionization (MALDI) is a process that enables the transfer 
of compounds in a solid, crystalline phase to the gas phase in an ionized state thus allowing their 
measurement by mass spectrometry(34-36). The process involves mixing the analyte of interest 
with a strongly ultra-violet absorbing organic compound, applying the mixture to a surface and 
then allowing it to dry. Examples of typical organic matrix compounds used are 2,5-
dihydroxybenzoic acid (DHB), 3,5-dimethoxy-4-hydroxy-trans-cinnamic acis (sinapic or 
sinapinic acid), and α-cyano-4-hydroxy-trans-cinnamic acid (α-CHCA). There are many 
techniques described for applying the matrix to the target such as the “dried droplet” 
method(36,37), and the “thin film” method(38). The dried crystalline mixture “film” or “spot” is 
then irradiated with a nitrogen laser (337 nm), or an Nd-YAG laser (266 nm).  The strongly UV 
absorbing species accepts energy from the laser and desorbs from the surface carrying along any 
analyte that is mixed with it. The analyte is cationized in the plume above the crystalline surface 
with, in the positive mode, either a hydrogen proton or a metal cation such as sodium.   
The desorbed, ionized compounds from the matrix assisted laser desorption ionization 
process are then introduced into a mass spectrometer for analysis. The most common mass 
spectrometer that is coupled to MALDI is the time-of-flight mass spectrometer (TOF MS)(39,40). 
The TOF mass spectrometer separates compounds according to their mass to charge ratios (m/z) 
through a direct relationship between a compounds drift time through a predetermined drift 
pathlength and its mass to charge ratio (m/z). Initially, all the ions have similar kinetic energies 
imparted to them from the draw-out pulse (representing time zero) which accelerates them into 
the flight tube.  Because the compounds have different masses their velocities will be different 
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 according to the relationship between kinetic energy and mass represented by: KE = eV = 
1/2mv2. From this expression, the mass to charge ratio is related to the ions flight time by the 
following expression: m/z = 2vt2/L2. There is a high transmission efficiency of the ions into and 
through the drift tube which equates to very low levels of detection limits which are in the 
femtamole to atamole ranges. Theoretically, the mass range of the spectrometer is unlimited due 
to the relationship of drift time for mass measurement. In practice though, the sensitivity needed 
to detect a very slow moving large molecular weight compound limits the TOF-MS to 1 to 2 
million Daltons or so.  
The early designs of time of flight mass spectrometers suffered from poor resolution 
which is the ability of the mass spectrometer to separate ions. This is usually expressed as 
resolution = m/∆m where m is the mass of the peak of interest and ∆m is the difference between 
this mass and the next closest peak. The poor resolution was due to nonuniform initial spatial and 
energy distributions of the formed ions in the mass spectrometer’s ionization source. Due to the 
distribution spreads the mass resolution was directly dependant upon the initial velocity of the 
formed ions. Early work reported by Wiley et al.(41) reported upon the correction for initial 
velocity distributions using a technique they described as “time-lag energy focusing” where the 
ions were produced in a field-free region, then after a preset time a pulse was applied to the 
region to extract the formed ions.  They also reported upon a way to correct for initial special 
distributions through a two field pulsed ion source.  They demonstrated though that correction 
can only be made for one of the distributions at a time. In MALDI, the spatial distribution spread 
is not a significant problem, therefore “delayed extraction” of the ions from the field free source 
region should correct for the initial energy distribution spread of the formed ions(42).  With this 
correction, the resolution should be directly dependent upon the total flight time ratioed to the 
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 error in the time measurement, thus an increase in the length of the flight path should equate to a 
higher resolution. The resolution enhancement due to the delayed extraction initial energy 
focusing and flight path was demonstrated in a study reported by Vestal et al.(42) using a 
MALDI-TOF mass spectrometer. 
A second modification of time of flight mass spectrometers involves time focusing of the 
ions while they are in flight through the use of an electrostatic mirror at the end of the flight 
tube(43,44). The electrostatic mirror focusing the ions with the same mass to charge ratio but 
slightly different kinetic energies by allowing a slightly longer path for the higher KE containing 
ion compared to a slightly lower KE ion thus allowing the ions to catch up to one another. The 
electrostatic mirror also increases the flight path length of the mass spectrometer, thus providing 
a double focusing effect. All recent TOF-mass spectrometers employ both delayed extraction and 
the reflectron electrostatic mirror for analysis of compounds below 10 kDa. For compounds 
greater than 10 kDa a linear mode is typically used where the electrostatic mirror is turned off.   
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 CHAPTER II:  DETERMINATION OF RELATIVE BINDING CONSTANTS 
BETWEEN π-DELOCALIZED LYMPHANGITIC DYES AND AN ANTI-CANCER AGENT 
BY CATION EXCHANGE LIQUID CHROMATOGRAPHY AND AFFINITY CAPILLARY 
ZONE ELECTROPHORESIS 
 
2.1 Introduction 
One of the major problems with anti-cancer therapy is the effective delivery of the anti-
cancer agent to the tumor site.  Skin permeability studies have demonstrated that the coupling of 
the anti-cancer agent A007 with a carrier dye molecule (methylene green, MEG, methylene blue, 
MEB, and toluidine blue, TB, see Figure 2.1 for structures) increases A007’s therapeutic 
activity(1), with a rating from most effective, to least, as MEG>MEB>TB.  Electrospray 
ionization tandem mass spectrometry(2-5) (ESI-MS/MS) has been used in our lab (results 
unpublished) to study the characteristics and relative binding strengths of the three dyes MEG, 
MEB, and TB, complexed with A007.  The gas phase binding strengths of the three complexes, 
determined by ESI-MS/MS, were ranked in the following order: MEG>MEB>TB, which 
indicates that a stronger binding between the carrier and anti-cancer agent directly correlates to a 
greater efficacy.  A high performance liquid chromatography (HPLC) method has been 
developed for the determination of A007 in plasma(6), but not for the complexes that are formed 
between A007 and carrier compounds.  A cation exchange chromatography (CEC) method has 
been developed in our lab (results unpublished) in order to rank the binding strengths of 
carrier:A007 complexes.  The CEC method determined binding strengths with the same trend as 
was determined by ESI-MS/MS, namely MEG>MEB>TB.  This effectively gave a “solution 
phase” ranking of binding strengths. 
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Figure 2.1.  Structures of (a) 4,4’-Dihydroxybenzophenone-2,4-dinitrophenylhydrazone 
(A007)(1), (b) methylene blue (MEB), (c) toluidine blue (TB), and (d) methylene green (MEG). 
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 The ACE method developed ranked the binding strengths of the carrier:A007 complexes, 
in the solution phase at an adjusted physiological pH (7.4), as MEG>MEB>TB.  These results 
are in agreement with the ESI-MS/MS, and cation exchange chromatography rankings that were 
previously determined.   
 
2.2 Experimental 
The UV/VIS experiments were performed with a PC controlled CARY 500 Scan UV-
Vis-NIR Spectrophotometer (Varian Australia Pty. Ltd.). 
The fluorescence experiments were performed with a PC controlled Photon Technology 
International Fluorometer (PTI, Canada). 
The CE experiments were performed with a BioFocus 2000 Capillary Electrophoresis 
System (BIO-RAD, Hercules, California) with a UV/VIS variable wavelength detector.  
Uncoated fused-silica capillaries were used with a total length of 56 cm, effective length 50 cm, 
and 50 um i.d.  The capillaries were maintained at a temperature of 25 oC.  The injection time 
was 30 psi*sec pressure.  All runs were made in a constant voltage mode with a running voltage 
of 30 kV.  The polarity was + to – (positive polarity mode where the negative pole is at the 
capillary outlet). Between runs, the CE capillary was conditioned through a series of washes 
comprised of 13 min. 1 M NaOH, followed by 13 min. of separation phase.  The separation 
phase consisted of (1) 50% MeOH/50% H2O buffered with 25 mM mono and dibasic hydrogen 
phosphate at a pH of 7.4 (adjusted), or (2) 50% MeOH/50% H2O, 25 mM phosphate buffer at 7.4 
pH (adjusted) and spiked with either MEG, MEB, or TB. 
The HPLC experiments were performed with an 1100 Series HPLC (Agilent 
Technologies, Palo Alta, CA) comprised of a vacuum degasser, a quarternary pump, and a diode 
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 array detector.  The column used was a 150 x 1.0 mm, 5 micrometer, 300-A, 
PolySULFOETHYL A column (PolyLC, Columbia, MD).  Instrumental parameters consisted of 
a 0.1 ml per minute flow, 10 microliter injection loop, and ambient column temperature.  Mobile 
phases consisted of (1) 50% MeOH/50% H2O, buffered at 7.4 pH (adjusted) with 15 mM 
triethylamine phosphate (TEAP), (2) 50% MeOH/50% H2O, buffered at 7.4 pH (adjusted) with 
15 mM TEAP, and spiked with either 5x10-5 M MEG, 5x10-5 M MEB, or 5x10-5 M TB, or (3) 
50% MeOH/50% H2O, buffered at 7.4 pH (adjusted) with 15 mM triethylamine phosphate and 
0.5 M NaCl. 
To mimic physiological conditions, all solutions are at a pH of 7.4, but adjusted due to 
the change in H+ activity for a 50 % methanol and 50 % water mixture(18,19). 
 
2.3 Results and Discussion 
2.3.1 UV/Vis Study of the Compounds and Complexes 
Figure 2.2 illustrates UV/Vis spectra of the complexes formed between the three dyes and 
A007.  What’s observed from the spectra is that each compound contains a unique absorbance 
peak which can be used to detect and monitor the compounds and complexes without 
interference.  The three dyes used in the study, methylene green, methylene blue, and toluidine 
blue, have unique absorbance maximums at 656 nm, 662 nm, and 630 nm, respectively.  The 
anti-cancer agent A007 has an absorbance maximum between 398 nm, and 405 nm.  Both dye 
and A007 peaks are found in the complexes, and the A007 max at 398 nm was used to detect the 
complex for mobility calculations and migration times (ACE), and retention times (CELC).  
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 2.3.2 Flourescence Study of the Dye-A007 Complexes 
The dyes used in the study naturally fluoresce at specific wavelengths.  It was initially 
felt that the complex between the dyes and the anti-cancer agent A007 enhanced this 
fluorescence.  Using the method of continuous variation(20,21), a fluorescence maximum was 
obtained for each dye-A007 complex versus mole fraction.  These dyes however are known to 
produce dimers in the liquid phase(22), where the production of the dimer will quench the 
fluorescence.  Further spectroscopic experiments showed that only one species of complex was 
being formed in solution between A007 and the dyes, but the enhancement in fluorescence was 
attributable to the decrease in dye dimer only, and not to the formation of the A007:dye complex. 
 
2.3.3 Cation Exchange Liquid Chromatography Results. 
A binding coefficient (BC) equation (see equation 1) was derived based on the retention 
times of the dyes, the A007:dye complexes, and the anti-cancer agent A007, in order to rank the 
binding strengths of the A007:dye complexes.  The scale spans a BC value from approximately 
0.1, representing a weak binding, to 1.0, representing the strongest binding.   
 
 
BC = (tdrug(carrier) – tdrug)/(tcarrier – tdrug)   (1) 
 
 
Figure 2.3 contains the CELC chromatograms illustrating the retention times used for the 
calculation of the binding constants.  It is felt that this approach gives a direct measurement of  
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Figure 2.2. UV/Vis absorbance spectrums of A007:Dye complexes illustrating 
absorbance maximums of (a) 405 nm for A007, 662 nm for MEB, (b) 630 nm for TB, and (c) 
656 nm for MEG. 
 
 19
 the binding strength between the dyes and A007.  The binding method is achieved through a kind 
of pseudo stationary phase that is produced in the cation exchange column between the dye in the 
mobile phase, and the sulfoethyl A stationary phase.  With a stronger binding between the dye 
and A007, A007 will have a longer elution time, as is observed in the chromatograms contained 
in Figure 1.  The binding strength scale of the three dyes was determined to be methylene green 
> methylene blue > toluidine blue, with calculated BC’s of 0.54 ± 0.05, 0.24 ± 0.02, and 0.18 ± 
0.02, respectively (BC values are the average plus or minus one standard deviation of at least 
three determinations).   
 
2.3.4 Capillary Electrophoresis Results 
Figure 2.4 illustrates the results of the change in mobilities of A007 versus increasing 
concentrations of the dye ligands titrated into the separation phase.  There are initial similarities 
in the effective mobilities of A007 observed between the three systems at a dye ligand 
concentration of 5x10-5 M (MEG dye A007 mobility of 14.9 cm2kV-1min-1, MEB dye A007 
mobility of 14.3 cm2kV-1min-1, and TB dye A007 mobility of 14.9 cm2kV-1min-1). Following this 
there is a subsequent decreasing mobility trend as the dye concentration is increased to 8x10-4 M. 
This suggests that the change in mobility could be attributed to a decrease in the electroosmotic 
flow with increasing background electrolyte(23-25). This type of effect is also observed with 
increasing percentages of organic solvent in the separation phase(26-30).  Salomon et al.(23) derived 
an expression which describes the change in electroosmotic mobility as a function of buffer 
(electrolyte) concentration: 
µeo = (Q0/n(1 + Kwall[M+]))(d0 + 1/(K’([M+])1/2))  (2) 
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Figure 2.3.  Typical CELC chromatograms of A007 (Tdrug) at 5x10-5 M A007, A007:TB 
Complex (Tdrug(carrier)) at 5x10-5 M TB and A007, A007:MEB Complex (Tdrug(carrier)) at 5x10-5 M 
MEB and A007, A007:MEG Complex (Tdrug(carrier)) at 5x10-5 M MEG and A007, and Dye 
(Tcarrier). 
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 The µeo is inversely proportional to both the ionic strength of the solution [M+], and to the 
association of the cations to the silica wall (Kwall).  An increase in either of these leads to a 
decrease in the mobility.  The studies reported by Salomon measured the change in 
electroosmotic mobilities for buffer concentrations ranging from approximately 2 mM to 40 mM.  
The mobility change experiments performed on the A007:dye complexes reported here ranged 
from 25.05 mM ionic to 25.8 mM ionic. This is a much lower change in ionic strength of the 
separation phases suggesting perhaps a negligible contribution. The anti-cancer agent A007 at a 
pH of 7.4 is neutral, therefore its mobility in buffer alone would represent the electroosmotic 
flow of the system before titrating the separation phase with the dye ligand.  A007’s mobility in 
buffer alone was measured at 13.5 cm2kV-1min-1.  This result is very similar to the mobilities 
measured for A007 when 5x10-5 M dye (first data point, Figure 2.3) had been titrated into the 
separation phases (MEG dye A007 mobility of 14.9 cm2kV-1min-1, MEB dye A007 mobility of 
14.3 cm2kV-1min-1, and TB dye A007 mobility of 14.9 cm2kV-1min-1).  Notice the slight increase 
in mobility of A007 in separation phases containing 5x10-5 M dye versus the mobility of A007 in 
buffer alone. The three dyes MEG, MEB, and TB are very similar in structure (see Figure 2.1), 
and all possess a permanent positive charge. Therefore, the change in EOF due to increasing 
concentrations of the dye ligands in the separation phase would be expected to be of similar 
magnitude for the three systems, as was observed with the mobility of A007 with the titration of 
5x10-5 M dye into the separation phases.  As higher dye concentrations are titrated into the 
separation phase, the mobilities of A007 are observed to decrease. This is attributed to the higher 
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Figure 2.4.  Plots of the mobility of A007 in increasing concentrations of methylene green, 
methylene blue, and toluidine blue. 
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 background electrolyte effect described by eq 2. However, as the dye ligand is titrated into the 
separation phase, the A007:dye electrostatic interaction is strong enough to produce a difference 
in the mobility of A007 when comparing the three systems (e.g., A007 mobilities at 8x10-4 M 
dye ligand: 4.03 ± 0.24 cm2kV-1min-1 for TB, 8.30 ± 0.76 cm2kV-1min-1 for MEB, and 9.04 ± 
0.78 cm2kV-1min-1 for MEG).  This illustrates that the dye ligand is playing an influential role in 
the change in A007 mobilities through a direct electrostatic interaction in addition to EOF 
changes due to high electrolyte background (see Figure 2.3).  It was at the 8x10-4 M 
concentration of the dye ligand in the separation phase that the ranking of the relative binding 
strength coefficients of the A007:dye complexes was calculated. 
A binding strength coefficient (BC), eq 3, was derived based on the ratio of the 
electrophoretic mobility of A007 in the presence of ligand, to that of the mobility of the free 
A007.  A BC of approximately 0.1 would indicate a weak binding, while a BC of 1 would 
indicate the strongest binding.  A similar ratio relationship was derived by Srinivasan et al.(31) to 
directly calculate disassociation constants for noncovalent complexes between cyclodextrin and 
barbiturates.  The relationship derived and used for the BC ranking is as follows: 
BC = µcomplex/µdrug     (3) 
Figure 2.5 is a series of electropherograms illustrating the migration times of the dyes, 
and A007 as sample in separation phases containing the dye ligands MEG, MEB, and TB.  The 
effective electrophoretic mobility, in the presence of electroosmotic flow, of component i was 
calculated using the following equation(32): 
ui = vi/E = vi⋅Lt/V  [cm2⋅kV-1⋅min-1]    (4) 
where: 
vi = vi(net) – veo = LD/ti – LD/teo  [cm⋅min-1]       (5) 
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 Combining equations 3 and 4 gives the standard mobility equation:  
ui = (LD/ti – LD/teo)⋅LT/V  [cm2⋅kV-1⋅min-1]   (6) 
Equation (5) was further simplified, due to the absence of a measurable EOF, to: 
ui = LDLTti-1V-1  [cm2⋅kV-1⋅min-1]    (7) 
The calculated binding strength coefficients by ACE are listed in Table 2.1 along with the BC 
values calculated from the CELC results.  
 
 
 
________________________________________________________________________
Compound       ACE BC    CEC BC  
Methylene green   0.67 ± 0.06   0.54 ± 0.05 
Methylene blue   0.62 ± 0.06   0.24 ± 0.02 
Toluidine blue    0.32 ± 0.02   0.18 ± 0.02 
________________________________________________________________________ 
 
Table 2.1 Binding constant values for the methylene green, methylene blue, and toluidine blue 
complexes with A007 by affinity capillary electrophoresis (ACE), and cation exchange 
chromatography (CEC). 
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Figure 2.5.  Electropherograms of (a) the three dyes (co-migration), (b) the anti-cancer agent 
A007, (c) A007:MEG complex, (d) A007:MEB complex, and (e) A007:TB complex. 
 26
 2.3.5 Comparison of Methods 
As illustrated in Table 2.1, the ACE results show that MEG and MEB have very similar 
binding coefficients, while TB was well differentiated. The ranking by CELC shows binding 
coefficients that are more differentiated between the three, probably due to a much more direct 
electrostatic binding strength determination than what is measured with the ACE approach.   
The affinity capillary electrophoresis, ACE, method does have some general advantages 
over the other two methods.  The ES-MS/MS method describes a relative binding strength 
between the complexes in the gas phase only. In general, gas phase binding strengths vary 
greatly in agreement with solution phase binding strengths, always dependent on the system 
being studied. In this work, a solution phase analytical method for binding strength 
determination was needed.  The cation exchange chromatography, CEC, approach gives a good 
separation between the ranking values for the complexes, but the method requires considerable 
column equilibration time with the changing of each mobile phase ligand (approximately 2 to 3 
hours).  In comparison the ACE method is fast (analysis completed between 10 to 30 minutes), 
and requires little treatment between the changing of ligand separation phases (13 minute caustic 
wash, followed by a 13 minute separation phase wash).  A further advantage is that typical ACE 
methods generally require samples in the nanomolar to micromolar concentration ranges, as 
compared to millimolar levels as used in chromatographic methods such as the CELC method(33).  
In general use, the ACE method would be utilized as a rapid screening determination of binding 
strengths, while the CELC method would act as a more accurate, confirmation method. 
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 2.4 Conclusions 
Affinity capillary electrophoresis has become a versatile tool in the study of many 
descriptive parameters of complexes.  Though this methodological approach has generally been 
used for high affinity complexes, it can also be successfully used for complexes of low affinity, 
or high disassociation, as demonstrated through the application to this dye-anti cancer agent 
complex.  The ACE method offers an alternative approach in the determination of binding 
strength coefficients of complexes, with advantages over the other two methods studied, ES-
MS/MS and cation exchange liquid chromatography, respectively.  The ACE method requires 
less time for analysis, and also smaller sample sizes as compared to ES-MS/MS and CELC.  The 
cost for ES-MS/MS instrumentation can also be prohibitive for some laboratories.  The ACE 
method is robust, and can be applied as a general method for the determination of binding 
strengths of non-covalent complexes.  In its specific use for the dye:A007 system, the ACE 
method would be utilized as a rapid screening determination of binding strengths, while the 
CELC method would act as a more precise, confirmation method. 
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 CHAPTER III:  DETERMINATION OF BOND DISSOCIATION ENERGIES USING 
ELECTROSPRAY TANDEM MASS SPECTROMETRY AND A NOVEL DERIVED 
EFFECTIVE REACTION PATH LENGTH APPROACH 
 
3.1 Introduction 
The measurement of the dissociation of gas-phase complexes by collision-induced 
dissociation (CID) tandem mass spectrometry has been a useful approach in the study of 
thermodynamic properties of complexes such as bond dissociation energies. Armentrout and 
Beauchamp1 introduced an ion beam apparatus for the study of the bond dissociation energy 
(BDE) of a cobalt carbene ion, and Armentrout et al. have since refined the measurement of non-
covalent, collision-induced threshold bond energies of metal-ligand complexes by mass 
spectrometry2-9. The array of uses of CID tandem mass spectrometry10 for the measurement of 
thermodynamic properties of gas-phase complexes includes investigations of bond dissociation 
energies11, gas-phase dissociative electron-transfer reactions12, non-covalent interactions10,13-15, 
bond dissociation energies using guided ion beam tandem mass spectrometry2-9, critical energies 
for ion dissociation using a quadrupole ion trap13, or a flowing afterglow-triple quadrupole14,15, 
or an electrospray triple quadrupole16,17, and gas-phase equilibria18-20. 
Electrospray21-24 is an ionization method that is well known to produce intact gas-phase 
ions with minimal fragmentation during the ionization process. Thus, studies of gas-phase 
thermochemical properties of species originating from solution are quite accessible by 
electrospray mass spectrometry.  MALDI is another “soft” ionization approach to gas-phase 
ionic complex analysis, but the complex’s character in the solution phase can be lost during 
crystallization with the matrix. However, Gidden et al.25 derived experimental cross sections for 
a set of alkali metal ion cationized poly(ethylene terephthalate) (PET) oligimers using a MALDI 
ion source coupled to a hybrid mass spectrometer. 
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 In this paper, we report on a mass spectrometry study of bond dissociation energies of 
alkali metal (Li+) adducts, and halide (Cl-) adducts, of monoacylglycerol, 1,2-diacylglycerol, and 
1,3-diacylglycerol lipids.  The energies required for the dissociation of one acylglyceride from 
lithium-bound dimers of monoacylglycerol, 1,2-diacylglycerol, and 1,3-diacylglycerol, were also 
studied.  The specific use of lithium adducts for ionization and structural analysis has been 
reported for fast atom bombardment (FAB) of aryl 1,2-diols26 and fatty acids27, and ES 
determinations of triacylglycerides28,29, and di- and tri-oligosaccharides30-33.  Chloride ion has 
also been reported to form adducts of diacylglycerols in liquid chromatography-negative 
chemical ionization mass spectrometry34,35, and its adducts have been used for structural 
elucidation employing ES-tandem mass spectrometry36-39. 
In this work, all bond dissociation energies were measured using a “triple quadrupole” 
(actually QhQ = quadrupole-hexapole-quadrupole) mass spectrometer using electrospray as the 
ionization method.  A new approach to the measurement of the dissociation of an alkali metal 
ion, or a halide ion from ionic adducts of intermediate molecular weight lipids (316 Da to 596 
Da) has been developed.  An analogous model (differing only in input parameters used for 
regression) to predict bond dissociation energies for low molecular weight cationic adducts such 
as CH3OHLi+, C2H5OHLi+, ACNLi+, CH3OCH3Li+, etc., is also presented. The results obtained 
from the mass spectrometry experiments were compared to both literature BDE values (when 
available), and to computer generated BDE’s employing the Becke-style 3-Parameter Density 
Functional Theory (B3LYP, using the Lee-Yang-Parr correlation functional, at the 6-31G* 
level)40. The newly developed method does not require extensive calculations of degrees of 
freedom, vibrational states, etc., which can be cumbersome for very high molecular weight 
systems.  It has been demonstrated to be applicable over a wide range of m/z values of the 
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 employed triple quadrupole, i.e. from the detection of the lithium ion at m/z 7, up to the 1-
stearin-2-palmitin diacylglycerol lithium-bound dimer ion at m/z 1199. 
 
3.2 Experimental 
Mass spectra were obtained using a “triple quadrupole” (actually quadrupole-hexapole-
quadrupole, QhQ) mass spectrometer (Quattro II, Micromass, Inc., Manchester, UK) equipped 
with an electrospray source operating at solution flow rates of 2-4 µL/min.  Nitrogen was used as 
both nebulizing and drying gas. Cone voltages were 18 V for the low molecular weight lithium-
solvent adducts, and 40 V for lithium adducts of the higher molecular weight lipids. The ES 
capillary voltage was set at 2.5 to 3.5 kV. Argon was used as collision gas during CID 
experiments at pressures of approximately 1.3 x 10-4 mBar (measured externally to the central 
hexapole collision cell) for single collision measurements. The hexapole offset energy values 
range from 0 eV up to 250 eV with a minimum increment of 1.0 eV.  MassLynx software 
(Micromass) was used to acquire, process, and store mass spectral data. 
  
3.3 Results and Discussion 
3.3.1 Measurement of Collision Cell Path Length 
In calculating thermochemical values such as the bond dissociation energy for a gas-
phase ionic complex by CID tandem mass spectrometry, the collision cell path length, or the 
mean free path of reaction, are most often unknown.  One approach to estimating this collision 
path length would be to interject guesses into data reduction equations to iteratively test which 
value results in a best fit.  Chen et al41 presented a new model for determining bond energies for 
holomyoglobin noncovalent gas-phase complexes where the collision cell path length is 
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 described as the average distance that ions travel before dissociating. In their method, estimated 
values for the path length were iteratively used until a realistic fit was obtained. A second 
approach would be to employ the actual measured dimensions of the gas cell, e.g., the central 
hexapole.  This is essentially the method used by Ervin et al.2, where the dimensions of their gas 
cell are well-defined, but they also take into account the pressure profile of the collision gas 
within the system to derive an effective cell length.  The approach taken in our new method is to 
measure the dissociation of standards with known BDE values to obtain IP/I0 values which then 
can be related to the reaction path length according to the thin target limit equation2: 
   IP/I0 = IP/(IR + ∑ IP) = σPnl     (1) 
where IP is the transmitted product ion signal intensity, IR is the transmitted reactant ion signal 
intensity, I0 is the incident ion signal intensity, σP is the product cross section (cm2), n is the 
number gas density (cm-3), and l is the collision cell path length (cm).  In this approach, it is 
assumed that the sum of the transmitted product peak intensities is equal to the incident reactant 
ion peak intensity; the latter in actuality, is not readily measurable. Therefore, a “derived 
effective reaction path length” is being obtained from the measurement of known standards.  At 
the thin target limit, the effective path length represents the average distance that the complex 
travels before dissociation takes place (or the average distance of travel before one collision 
resulting in dissociation occurs).  According to the thin target limit (eq 1), the slope of a plot of 
the IP/(IR + ∑ IP) ratio, versus number gas density, is related to the collision cross section2.  The 
number gas density, n, is calculated according to the ideal gas law42:  
n = PL/RT = P/kBαT      (2) 
where P is the pressure in atm, kB is the Boltzmann constant, α is a conversion factor of 9.869 
cm3atm/J, and T is the temperature in kelvin.  Figure 3.1 displays mass spectra obtained from 
 33
 lithium adducts of methanol, used as a standard for effective reaction path length determination, 
and it depicts the emergence of the dissociation of the lithium cation from the precursor adduct. 
For bond dissociation energy calculations, the supplied energy for the collision is converted from 
the laboratory frame of reference to the center-of-mass frame of reference according to ECOM = 
ELAB(m/(m + M)), where ELAB is the selected value of the offset for the central hexapole, m is the 
mass of the stationary target Ar atom, and M is the mass of the precursor ion.  Figure 3.1a shows 
the measurement of the incident lithium adduct ion without the detection of the lithium cation at 
0 eV offset value for the central hexapole. Figure 3.1b shows the emergence of the dissociated 
lithium cation, at m/z 7, from the precursor methanol/lithium adduct at an offset value = 0.50 eV 
(center-of-mass frame of reference, ECOM) for the central hexapole. This illustrates that the initial 
dissociation of the adduct can be measured, but the spectra indicate an earlier threshold energy 
value than what is expected from the known BDE of 1.596 eV9.  Figure 3.1c is the spectrum 
acquired at a 1.01 eV ECOM offset for the central hexapole. The ratio of the intensities of the 
lithium cation peak to the precursor peak at 0.5 eV is 8.0 x 10-5, while at 1.0 eV the ratio is 2.5 x 
10-4, demonstrating that the employed triple quadrupole possesses the required sensitivity to 
perform gas-phase thermochemical bond dissociation energy measurements. 
Figure 3.2a is a graph of the IP/(IR + ∑ IP) ratio versus number gas density for a dimethyl 
sulfoxide (DMSO) lithium adduct standard.  The values in the graph were obtained by acquiring 
product ion mass spectra from CID of the DMSO lithium adduct at fixed collision energy (ELAB 
= 10 eV) but increasing gas cell pressures; the latter equates to an increasing number gas density 
of argon.  The “zero point” collision cell gas pressure corresponds to the pressure measured in 
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Figure 3.1.  CID product ion mass spectra of the lithium adduct of methanol (m/z 39) illustrating 
the appearance of the dissociation of the lithium cation (m/z 7, BDE = 1.596 eV12). (a) 0 eV, no 
detection of lithium, (b) emergence of the dissociated lithium cation at 0.50 eV (ECOM), and (c) 
1.01 eV (ECOM). 
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 the analyzer in the absence of argon, i.e., 7 - 8 x 10-6 mbar (1.7 - 1.9 x 1011 cm-3, expressed as 
number gas density), representing a very small probability for collisions with nitrogen or other 
ambient gas.  The slope of the curve in Figure 3.2a, which is related to the product cross section 
according to the thin target limit (eq 1)2 as slope = σPl, can be extracted from the plot and then 
used to calculate the cross sections of the DMSO lithium adducts, and estimate l of the QhQ 
mass spectrometer. For the initial cross section calculations using the thin target limit ratio 
relationship σP = slope/l, we assign l = 1 cm. This assignment allows the simplifying 
approximation that σP = slope, but also necessitates a subsequent correction of the derived 
reaction path length, i.e., actual length l = 1 cm + correction. Figure 3.2b is a plot of the IP/(IR + 
∑ IP) ratio versus ECOM for CID of the DMSO lithium adduct, at a fixed collision gas pressure of 
1.3 x 10-4 mBar (number gas density of 3.14 x 1012 cm-3). The IP/(IR + ∑ IP) ratio is directly 
related to the cross section according to the thin target limit (eq 1). Therefore, it is assumed that 
at constant n and l values, the change in the IP/(IR + ∑ IP) ratio will be directly proportional to the 
change in the cross section. From this assumption arises the basic premise of our method, i.e., the 
magnitude in the change of the IP/(IR + ∑ IP) ratio can be used to predict the subsequent 
decreasing cross sections, from the initial number gas density determined cross section, for 
decreasing energies in the center-of-mass frame of reference. 
Figure 3.2c shows the derived cross sections for the DMSO lithium adduct. Figure 3.2c is 
generated by first evaluating the cross section from the number gas density plot of Figure 3.2a 
obtained at the highest collision energy (ELAB = 10 eV) where the S/N of the product ion is 
maximized.  Then, each subsequent energy cross section at progressively lower energies is 
calculated relative to this initial point, according to the magnitude of the change in the ratios 
given in Figure 3.2b. The reference BDE value for the DMSO lithium adduct is 2.36 eV43.  
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 Taking this literature BDE value, the best fit of Figure 3.2b gives an IP/(IR + ∑ IP) ratio of 1.879 
x 10-3, at a number gas density of 3.14 x 1012. The best fit of Figure 3.2c gives a cross section 
value of 2.878 x 10-16 cm2, at 2.36 eV, and number gas density of 3.14 x 1012. These three values, 
the number gas density of 3.14 x 1012, the IP/(IR + ∑ IP) ratio of 1.879 x 10-3, and the cross 
section of 2.878 x 10-16 cm2, can then be used to calculate an experimentally derived corrected 
effective reaction path length (initially set at 1 cm) using the thin target limit relationship, 
namely l = 2.08 cm (see Appendix 1 for example calculations).  This approach was also used 
with lithium adducts of MeOH, DMF, and ACN to calculate an average effective reaction path 
length of 1.95 ± 0.56 cm (using 7 individual determinations).  This experimentally derived 
effective reaction path length value was then used in all subsequent cross section calculations 
and ensuing BDE evaluations. 
 
3.3.2 Theoretical Calculation of BDE and Optimized Structures 
There are now numerous bond dissociation energy values in the literature for many small 
compounds that are adducted to lithium ion (ranging anywhere from 4 up to 30 atoms), but not 
larger compounds such as the lipids which are described here (ranging from 40 to 119 atoms). 
With no literature values available, in order to determine whether reasonable bond energy values 
were obtained for the unknown lipids using the triple quadrupole mass spectrometer, theoretical 
bond energy values were calculated using Becke-style 3-Parameter Density Functional Theory 
computational methods (B3LYP, using the Lee-Yang-Parr correlation functional, at the 6-31G* 
level). The computer modeling experiment consists of minimizing the potential energy of a 
lithium-lipid adduct structure, and then sequentially altering the lithium ion distance to the lipid  
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Figure 3.2.  (a) Ratio of product ion abundances to incident ion abundances (the latter is 
approximated by (IR + ∑ IP)), versus number gas density for the lithium adduct of DMSO at 
constant collision energy (ELAB = 10 eV).  The slope of the curve is related to the product cross 
section (σP) of the lithium-DMSO cationic complex according to the thin target limit as σP = 
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 slope/l, (b) plotted results of IP/(IR + ∑ IP) ratio versus collision energy (ELAB, top) (ECOM, 
bottom) for the dissociation of the DMSO-lithium adduct.  The best fit gives an IP/(IR + ∑ IP) 
ratio of 1.879 x 10-3, at 2.36 eV42, and a number gas density of 3.14 x 1012, used in calculating a 
derived effective reaction path length, and (c) calculated cross sections for the DMSO-lithium 
cationic adduct employing the σP = slope/l relationship from Figure 3.2a and the proportional 
changes of the IP/(IR + ∑ IP) ratios with collision energy in Figure 3.2b.  Using the 2.36 eV BDE 
value, the best fit of Fig. 3.2c gives a cross section value of 2.878 x 10-16 cm2 and, by the thin 
target limit relationship, a path length of l = 2.08 cm.  
 
 
(i.e., assigning incrementally larger distances to the nearest neighboring atom via increases in the 
“R” parameter of Gaussian 9840) while performing potential energy surface scans of the adduct 
complex at each step.  The obtained potential energies are plotted versus distance, and the 
electrostatic bond dissociation energy can be calculated from the difference between the potential 
energy obtained at the minimum, and the potential energy at complete dissociation, i.e., where 
the charge on the lithium has reached +1 and does not change. Figure 3.3a illustrates an 
optimized structure, and a plot of the potential energy surface scans versus distance for the 
orientation is found for the lithium adduct of 1,3-dipentadecanoin, where the lithium cation has 
oriented itself between the two carbonyl oxygens, and the oxygen atom of the hydroxyl group. 
The distance between the lithium cation and the hydroxyl oxygen is 2.01 angstroms, and the 
distance between the lithium cation and the two carbonyl oxygens is 1.88 and 2.00 angstroms.  
For the lithium adduct of 1-stearin-2-palmitin diacylglycerol, the lithium cation was also found 
to orient itself between the two carbonyl oxygens of the 1- and 2-position fatty acyl chains and 
the oxygen of the hydroxyl group. The distance between the lithium cation and the hydroxyl 
oxygen is 1.97 angstroms, whereas the distance between the lithium cation and the two carbonyl 
oxygens is 1.88 and 2.04 angstroms. 
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Figure 3.3.  Optimized structures and computer modeling results for the theoretical 
determination of the electrostatic bond dissociation energies for: (a) The monopentadecanoin 
lithium adduct. The lithium cation is initially located between the carbonyl oxygen at a distance 
of 1.86 angstroms, and the 1-position hydroxyl oxygen at 1.96 angstroms. The distance to the 2-
position hydroxyl oxygen is 1.92 angstroms. The bond dissociation energy value is extracted as 
the difference in the energy from the minimum of the potential well, to the electrostatic bond 
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 distance where the charge has reached unity for the adducted ion. The BDE was calculated to be 
3.72 eV. (b) The monopentadecanoin chloride adduct. The chloride anion is between the 1-
position and 2-position hydoxyl hydrogens, each at a distance of 2.18 angstroms. The BDE was 
calculated to be 1.56 eV. 
 
The same approach was used for calculating the bond dissociation energies for chloride 
adducts of the lipids: Figure 3.3b illustrates an optimized structure, and a plot of the potential 
energy surface scans versus bond distance for the chloride adduct of monopentadecanoin. The 
chloride anion is situated nearest to the 1-position and 2-position hydroxyl hydrogens at 
distances of 2.18 angstroms and 2.18 angstroms, respectively, as would be expected due to their 
higher acidities (more electropositive hydrogens) as compared to hydrocarbon hydrogen atoms. 
Orientation of the chloride ion in close proximity to the lone hydroxyl hydrogen is found for the 
optimized structures of the 1,2- and 1,3-diacylglycerols. For the 1,2-diacylglycerol-chloride 
adduct, the distance between the hydroxyl hydrogen and the chloride ion is 2.09 angstroms, 
while for the 1,3-diacylglycerol, the distance is 2.07 angstroms. 
 
 
3.3.3 Mass Spectral Determination of Li+ and Cl- Lipid Adduct BDE’s 
The first electrostatic complex that was measured using the newly proposed derived 
effective path length approach was the cationic lithium adduct of monopentadecanoin.  In order 
to determine the thresholds for the endothermic CID reaction: 
M+L    Ar (gas)      M+ + L       (3) 
 
where M is the metal cation, L is the lipid, and Ar is the stationary target gas, the free metal 
cation M+ (m/z 7) and the precursor ion M+L (m/z 323) signals are measured at increasing 
collision energies, as are all other products formed via CID.   Figure 3.4 shows the emergence of 
the lithium cation (m/z 7) near the threshold energy for eq 3.  Figure 3.4a is the CID product ion 
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 mass spectrum obtained at 2.75 eV (ECOM), where the lithium metal cation is present only at 
noise level (S/N = 2). In Figure 3.4b, a significant peak at m/z 7 has emerged for the lithium 
cation (S/N = 6) at 3.30 eV (ECOM) indicating that the threshold energy for eq 3 has been 
acheived. The bond dissociation energy value for the lithium-monopentadecanoin adduct 
calculated from the computer modeling results illustrated in Fig. 3.3a was 3.72 eV.  This gives a 
threshold energy value that is just below the ECOM value of 3.85 eV that was used to obtain the 
CID product ion spectrum shown in Fig 3.4c. 
The appearance of decomposition products at an energy lower than the threshold energy 
for dissociation as calculated by computer modeling can be the result of a combination of factors 
which contribute to error in the direct measurement of a threshold energy value for eq 3. The 
magnitude of uncertainty in potential energy calculations at the B3LYP 6-31G* level has been 
estimated to be 3.9 kcal•mol-1, or 0.17 eV44 (mean absolute deviation). 
Uncertainty in mass spectrometrically estimating dissociation energies has been 
attributed to: (1) initial internal energy content which may lead to metastable decompositions 
(resulting in underestimation of BDE’s), (2) non-neglible translational energy at 0 eV (ELAB) 
collision energy (underestimation of BDE’s)15,16, (3) collisions outside of the reaction cell (e.g., 
in Q1)15,16 (underestimation of BDE’s), (4) instrumental bias against observation of “slow 
kinetics” reactions (overestimation of BDE’s)45, and (5) deposition of energy in competitive 
vibrational excitation modes (overestimation of BDE’s)46. Some competitive fragmentation 
reactions were observed in most of the product ion mass spectra, as illustrated in Figure 3.5.  
Figure 3.5a is the CID spectrum obtained for the decomposition of lithium adducts in the 
reaction threshold range at 3.85 eV (ECOM), illustrating a small contribution to the relative error 
in the measurement of the BDE if only the intensity of the lithium cation is used as ∑ Ip instead 
of using the actual sum of the products as ∑ IP in calculating I0 = IR + ∑ IP.  If the intensities of 
the “extraneous” products are much smaller than the precursor, then the product ion intensities 
that are not being monitored can be neglected when applying eq 12.  However, in this study it 
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Figure 3.4.  Product ion mass spectra illustrating the appearance of the lithium cation upon CID 
of the lithium-monopentadecanoin adduct near the threshold energy for dissociation. ECOM 
energies: (a) 2.75 eV, (b) 3.30 eV, (c) 3.85 eV, threshold area, and (d) 4.40 eV. 
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 was observed that many of the lipids yielded other CID fragment ions, in addition to the loss of 
the lithium cation, at abundances that could not be considered much smaller than the precursor. 
Therefore, in evaluating cross sections for each precursor adduct displayed in Fig. 3.5, product 
ion abundances for all fragmentation pathways were summed along with the transmitted 
precursor abundance when applying eq 1. 
Figure 3.5b is the product ion spectrum of the Li+ adduct of another lipid, i.e., 1-stearin,2-
palmitin diacylglycerol at 3.10 eV (ECOM). The spectrum shows a considerable number of lower 
abundance products formed during CID, in addition to the lithium cation.   Figure 3.5c also 
shows product ions in addition to the lithium cation for the CID of a third lipid, 1,3-
dipentadeacoin lipid, at 3.74 eV (ECOM).  In both the chloride adduct studies and the dimer 
dissociation studies, competitive product fragment ions were not observed and posed no problem 
as contributors to error in estimating I0.  Furthermore, the use of electrospray as the ionization 
method helps to reduce error, as only a minimal amount of internal energy is imparted to the 
complex during ionization, owing to the soft nature of the ES process (no physically imparted 
desorption/ionization energy such as laser flux or heat in MALDI). In addition, cooling collisions 
in the source region, and relaxation of the complex through the desolvation process, help to 
dissipate the low amount of internal energy initially present. 
According to the simplified version of Rice-Ramsperger-Kassel-Marcus (RRKM) 
theory47, the rate of a unimolecular decomposition is approximated by: 
k(E) = ν(E – E0/E)n-1       (4) 
where n is the number of vibrational degrees of freedom, ν is the frequency factor, E is the 
kinetic energy, and E0 is the threshold energy for reaction.  Eq 4 is directly related to the  
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Figure 3.5.  Competitive fragmentation reactions in CID of product ion mass spectra of lithium-
lipid adducts illustrating a contribution to error in the measurement of BDE’s. (a) Lithium adduct 
of monopentadecanoin in the reaction threshold range (3.85 eV ECOM).  (b) Lithium adduct of 1-
stearin,2-palmitin diacylglycerol at 3.10 eV (ECOM).  (c) Lithium adduct of 1,3-dipentadeacoin at 
3.74 eV (ECOM).  All three show a considerable array of fragmentation products.  
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 activated complex’s populated energy states. The theoretically derived mathematical function 
used to obtain a best fit of the experimentally determined cross sections, according to the 
transient energy states of the decomposing ion at the time of the dissociating collision is1,9: 
σ(E) = σ0∑gi(E + Ei – E0)n / Em     (5) 
where E and E0 remain as above, Ei represents the individual reactant states (electronic, 
rotational and vibrational) with populations gi, σ0 is a scaling factor, and n and m are adjustable 
parameters.  According to the thin target limit relationship of the reaction cross sections (σp) to 
the measured intensities in eq 1, the cross sections for the determination of the threshold energy 
for eq 3 can be calculated for each of the lithium adducts in Figs. 3.5a, b, and c.  Figure 3.6a 
shows the results of these cross section calculations at increasing collision energies, covering an 
activation energy range approximately three times that of the threshold energy region, for 
decompositions of the lithium adduct of monopentadecanoin. The cross sections (right axis) are 
related to the ratio of abundances of the product ions over all ions (left axis) through eq 1. 
Consistent with the mathematical forms of equations 4 and 5, curve fitting of the cross sections 
obtained from the mass spectrometric measurements of the BDE’s for the lithium-
monopentadecanoin electrostatic adduct, as well as all the other adducts measured, was 
empirically observed to fit an exponential growth equation of the following form: 
σP(E) = σ0exp(ECOM/α) + y0     (6) 
where σP(E) is the experimentally determined cross section in cm2, σ0 + y0 is the y-intercept of 
the fit in cm2 (for multivariate regression, y0 is insignificant enough to be neglected, see 
multivariate regression bond energy prediction section below). This equation effectively relates 
the product cross section to the system energy (supplied by the central hexapole offset) in the 
center-of-mass frame of reference. The suitability of a single exponential equation is 
 46
 serendipitous in that the ensuing multivariate regression entails fewer independent variables (as 
compared to higher order equations), allowing relative ease in deriving the polynomial equation 
used to estimate BDE values. The solid line in Figure 3.6a shows the fit of the experimentally 
determined cross sections in the threshold region of the dissociation of the lithium-
monopentadecanoin adduct, calculated using eq 6. Figure 3.6b shows the results of single 
exponential curve fitting of the cross section vs energy for the chloride adduct of 
monopentadecanoin.  Analogous calculations were made for the other two lipids, i.e., the 
diacylglycerols 1-stearin,2-palmitin diacylglycerol, and 1,3-dipentadecanoin introduced in Figs. 
3.5b and 3.5c, respectively.  Figure 3.7a shows the cross sections for the lithium adduct of 1-
stearin,2-palmitin diacylglycerol, and Figure 3.7b is a plot of the cross sections for the chloride 
adduct of 1-stearin,2-palmitin diacylglycerol, each versus collision energy.  Figures 3.8a and 
3.8b are plots of the cross sections versus collision energy for the lithium and chloride adducts, 
respectively, of 1,3-dipentadecanoin diacylglycerol.  The curves shown in Figs. 3.6-3.8 will be 
used to apply the derived effective reaction path length method to deduce BDE values for each 
compound in the following section. 
 
3.3.4 MULTIPLE REGRESSION MODEL FOR PREDICTING BDE’s 
3.3.4.1 High molecular weight BDE predictive model 
The general multivariate growth curve model (GCM-Polynomial Regression)48 was used 
to create a predictive model for bond dissociation energies involving the relatively high 
molecular weight lipid standards, using the cross section results obtained for the ES triple 
quadrupole mass spectrometer.  Single exponential cross section vs energy curves, derived as 
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Figure 3.6.  (a) Plot of the ratio of abundances of the dissociated lithium cation to the total 
product ions (IP/(IR + ∑ IP), left y-axis) in an energy range that is approximately 3 times greater 
than the expected dissociation threshold energy of 3.72 eV predicted by computer modeling.  
The reaction cross sections for the lithium adduct of monopentadecanoin, illustrated on the right 
y-axis, are calculated from the experimentally obtained ratios according to eq 1. The solid line is 
the best-fit of the experimental data using eq 6.  The bond dissociation energy for CID of the 
lithium cation was experimentally determined to be 3.69 ± 0.29 eV (ECOM). The theoretical value 
was calculated to be 3.72 eV. (b) Cross sections of the chloride adduct of monopentadecanoin. 
The bond dissociation energy was experimentally determined to be 1.65 ± 0.05 eV (ECOM) for 
CID of the chloride anion.  The theoretical value was calculated to be 1.56 eV. 
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Figure 3.7. Cross section vs collision energy for: (a) the lithium adduct of 1-stearin,2-palmitin 
diacylglycerol, with a growth curve model predicted BDE of 3.59 ± 0.18 eV (theoretical 
predicted value: 3.98 eV), (b) the chloride adduct of 1-stearin,2-palmitin diacylglycerol, with a 
growth curve predicted BDE of 1.26 ± 0.03 eV (theoretical predicted value: 1.37 eV). 
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Figure 3.8. Cross section vs collision energy for: (a) the lithium adduct of 1,3-dipentadecanoin 
diacylglycerol, with a growth curve model predicted BDE of 3.78 ± 0.39 eV (theoretical 
predicted value: 3.52 eV), (b) the chloride adduct of 1,3-dipentadecanoin diacylglycerol, with a 
growth curve predicted BDE of 1.63 ± 0.23 eV (theoretical predicted value: 1.48 eV). 
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 outlined in the previous section for each lithium and chloride adduct of the monopentadecanoin, 
dipentadecanoin, and 1-stearin,2-palmitin diacylglycerol standards, were used to create a 
multivariate curve polynomial expression that can be used to calculate BDE values for unknown 
complexes. To create the polynomial expression, the independent parameters of eq 6, σ0 and α, 
are regressed with the dependent variable represented by the BDE values (obtained from DFT 
computational methods) for each experimentally evaluated complex that had generated a single 
exponential cross section vs energy curve.  Analysis of the variance gave an adjusted regression 
factor of 0.928, and a probability factor of < 0.0001, demonstrating the statistical significance of 
the multivariate growth curve model. The model resulted in the following general second order 
polynomial descriptive equation that was subsequently used to predict the bond dissociation 
energies of the higher molecular weight (e.g., m/z 300 to 700) adducts: 
BDE (eV) = 0.78051 – 1.7180x1013σ0 + 1.4627α - 0.16327α2        (7) 
To use this equation to predict a BDE for an unknown complex, it is first necessary to generate a 
single exponential cross section vs energy curve that will provide values for the σ0 and α 
parameters. Table 3.1 is a compilation of the results obtained from the newly developed single 
exponential cross section vs energy method, juxtaposed against the theoretical computer 
modeling method, and where applicable, the “50% dissociation of dimers” method (see “Mass 
Spectral Determination of Li+ Lipid Dimer Adduct BDE’s” section below).  Also included in the 
table are the theoretical charges and closest electrostatic bond distances of either the lithium ion, 
or the chloride ion, for the computationally optimized structures of the complexes.  The cationic 
lithium adducts, the anionic chloride adducts, and the dimers are relatively large systems, 
spanning molecular weights from 323 Da to 603 Da, that contain substantial numbers of 
vibrational degrees of freedom.  This is reflected in the magnitude of observed coefficients of 
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 variation (CV) for the studied systems such as 7.6% for the lithium adduct of 
monopentadecanoin, 10.5% for the lithium adduct of dipentadecanoin diacylglycerol, and 4.8% 
for the lithium adduct of 1-stearin,2-palmitin diacylglycerol.  Overall, excellent agreement is 
observed between the theoretical BDE’s obtained from computational molecular modeling, and 
those obtained by the multivariate growth curve fitting method using one second order 
polynomial (eq 7) to evaluate all three types of complexes (Table 3.1).  The relative uncertainty 
of the experimentally determined bond dissociation energies using this method is approximated 
to be ± 7%, while absolute uncertainties are estimated to range between 10 and 20%.  Rodgers et 
al.8, reported cross section absolute uncertainties of ± 20%, and relative uncertainties of ± 5% for 
their guided ion beam mass spectrometer.  The variation in their cross section measurements was 
attributed to errors in gas cell pressure measurements, and errors in estimating interaction region 
lengths.  In the method reported here, gas cell pressure uncertainty still exists, but the calculation 
of an effective reaction path length is believed to reduce the magnitude of the path length error’s 
contribution to uncertainty in BDE estimations.   
  
3.3.4.2 Low molecular weight BDE predictive model 
The general multivariate growth curve model (GCM-Polynomial Regression) was used to 
evaluate bond dissociation energies of adducts of relatively low molecular weight solvent 
standards, using the ES triple quadrupole mass spectrometer cross section results according to 
the procedure outlined above. It was found that the regression and probability factors were much 
improved when high molecular weight compounds were regressed separately from low 
molecular weight compounds. For this reason, a separate general second order polynomial 
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 Adduct Theoretical 
BDE 
(eV) 
Measured BDE 
(eV) 
Charge 
on 
Li+ or Cl-
Electrostatic 
bond Distance 
of 
Li+ or Cl-
(angstroms) 
Li+ monopentadecanoin 3.72 3.69 ± 0.29 +0.628 1.9 
Cl- monopentadecanoin 1.56 1.65 ± 0.05 -0.777 2.2 
Li+ monopentadecanoin Dimer NAc 1.43 ± 0.04 (exp)a
or 
1.31 ± 0.32 (50%)b
+0.527 NAc
Li+ 1,3-dipentadecanoin 3.52 3.78 ± 0.39 +0.669 1.9 
Cl- 1,3-dipentadecanoin 1.48 1.63 ± 0.23 -0.845 2.1 
Li+ 1,3-dipentadecanoin Dimer NAc 1.43 ± 0.01 (exp)a 
or  
0.90 ± 0.09 (50%)b
+0.595 NAc
Li+ 1-stearin-2-palmitin 
glycerol 
3.98 3.59 ± 0.18 +0.579 1.9 
Cl- 1-stearin-2-palmitin 
glycerol 
1.37 1.26 ± 0.03 -0.836 2.1 
Li+ 1-stearin-2-palmitin 
glycerol Dimer 
NAc 1.38 ± 0.01 (exp)a 
or  
1.16 ± 0.07 (50%)b
NAc NAc
aExperimental BDE obtained from the newly developed single exponential cross section vs 
energy method. 
bExperimental BDE obtained from 50% dissociation as illustrated in Figure 3.10. 
c NA: Not analyzed, computational BDE not reported. 
 
Table 3.1.  Calculated (theoretical) BDE values, charges on Li+ or Cl-, and distances obtained 
using the Becke-style 3-Parameter Density Functional Theory.  The measured BDE values were 
extracted from the plotted results of cross sections versus center-of-mass energies, obtained by 
tandem mass spectrometry.  
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 descriptive equation was used to predict the bond dissociation energies of the low molecular 
weight (e.g., m/z 30-100) adducts: 
BDE (eV) = -4.22589 – 9.83647x1015*σ0 + 14.3319*α +2.20399x1031*σ02 – 7.43328*α2       
(8) 
Table 3.2 is a compilation of the results obtained from the newly developed single exponential 
cross section vs energy method using eq 8 to predict the BDE’s.  Overall, excellent agreement 
between the literature BDE’s and the single exponential cross section vs energy method is 
observed for the low molecular weight complexes studied, as illustrated in Table 3.2. 
 
 
Adduct Reference BDE 
(eV) 
Model Fit BDE 
(eV) 
CH3OHLi+ 1.596 (0.083)9 1.57 ± 0.08 
ACNLi+ 1.46843 1.60 ± 0.15 
DMSOLi+ 2.3643 2.44 ± 0.12 
DMFLi+ 2.4343 2.20 ± 0.09 
C2H5OHLi+ 1.70 (0.08)9 1.72 ± 0.06 
CH3OCH3Li+ 1.71 (0.11)9 1.68 ± 0.18 
 
Table 3.2.  Comparison of the model fitted results for the low molecular weight lithium adduct 
standards versus the measured BDE calculated from growth curve multivariate regression 
models from the single exponential cross section vs energy method, obtained by ES triple 
quadrupole tandem mass spectrometry. Parentheses represent uncertainties in the BDE values. 
 
 
3.3.5 Mass Spectral Determination of Li+ Lipid Dimer Adduct BDE’s 
The primary method used for the CID tandem mass spectrometric determination of BDE 
values for dimers is to equate the point of 50% dissociation, measured as ML/(ML + M2L), to the 
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 center-of-mass collision energy11,39.  All of the lipids that were used in the current study (i.e., the 
monoacylglycerol, the 1,2-diacylglycerol, and the 1,3-diacylglycerols), have been observed to 
form lithium-bound noncovalent dimers of the form [M2Li]+.  Using the high molecular weight 
growth model developed for our triple quadrupole, the energy for the dissociation of the 
monopentadecanoin dimer was measured to be 1.43 ± 0.04 eV.  Figure 3.9a shows the results of 
the mass spectrometric determination of the BDE for the lithium-bound monopentadecanoin 
dimer in the range of the threshold energy for dissociation.  Figure 3.9b plots the experimentally 
determined cross sections versus collision energy for the dissociation of the 1,3-dipentadecanoin 
lithium bound dimer.  The growth curve model yields a dissociation energy of 1.43 ± 0.01 eV for 
the 1,3-dipentadecanoin lithium-bound dimer.  Figure 3.9c presents the results of the 1-stearin,2-
palmitin diacylglycerol lithium-bound dimer dissociation with an estimated BDE value of 1.38 ± 
0.01 eV. 
Figure 3.10a is a plot of the ratio of the product ion abundance (from the dissociation of 
the monoacylglycerol dimer) over the total ion abundance (to approximate the precursor ion 
abundance), MLi+ / (MLi+ + M2Li+).  The BDE’s for the different dimer systems were obtained 
by fitting 4th order polynomials to the MLi+ / (MLi+ + M2Li+) ratio data versus collision energy, 
setting the fitted polynomial equal to 0.50, and then solving for the roots.  Inspection of the roots 
always gave an obvious choice as to the BDE for the dimer system being studied.  For 50% 
dissociation of the monopentadecanoin dimer an ECOM of 1.31 ± 0.32 eV was experimentally 
required (growth curve model predicted a BDE = 1.43 ± 0.04 eV).  Figure 3.10b is a plot of the 
ratio of the product ion from the dissociation of one of the 1,3-diacylglycerol dimers over the 
parent ion intensity, MLi+ / (MLi+ + M2Li+).  For 50% dissociation, an ECOM of 0.90 ± 0.09 eV 
was needed (growth curve model predicted a BDE = 1.43 ± 0.01 eV).  Figure 3.10c is the plotted 
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 results of the 1- stearin,2-palmitin diacylglycerol lithium bound dimer, with a 50% dissociation 
ECOM value of 1.16 ± 0.07 eV (growth curve model predicted a BDE = 1.38 ± 0.01 eV). The 
experimentally obtained energy values corresponding to 50% dissociation are fairly close to the 
growth curve model predicted BDE’s (Table 3.1). The former may be slightly lower owing to 
specific issues leading to underestimation of BDE’s as previously discussed. 
 
3.4 CONCLUSIONS 
An important aspect of accurately determining bond dissociation energies by CID mass 
spectrometry is the measurement of a gas-phase reaction cell path length.  The newly developed 
“derived effective reaction path length” method described here does not require extensive 
calculations of degrees of freedom, vibrational states, etc., which can be quite cumbersome for 
very large molecular weight systems.  Unlike previous approaches, the method bases the 
determination of the reaction path length on data obtained from the CID reactions of known 
standards. Moreover, it can be implemented on standard commercial tandem mass spectrometers 
such as the triple quadrupole. By deriving an effective reaction path length using known 
standards, an empirically “error corrected” collision cell length is made available for use in the 
ensuing cross section/BDE calculations, and the error associated with reaction path length 
assignment is decreased.  This reduction in uncertainty combined with the fact that electrospray 
can effectively transfer a solution phase complex into the gas phase with minimal energy uptake 
and perturbation of the complex, make the study of adducts by the derived effective reaction path 
length approach attractive. We have further built upon the derived effective reaction  
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 Figure 3.9. Cross section vs collision energy for: (a) the lithium-bound monopentadecanoin 
dimer.  The BDE of 1.43 ± 0.04 eV (ECOM), for dimer dissociation was obtained from the 
exponential growth curve model, (b) the lithium-bound 1,3-dipentadecanoin dimer.  The growth 
curve model yielded a dissociation energy of 1.43 ± 0.01 eV, (c) the lithium-bound 1-stearin,2-
palmitin diacylglycerol dimer, yielding a BDE value of 1.38 ± 0.01 eV. 
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Figure 3.10. Ratio of MLi+ to (MLi+ + M2Li+) for the CID of lithium-bound dimers of: (a) 
monopentadecanoin.  The BDE extracted from the point of 50% dissociation gives a value of 
1.31 ± 0.32 eV ECOM (exponential growth curve model predicted 1.43 ± 0.04 eV). (b) 1,3-
dipentadecanoin. At 50% dissociation, the BDE was measured to be 0.90 ± 0.09 eV (growth 
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 curve model predicted 1.43 ± 0.01 eV). (c) 1-stearin,2-palmitin diacylglycerol with a 50% 
dissociation energy value of 1.16 ± 0.07 eV (growth curve model predicted 1.38 ± 0.01 eV). 
 
path length and introduced a single exponential cross section vs energy method to enable the 
estimation of BDE’s for relatively high molecular weight compounds. While the newly 
developed methodology has been rigorously tested on a triple quadrupole that uses a central 
hexapole collision cell, we see no reason that the method could not be applied to a Q-ToF, or any 
other instrumental configuration employing a floated collision cell under user control. 
Density functional theory calculations of BDE’s allowed a comparison with BDE’s 
obtained using the derived effective reaction path length approach and subsequent curve fitting 
procedures; excellent agreement was observed for all of the lipid adducts and dimers studied.  
The monoacyl, 1,2- and 1,3-diacylglycerols, had very similar bond energies for the adducted 
lithium (3.5 eV to 4.0 eV), and adducted chloride (1.4 eV to 1.6 eV) ions.  This study 
demonstrates that the derived effective reaction path length approach can be used for cationic 
and anionic adducted compounds, for dimers, and for larger molecular weight complex systems 
such as lipids. 
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3.6 APPENDIX 1 
Derived effective path length calculation 
Using the three following values for the BDE determination of the lithium adduct of DMSO: 
number gas density, n = 3.14 x 1012 cm-3
IP/(IR + ∑ IP) = 1.879 x 10-3
product cross section, σP = 2.878 x 10-16 cm2
The unit cell path length can be calculated using the following thin target limit relationship: 
IP/I0 = IP/(IR + ∑ IP) = σPn l 
rearranged into the form: 
l = [IP/(IR + ∑ IP)]/σPn 
l = (1.879 x 10-3)/( 2.878 x 10-16 cm2)( 3.14 x 1012 cm-3) 
l = 2.08 cm 
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 CHAPTER IV:  DETERMINATION OF APPARENT THRESHOLD ENERGIES OF 
LITHIATED ACYLGLYCEROLS USING TANDEM MASS SPECTROMETRY AND A 
NOVEL DERIVED EFFECTIVE REACTION PATH LENGTH APPROACH 
 
4.1 Introduction 
 
Electrospray [1-3] tandem mass spectrometry (ES-MS/MS) is a well established and 
powerful analytical tool for compound identification and structural elucidation [4-6].   
Employing collision-induced dissociation (CID) [7] tandem mass spectrometry, a wide range of 
mass spectrometers have been used to study thermochemistry in the gas phase such as that of 
non-covalent receptor-ligand complexes by electrospray triple quadrupole [8-10], non-covalent 
bond dissociation energy studies by guided ion beam tandem mass spectrometry [11-19], critical 
energies for ion dissociation by quadrupole ion trap [21] or flowing afterglow-triple quadrupole 
[22, 23], reaction enthalpies and ion-ligand bond energies by electrospray triple quadrupole [24, 
25], and binding energies from gas phase ion-equilibrium [26] studies by electrospray triple 
quadrupole [27-28].  For structural elucidation by triple quadrupole tandem mass spectrometry, 
the precursor ion of interest is isolated by the first quadrupole acting as a mass filter, subjected to 
collision induced dissociation in the rf-only second quadrupole (actually hexapole), and finally 
the product ions are scanned in the third quadrupole.  Typically, collision energy and collision 
cell gas pressure are chosen to achieve 20 - 70% attenuation of the precursor ion abundance, and 
the products from the collision induced fragmentation are thereby formed under multiple 
collision conditions. However, in energy-resolved mass spectrometry studies [29-36] where the 
specific kinetics of the fragmentation pathways are of interest, single collision conditions (~10% 
attenuation of precursor) are employed in the triple quadrupole, and multiple spectra are obtained 
at increasing activation energies controlled by the energy offset of the central hexapole.  During 
energy-resolved mass spectrometry studies, a wealth of information is being collected which can 
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 be used to qualitatively describe the unimolecular fragmentation pathways through the use of 
breakdown graphs, where the percentage of the total abundance for each product ion is plotted 
versus collision energy.  One quantitative aspect of the breakdown graphs is the comparative 
abundances of the product ions at specific collision energies.  A higher relative product ion 
abundance, expressed as the percentage of total ions measured, equates to a more favored 
reaction pathway at that energy as compared to other product ions under the same condition.  
The collection of spectra at incrementally increasing energy offset allows for the calculation and 
graphing of branching ratios [37], and product cross sections.  The product cross sections of 
unimolecular reactions are directly related to the activation energies required for dissociation 
according to the Rice-Ramsperger-Kassel-Marcus (RRKM) theory [38] of unimolecular 
reactions which occur during fragmentation studies employing CID.  Our previous work, taking 
advantage of the thin target limit relationship to collision cross sections [12], resulted in the 
development of a predictive model for bond dissociation energies of alkali metal or halide ion 
adducts [39], where only the simple dissociation of the alkali metal cation or halide anion was 
considered. In the current work, we have extended this new model by applying it to the 
description of covalent bond dissociation energies (apparent threshold energies, ∆E0) involved in 
the unimolecular fragmentations of lithiated acylglycerols. 
 
4.2 Experimental 
4.2.1 Materials and Methods 
Methanol and chloroform solvents were of HPLC/spectroscopy grade and were 
purchased from EM Science (Darmstadt, Germany).  Monopentadecanoin and 1,3-
dipentadecanoin were obtained from Nu-Chek Prep, Inc. (Elysian, MN), with stated purities of > 
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 99%.  1-Stearin-2-palmitin diacylglycerol was purchased from Larodan Fine Chemicals AB 
(Malmo, Sweden), with stated purity of 99%. Lithium chloride was ACS grade in granular form 
from J. T. Baker Inc. (Phillipsburg, NJ).  All standards were used as received without further 
purification. 
 
4.2.2 Instrumentation 
Mass spectra were obtained using a “triple quadrupole” (actually quadrupole-hexapole-
quadrupole, QhQ) mass spectrometer (Micromass, Inc., Manchester, UK, model Quattro II) 
equipped with an electrospray source operating at typical sample solution flow rates of 2-4 
µL/min.  Nitrogen was used as both nebulizing and drying gas. Typical cone voltage was 40 V 
for CID of the lithium adducts of the acylglycerols. The ES capillary voltage was held at 2.5 to 
3.5 kV. Argon was used as collision gas during CID experiments at collision gas pressures of 
approximately 1.3 x 10-4 mBar (measured externally to the central hexapole collision cell) to 
obtain the single collision conditions employed in all experiments. The hexapole offset energy 
values range from 0 eV up to 250 eV with a minimum increment of 1 eV (ELAB).  MassLynx 
software (Micromass) was used to acquire, process, and store mass spectral data.  
 
4.2.3 Apparent threshold energy predictive model 
A typical experiment consists of collecting a product ion spectrum at 0 eV (ELAB), as set 
by the energy offset of the central hexapole, followed by sequentially collecting spectra at 
increasing offset values in 1 eV (ELAB) increments. Most experiments employed collision energy 
values ranging from 0 eV up to 200 eV (ELAB). The supplied energy for the collision is converted 
from the laboratory (LAB) frame of reference to the center-of-mass (COM) frame of reference 
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 according to ECOM = ELAB(m/(m + M)), where ELAB is the measured offset for the central 
hexapole, m is the mass of the stationary target Ar atom, and M is the mass of the analyte.  Using 
the thin target limit relationship [12]: 
IP/I0 = IP/(IR + ΣIP) = σPnl   (1) 
where IP is the transmitted product ion abundance, IR is the transmitted reactant ion abundance, I0 
is the incident (precursor) ion abundance, σP is the product cross section (cm2), n is the number 
gas density (cm-3), and l is the collision cell path length (cm), individual product cross sections 
can be obtained for each product ion at a specified collision energy.  The product cross sections 
are plotted versus the collision energy, in the center-of-mass frame of reference, and the 
following exponential growth equation: 
σP(E) = σ0exp(ECOM/α) + y0     (2) 
is fit to the data in the threshold activation energy range for product ion formation, between 
approximately 0.06 - 4 eV (ECOM).  The parameters of the fitted curve are then used in the 
following general multivariate growth curve model (GCM-Polynomial Regression) [40] 
developed for the triple quadrupole in our laboratory [39]: 
BDE (eV) = 0.78051 – 1.7180x1013σ0 + 1.4627α - 0.16327α2  (3) 
to calculate the apparent bond dissociation energy from unimolecular fragmentation for that 
particular product ion. 
 
4.3 Results and Discussion 
4.3.1 Apparent threshold energies for lithiated mono-pentadecanoin 
The first monoacylglycerol that the derived effective reaction path length approach for 
the measurement of apparent threshold energies was applied to was the lithium adduct of mono-
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 pentadecanoin.  Figure 4.1a is a product ion spectrum of the collisionally activated 
monopentadecanoin lithium adduct, collected at 40 eV (ELAB) under single collision conditions, 
showing the major fragments produced during unimolecular dissociation.  There are four major 
product ions produced, and their assignments are presented in Figure 4.1b.  The m/z 99 product 
ion is the result of the neutral loss of the C15 fatty acyl chain as a ketene from the precursor ion, 
and it is the most abundant ion in the spectrum.  The m/z 81 and m/z 63 ions are produced from 
one water loss, and two water losses, respectively, from the m/z 99 product ion.  The m/z 57 ion 
is the result of LiOH loss from the m/z 81 ion, as depicted in Figure 4.1b, with a potential minor 
contribution from the fragmentation pathway which produces the hydrocarbon series CnH2n+1+ (n 
= 4).  Over a wide range of collision energies, the “% Total Ion Abundance” of the four product 
ions follows the trend: m/z 99 > m/z 81 > m/z 63 > m/z 57, as is visually apparent in the 
breakdown graph presented in Figure 4.2.  For these energy-resolved determinations, CID 
spectra acquired were under single collision conditions; therefore the % Total Ion Abundances 
for the product ion fragments are very low.  The precursor % Total Ion Abundance was also 
plotted (but note the discontinuity in the y-axis) to further contrast the precursor vs product ion 
abundances during these experiments. 
It is known from the theory of unimolecular ion decompositions [38] that the bond with 
the lowest critical energy for dissociation is not always the one to rupture at each respective 
internal energy state.  This arises due to kinetic considerations in enthalpy driven reactions where 
the energy barrier required to cleave a given bond may be lowered due to simultaneous 
formation of new bonds during the fragmentation process, thus resulting in a more abundant 
product ion at a certain internal energy state.  Moreover, fragment ions produced from a “loose 
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Figure 4.1. (a) Product ion spectrum of the collision activated monopentadecanoin lithium 
adduct, collected at 40 eV (Lab). Major fragments produced: (1) m/z 99 from the neutral loss of 
C15 fatty acyl chain as ketene, producing lithiated glycerol, (2) m/z 81 produced by water loss 
from m/z 99, (3) m/z 63 produced by two water losses from m/z 99, and (4) m/z 57 formed by 
loss of LiOH from m/z 81, and from part of the CnH2n+1+ hydrocarbon series from the fatty acid 
acyl chain. (b) Fragmentation pathways, structures, apparent threshold energies, and % Total Ion 
Abundance for the four major product ions formed from CID of lithiated mono-pentadecanoin.  
 67
 The m/z 99 ion is the result of the neutral loss of C15 fatty acyl chain as ketene from the 
precursor ion, and is the most abundant ion in the spectrum, at an apparent threshold energy of 
2.87 ± 0.14 eV (ECOM).  The m/z 81 and m/z 63 ions are produced from one water loss, then two 
water losses, respectively. The m/z 81 ion has the lowest threshold energy at 1.74 ± 0.27 eV 
(ECOM).  The m/z 57 ion is formed primarily by LiOH loss from the m/z 81 ion. 
 
 
complex” state are often observed at higher threshold energies than those formed from “tight 
complexes” because the later more often benefit from stabilization of the transition state owing 
to new bond formation.  But decomposition reactions that proceed through “tight complexes” 
have unfavorable entropic factors, hence, they are disfavored in cases where substantial amounts 
of excess energy are present, and insufficient time is available for the tight complex to form. 
Our predictive model for calculating apparent threshold energies for the fragmentation 
pathways from the energy-resolved mass spectral data gives a new quantitative aspect to describe 
the product ions produced from CID experiments.  As can be deduced from Figure 4.1b, the % 
Total Ion Abundance calculated at a given collision energy (at saturation, i.e. 7 eV, ECOM) are not 
inversely related to the apparent threshold energies (∆E0).  This indicates that some of the 
product ions are produced through secondary or competitive processes.  If a closer look is taken 
at the apparent threshold energies, it can be noted that the production of the m/z 81 ion, ∆E0 = 
1.74 ± 0.27 eV (ECOM) is the most enthalpy favored process compared to the other three product 
ion pathways.  This is followed by the m/z 63 ion at ∆E0 = 2.10 ± 0.36 eV (ECOM), the m/z 57 ion 
at ∆E0 = 2.24 ± 0.13 eV (ECOM), and finally the m/z 99 ion at ∆E0 = 2.87 ± 0.14 eV (ECOM).  
Clearly from a % Total Ion Abundance of 15.52%, the m/z 99 product ion has a much greater 
rate of formation than the other three product ions at elevated collision energies, suggesting that 
the m/z 99 product ion is the most entropically favored fragmentation pathway. 
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Figure 4.2. Energy-resolved breakdown graph for the dissociation of the lithiated mono-
pentadecanoin diacylglycerol. The % Total Ion Abundances are very low due to collection under 
single collision conditions. The precursor % Total Ion Abundance is included in the plot to 
illustrate the small percentage losses during these experiments. % Total Ion Abundances appears 
to follow the trend of m/z 99 > m/z 81 > m/z 63 > m/z 57.  
 
 
 
From the breakdown graph an additional interesting pathway description is observed. At 
lower collision energies, the m/z 63 product ion is slightly favored compared to the m/z 81 
product ion, suggesting a very initial favored pathway (due to stearic arrangement?), but is 
quickly overcome by the m/z 81 product ion, which has a considerably lower apparent reaction 
enthalpy, overall. 
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 4.3.2 Apparent threshold energies for lithiated 1-stearin,2-palmitin diacylglycerol 
The lithium adduct of diacylglycerol 1-stearin,2-palmitin was the next to be studied using 
energy-resolved mass spectra.  The product ion spectrum of the collision induced dissociation of 
1,2-diacylglycerol is shown in Figure 4.3a, at a collision energy of 50 eV (ELAB).  The spectrum 
shows a number of lower molecular weight fragment ions from approximately m/z 43 to m/z 
123, and higher molecular weight product ions ranging from m/z 257 to m/z 365.  The latter 
higher molecular weight range contains 7 product ions, which are assigned in Figure 4.3b.  All 7 
of these higher mass product ions appear to have plausible fragmentation pathways that do not 
arise from consecutive dissociations. The proposed mechanisms each constitute a single 
dissociation involving one H-transfer in concert with cleavage to produce the array of product 
ions listed in Figure 4.3b. 
In contrast to the product ions of the lithium adduct of mono-pentadecanoin presented, 
the product ions from 1-stearin,2-palmitin diacylglycerol dissociations appear in % Total Ion 
Abundances have that are inversely related to the apparent threshold energies.  Table 4.1 is a 
listing of the apparent threshold energies versus % Total Ion Abundance, which more clearly 
shows the inverse relationship.  For this set of fragmentation pathways, except for a slight 
anomaly for the last ion (m/z 365), a lower threshold energy equates to a higher % Total Ion 
Abundance. 
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Figure 4.3. (a) Product ion spectrum of the collision induced dissociation of lithiated 1-stearin,2-
palmitin diacylglycerol, at collision energy of 50 eV (Lab).  Lower molecular weight fragment 
ions appear from approximately m/z 43 to m/z 123, primarily representing the hydrocarbon 
series CnH2n+1+ from σ-bond fatty acyl chain cleavage. Higher molecular weight product ions 
ranging from m/z 257 to m/z 365 produced from single cleavage reactions of fatty acyl loss in 
several forms (fatty acyl chain as ketene, lithium fatty acetate, and fatty acid). (b) Fragmentation 
 71
 pathways, structures, apparent threshold energies, and % Total Ion Abundance for the high 
molecular weight range product ions produced from the CID of 1-stearin,2-palmitin, ranging 
from m/z 257 to m/z 365.  Paired products include the neutral loss of C18 and C16 lithium fatty 
acetate at m/z 313 and m/z 341, and neutral loss of C18 and C16 fatty acid at m/z 319 and m/z 
347. M/z 365 is formed by the neutral loss of C16 fatty acyl chain as ketene.  Fragmentation 
ranking of: loss of lithium fatty acetate > loss of fatty acid > loss of fatty acyl ketene. 
 
 
 
Product ion 
(m/z) 
% Total Ion 
Abundance 
(%) 
Apparent 
Threshold Energy 
(∆E0, eV) 
Cross Section 
(cm2) 
313 4.74 1.35 ± 0.13 7.74 x 10-13
341 3.23 1.60 ± 0.13 5.28 x 10-13
319 2.38 1.66 ± 0.15 3.90 x 10-13
347 1.77 1.79 ± 0.16 2.90 x 10-13
263 1.01 1.97 ± 0.26 1.65 x 10-13
291 0.99 2.26 ± 0.01 1.62 x 10-13
365 0.82 2.02 ± 0.11 1.34 x 10-13
 
Table 4.1. % Total Ion Abundances, apparent threshold energies, and cross sections of high 
molecular weight product ions for the lithium adduct of 1-stearin,2-palmitin diacylglycerol.  
 
 
Figure 4.4a is the breakdown graph of the higher molecular weight product ions, which also 
illustrates that each fragmentation pathway increases in product ion intensity, in a roughly 
similar pattern, with increasing collision energy, i.e., little curve crossing occurs. The fact that 
 72
 curves in Fig. 4.4a do not cross indicates that the relative importance of entropic vs enthalpic 
factors which govern the rates of decomposition for each process, does not change substantially 
as higher internal energy uptake is achieved.  The m/z 313 product ion has the greatest 
abundance as seen in the breakdown graph, followed by the m/z 341 ion.  As illustrated in Figure 
4.3b, the structures of these two product ions are related in that both have lost a neutral lithium 
fatty acetate molecule.  As has been observed previously in our laboratory [41], the loss of the 1-
position substituent giving rise to the m/z 313 product ion is the favored pathway, a conclusion 
which the current studies also support.  As noted above, the m/z 313 product ion has the lowest 
apparent threshold energy at 1.35 ± 0.13 eV (ECOM), followed by the m/z 341 product ion at 1.60 
± 0.13 eV (ECOM).   
In summary then, for the losses involving the fatty acid substituents from this 
diacylglycerol, the pair of product ions with the highest abundances, and lowest apparent 
threshold energies, are from the neutral loss of the lithium fatty acetates at m/z 313 and m/z 341.  
The next most abundant pair, with somewhat higher apparent threshold energy product ions 
observed are from the neutral loss of the fatty acid substituent (acid form) at m/z 347 and and 
m/z 319.  Third in this fatty acid loss series, with the lowest abundance, and highest apparent 
threshold energy, is the neutral loss of the fatty acyl chain as ketene at m/z 365, suggesting the 
following favored fragmentation pathway neutral loss ranking of: loss of lithium fatty acetate > 
loss of fatty acid  > loss of fatty acyl chain as ketene. 
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igure 4.4. Breakdown graph of: (a) the higher molecular weight product ions from CID of 1-
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F
stearin,2-palmitin.  Fragmentation pathways arise primarily from losses of fatty acid substituents 
in the form of fatty acyl chain as ketene, lithium fatty acetate, and fatty acid. All increase in 
product ion intensity in a similar pattern for increasing collision energy.   (b) The lower 
molecular weight product ions from CID of 1-stearin,2-palmitin. Peak series m/z 43, m/z 57, m/z 
71, m/z 85, m/z 99 result from alkyl chain fragmentation through σ-bond cleavage of the fatty 
acid hydrocarbon chains producing the series CnH2n+1+. 
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 The breakdown graph of the lower molecular weight product ions is illustrated in Figure 
4.4b; the corresponding apparent threshold energies are listed in Table 4.2.  Often, low molecular 
weight product ions in the m/z 43 to 127 region are the result of alkyl chain fragmentation 
through σ-bond cleavage of the fatty acid hydrocarbon chain producing the series CnH2n+1+.  In 
the product ion spectrum in Figure 3a, the hydrocarbon series from σ-bond cleavages of the fatty 
acid alkyl chain consists of m/z 43, m/z 57, m/z 71, m/z 85, and m/z 99.  The m/z 57 product ion 
has the highest % Total Ion Abundance at 15.96%, and the lowest apparent threshold energy at 
1.35 ± 0.26 eV (ECOM).  Analogous to the fragmentation of the mono-pentadecanoin acylglycerol 
in Figure 4.1b, the m/z 57 product ion may also be formed through a multi-step process requiring 
first, losses of both fatty acyl chains to form m/z 99, then loss of water, followed finally by loss 
of LiOH.  Thus, two processes may be responsible for formation of the m/z 57 product ion 
resulting in the observance of a greater abundance, and lower apparent threshold energy.  Also 
included in the low molecular weight series are the m/z 81 and m/z 63 product ions from the 
losses of one, and then two waters, respectively, from the lithiated glycerol backbone, in a 
manner analogous to the pathways illustrated in Figure 4.1b. 
 
4.3.3 Reaction enthalpies for lithiated 1,3-dipentadecanoin 
Figure 4.5a is a product ion spectrum for the collision induced dissociation of lithiated 
1,3-dipentadecanoin, acquired at 60 eV (ELAB). Similar to the 1-stearin,2-palmitin diacylglycerol 
CID spectrum, the 1,3-dipentadecanoin produces low molecular weight product ions ranging 
from m/z 29 to m/z 99 by the same processes that were 
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Mono-pentadecanoin 
1-stearin,2-palmitin 
diacylglycerol 
 
1,3-dipentadecanoin 
Product ion 
(m/z) 
Abund. 
(%) 
∆E0
(eV) 
Abund. 
(%) 
∆E0
(eV) 
Abund. 
(%) 
∆E0
(eV) 
43 ----- ----- 3.54 1.78 ± 0.03 2.36 1.87 ± 0.30 
57 1.13 2.24 ± 0.13 15.96 1.35 ± 0.26 8.16 1.69 ± 0.10 
63 2.24 2.10 ± 0.36 5.43 1.71 ± 0.03 3.30 1.68 ± 0.19 
71 ----- ----- 10.24 1.55 ± 0.09 5.08 1.53 ± 0.07 
81 3.50 1.74 ± 0.27 3.54 1.87 ± 0.18 5.07 1.51 ± 0.26 
85 ----- ----- 7.46 1.70 ± 0.05 3.34 1.70 ± 0.15 
95 ----- ----- 3.63 1.88 ± 0.05 1.48 1.65 ± 0.35 
99 15.52 2.87 ± 0.14 1.84 2.07 ± 0.35 2.16 1.62 ± 0.15 
 
 
Table 4.2. % Total Ion Abundance and apparent threshold energy for the lithium adduct of 
mono-pentadecanoin acylglycerol, 1-stearin,2-palmitin diacylglycerol, and 1,3-dipentadecanoin. 
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∆E0 = 2.30 ± 0.33 eV 
% Total Ion Abund = 0.82% 
∆E0 = 2.10 ± 0.44 eV 
% Total Ion Abund = 0.91% 
∆E0 = 1.97 ± 0.21 eV 
% Total Ion Abund = 1.25% 
∆E0 = 1.79 ± 0.21 eV 
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∆E0 = 1.66 ± 0.24 eV 
% Total Ion Abund = 3.13%
Figure 4.5. (a) Product ion spectrum of the collision induced dissociation of lithiated 1,3-
dipentadecanoin, collected at 60 eV (ELAB). Low molecular weight product ions ranging from 
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 m/z 29 to m/z 99 expressed by the hydrocarbon series CnH2n+1+ produced from σ-bond fatty acyl 
chain cleavage.  Higher molecular weight range of m/z 249 to m/z 323 produced from single 
cleavage reactions of fatty acyl loss in several forms (fatty acyl chain as ketene, lithium fatty 
acetate, and fatty acid). (b) Fragmentation pathways, structures, apparent threshold energies, and 
% Total Ion Abundance for the high molecular weight range product ions produced from the 
CID of 1,3-dipentadecanoin, ranging from m/z 249 to m/z 323. Neutral loss of fatty acyl chain as 
ketene at m/z 323 contains the highest abundance, and lowest threshold energy. This is followed 
by neutral loss of lithium fatty acetate at m/z 299, then neutral loss of the fatty acid at m/z 305. 
Fragmentation ranking of: loss of fatty acyl ketene > loss of lithium fatty acetate > loss of fatty 
acid.  The m/z 289 product ion is produced from the consecutive neutral losses of H2O followed 
by C15:1 alpha-beta unsaturated fatty acid. 
 
 discussed above.  In the higher molecular weight range of m/z 249 to m/z 323, 5 principle 
product ions are observed. Similar to 1,2-diacylglycerol described above, these product ions also 
are formed primarily through single cleavages of a fatty acid substituent with concomitant H-
transfer resulting in the losses of various neutrals, such as loss of the fatty acyl chain as a ketene, 
loss of lithium fatty acetate, and loss of fatty acid (acid form).  Figure 4.5b depicts assignments 
for the product ions along with their respective % Total Ion Abundances and apparent threshold 
energies.  Similar to the 1-stearin,2-palmitin diacylglycerol example there is an inverse 
relationship observed between % Total Ion Abundance and apparent threshold energy, as listed 
in Table 4.3.  Among the competitive decomposition processes, the product ion with the highest 
abundance, and lowest threshold results from the neutral loss of the fatty acyl chain as a ketene at 
m/z 323.  The next highest abundance, slightly higher threshold energy product ion observed is 
from the neutral loss of lithium fatty acetate at m/z 299.  Third in this fatty acid loss series, with 
the next highest abundance, and even higher reaction threshold, is the neutral loss of the fatty 
acid substituent at m/z 305, suggesting the following ranking favored of fragmentation pathways: 
neutral loss of fatty acyl chain as ketene > neutral loss of lithium fatty acetate > neutral loss of 
fatty acid.  The m/z 289 product ion is produced from the consecutive neutral losses of H2O 
followed by C15:1 alpha-beta unsaturated fatty acid (this order was established by precursor scan 
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 inspection of m/z 289 [41]), thus resulting in the lowest % Total Ion Abundance, and highest 
apparent threshold energy up to this point.  Figure 4.6a is the breakdown plot for formation of 
the higher molecular weight product ions which graphically illustrates the observed % Total Ion 
Abundances vs collision energy. 
 
 
Product ion 
(m/z) 
% Total Ion 
Abundance 
(%) 
Apparent 
Threshold Energy 
(∆E0, eV) 
Cross Section 
(cm2) 
323 3.13 1.66 ± 0.24 5.11 x 10-13
299 2.06 1.79 ± 0.21 3.37 x 10-13
305 1.25 1.97 ± 0.21 2.05 x 10-13
249 0.91 2.10 ± 0.44 1.49 x 10-13
289 0.82 2.30 ± 0.33 1.34 x 10-13
 
Table 4.3. % Total Ion Abundances, apparent threshold energy, and cross sections of high 
molecular weight product ions for the lithium adduct of 1,3-dipentadecanoin 
 
 
The low molecular weight product ions range from m/z 43 to m/z 99, produced primarily 
from a mixture of the CnH2n+1+ hydrocarbon series (m/z 43, m/z 57, m/z 71, m/z 85, and m/z 99), 
and product ions arising from the glycerol backbone (m/z 63, m/z 81, and m/z 99).  Table 4.2 
shows the % Total Ion Abundance and apparent threshold energies for the 1,3-dipentadecanoin 
diacylglycerol, as compared with the mono-pentadecanoin acylglycerol, and the 1-stearin,2- 
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Figure 4.6.  Breakdown graphs for: (a) high molecular weight product ions produced from CID 
of 1,3-dipentadecanoin, and (b) low molecular weight product ions produced from CID of 1,3-
dipentadecanoin. M/z 57 product ion is the favored fragmentation pathway due to joint 
production by glycerol backbone water loss, and fatty acyl chain hydrocarbon cleavage. M/z 43 
product ion rapidly increases, as the collision energy is increased, produced from σ-bond 
cleavage of the fatty acyl hydrocarbon chain and the glycerol backbone [C2H3O]+, appearing to 
be a favored pathway at increasing collision energies. 
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 the other product ions, as the collision energy is increased. The m/z 43 product ion is produced 
through two processes: σ-bond cleavage of the fatty acyl hydrocarbon chain, and a two carbon 
species from the glycerol backbone [C2H3O]+. 
 
4.3.4 Computational Reaction Enthalpies versus Predicted Apparent Threshold Energies 
Computational methods for surface potential energies were obtained by Gaussian 98 [42] 
to create a benchmark to evaluate the derived effective reaction path length approach for 
predicting the apparent threshold energies of covalent dissociations arising from CID of the 
acylglycerols. For all of the monopentadecanoin CID products listed in Fig. 4.1b, surface 
potential energies were calculated along with those of the respective neutral molecules formed 
concomitantly. For the pathway producing the m/z 99 lithiated glycerol product and the neutral 
fatty acyl chain as ketene, the computational reaction enthalpy (∆H0rxn) was determined to be 
2.19 eV. The magnitude of uncertainty in potential energy calculations at the B3LYP 6-31G* 
level has been estimated to be 3.9 kcal·mol-1, or 0.17 eV [42] (mean absolute deviation). The 
apparent threshold energy (∆E0) was experimentally determined to be 2.87 ± 0.14 eV. This is 
illustrated in Figure 4.7a where the ground state surface potential energy of the precursor m/z 
323 monopeantadecanoin lithium adduct has been set to a value of 0 eV.  The three product ions 
m/z 81, 63, and 57 (m/z 57 not shown), are observed to have lower ∆E0 values than the m/z 99 
product ion (Fig. 4.1b). For the three product ions m/z 81, 63, and 57 an inverse relationship 
between the % Total Ion Abundance and the apparent threshold energy ∆E0 is observed.  
However, these three product ions are produced by consecutive decompositions after the first 
step of loss of the fatty acyl chain as a ketene yielding the m/z 99 ion which initially requires a 
∆E0 of 2.87 ± 0.14 eV. 
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Figure 4.7. Energy diagrams for: (a) production of the m/z 63, 81, and 99 product ions from the 
monopentadecanoin lithium adduct, (b) production of the m/z 63, 81, and 99 product ions from 
the monopentadecanoin lithium adduct including the high energy pathways. 
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 The pathway for the production of the m/z 99 product involves a single hydrogen transfer. If a 
consecutive loss is assumed for the production of the m/z 81 ion, two hydrogen transfers are 
involved suggesting a higher energy barrier.  For the production of the m/z 81 ion: 
                                            CID 
M/z 323                         m/z 81 + ketene + H20  (4) 
 
 the ∆H0rxn was determined to be 0.66 eV (by the Gaussian 98 method), and the ∆E0 was 
determined to be 1.74 ± 0.27 eV (by the derived effective reaction path length approach). The 
production of the m/z 81 ion may be passing through the initial ketene loss mechanism which 
produces the m/z 99 product ion, thus requiring an activation energy of 2.87 ± 0.14 eV. Or, 
alternatively the m/z 81 product ion may be produced through a separate pathway requiring the 
1.74 ± 0.27 eV predicted by the derived effective reaction path length approach.  Figure 4.8 
illustrates a proposed mechanism for the production of the m/z 81 product ion from the m/z 323 
precursor ion.  In order to ascertain the production of the m/z 81 ion, the product ions m/z 99, 81, 
63, and 57 that are also produced in the CID of the 1,2- and the 1,3-diacylglycerols can also give 
information concerning the fragmentation pathways involved. As can be seen in Table 4.2, the 
experimentally derived ∆E0 for the m/z 99, 81, 63, and 57 of the 1,2- and the 1,3-diacylglycerols 
are all lower than 2.2 eV (most are much lower around 1.6 to 1.7 eV). Ratio plots of m/z 81, 63, 
and 57 to m/z 99 are shown in Figure 4.9 for the three acylglycerols. As illustrated in the plots, 
the mechanisms for the production of the m/z 81, 63, and 57 product ions are different for the 
monoacylglycerol (Fig. 4.9a) as compared to the 1,2- (Fig. 4.9b) and the 1,3-diacylglycerols 
(Fig. 4.9c). For the 1,2- and the 1,3-diacylglycerols, the m/z 81, 63, and 57 product ions increase 
in production as the internal energy uptake of the system increases, whereas for the 
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igure 4.8. Proposed pathway for the direct production of the m/z 81 product ion from the m/z 
 
monoacylglycerol, the m/z 81, 63, and 57 product ions decrease in production as the internal 
energy uptake of the system increases. This suggests that the m/z 81, 63, and 57 product ions for 
the monoacylglycerol have pathways of formation that are competitive with the m/z 99 product 
ion at lower internal energies, and could have lower activation energies than the m/z 99 product 
ion as is reflected in the lower ∆E0 values predicted by the derived effective reaction path length 
approach. An energy diagram describing the three pathways for the production of the m/z 99, 81, 
and 63 ions from the m/z 323 precursor is illustrated in Figure 4.7a. The energy diagram 
represents low energy pathways that do not require initial production of m/z 99.  However, the 
apparent threshold energies that are being calculated represent the weighted average of all 
pathways that result in these product ions.  Near the threshold region this is most likely to 
correspond to a single or predominant pathway to for a given m/z ion.  The 1,3-dipentadecanoin 
lithium adduct was also modeled by Gaussian 98 for potential energy surfaces for the prediction 
of ∆H rxn values for the production of the m/z 323 product ion through the neutral loss of a fatty 
acyl chain as a ketene. For the production of the m/z 323 product ion the ∆H rxn was determined 
 
F
323 precursor ion. 
 
0
0
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 to be -0.42 eV (indicating an exothermic process), and the ∆E0 was determined to be 1.66 ± 0.24 
eV. The lower ∆E0 for the initial ketene loss from the 1,3-dipentadecanoin compared to the 
ketene loss from the monopentadecanoin (1.66 ± 0.24 versus 2.87 ± 0.14 eV) is reflected in the 
lower energy state of the m/z 323 monopentadecanoin’s ∆H0rxn of –0.42 eV.  Though the 
mechanism for the dominant fatty acid substituent loss from the 1,2-diacylglycerol (loss of 
lithium fatty acetate forming m/z 313, ∆E0 of 1.35 ± 0.13 eV) is different from that from the 1,3-
diacylglycerol, i.e. loss of fatty acyl chain as ketene forming m/z 323, ∆E0 of 2.87  ± 0.14 eV, 
(see Table 4.1 and Figure 4.3b) indicates an even lower stability of the 1,2-diacylglycerol as 
compared to the 1,3-diacylglycerol (and the monoacylglycerol). As illustrated in Fig. 4.7a, at low 
energies the production of the m/z 81 and m/z 63 ions appear to be from channels that 
circumvent m/z 99, and their apparent threshold energies are lower. However, at higher collision 
energies the predominant pathway for the production of the m/z 81 and m/z 63 product ions 
appears to occur by consecutive decompositions of the m/z 99 product ion as is illustrated in 
Figure 4.7b.  The breaks in the higher energy pathways illustrate that the second threshold for the 
production of the m/z 81 and 63 product ions is unknown, and the current methodology cannot 
predict these. 
 
4.4 Conclusions 
The newly developed derived effective reaction path length approach for predicting 
BDE’s with the triple quadrupole in our lab has demonstrated an effective use in fragmentation 
pathway studies as an enhancement to traditional energy-resolved mass spectrometry studies.  By 
combining the calculated apparent threshold energies with the % Total Ion Abundance 
breakdown graphs, a more extensive quantitative description of fragmentation pathways is 
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(c) 
Figure 4.9. Ratio plots of m/z 57, 63, and 81 to m/z 99 for: (a) monopentadecanoin lithium 
adduct, (b) 1-stearin,2-palmitin diacylglycerol lithium adduct, and (c) 1,3-dipentadecanoin 
lithium adduct. 
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 possible.  The use of the derived effective reaction path length approach to calculate apparent 
threshold energies for the unimolecular fragmentation reactions of lithiated acylglycerols, by 
triple quadrupole, enabled unique interpretation of the product ion results.  The observance of an 
inverse relationship between % Total Ion Abundance versus apparent threshold energies for the 
dissociation of the fatty acid substituents of the 1,2- and the 1,3-diacylglycerols suggests simple 
cleavage mechanisms that are competitive on the basis of activation energy.  Also revealed by 
the calculated apparent threshold energies are the dissociation rankings of the form of the neutral 
loss of the fatty acyl substituent for the 1,2- and the 1,3-diacylglycerol.  For the 1-stearin,2-
palmitin diacylglycerol, the following favored fragmentation pathway was observed: loss of 
lithium fatty acetate > loss of fatty acid > loss of fatty acyl chain as ketene, and for the 1,3-
dipentadecanoin diacylglycerol, the following favored fragmentation pathway was observed: loss 
of fatty acyl chain as ketene > loss of lithium fatty acetate > loss of fatty acid.  Coupling the 
interpretative results for the mono-pentadecanoin fragmentation pathways and product ions, the 
high abundance, low apparent threshold energy observed for the production of the low molecular 
weight m/z 57 ion in the CID of the 1,2- and the 1,3-diacylglycerols was explained through two 
production mechanisms.  In general, the derived effective reaction path length approach for 
apparent threshold energy determinations is relatively fast, straightforward, and easy to use, and 
has demonstrated itself to be applicable to both non-covalent, and covalent bond dissociation 
studies, making it versatile and general in gas-phase thermochemistry applications. 
 
4.5 References 
1. Whitehouse, C. M.; Dryer, R. N.; Yamashita, M.; Fenn, J. B. Electrospray interface for 
liquid chromatographs and mass spectrometers. Anal. Chem. 1985, 57, 675-679. 
2. Kebarle, P.; Ho, Y. In Electrospray Ionization Mass Spectrometry, Cole, R. B.; Ed.; 
Wiley: New York, 1997; p 17. 
 87
 3. Cole, R. B. Some tenets pertaining to electrospray ionization mass spectrometry. J. Mass 
Spectrom. 2000, 35, 763-772. 
4. Cao, P.; Stults, J. T. Mapping the phosphorylation sites of proteins using on-line 
immobilized metal affinity chromatography/capillary electrophoresis/electrospray 
ionization multiple stage tandem mass spectrometry. Rapid Commun. Mass Spectrom. 
2000, 14, 1600-1606. 
5. Ho, Y. P.; Huang, P. C.; Deng, K. H. Metal ion complexes in the structural analysis of 
phospholipids by electrospray ionization tandem mass spectrometry. Rapid Commun. 
Mass Spectrom. 2003, 17, 114-121. 
6. Kocher, T.; Allmaier, G.; Wilm, M. Nanoelectrospray-based detection and sequencing of 
substoichiometric amounts of phosphopeptides in complex mixtures. J. Mass Spectrom. 
2003, 38, 131-137. 
7. Shukla, A. K.; Futrell, J. H. Tandem mass spectrometry: dissociation of ions by 
collisional activation. J. Mass Spectrom. 2000, 35, 1069-1090. 
8. Katta, V.; Chait, B. T. Observation of the Heme-Globin complex in native myoglobin by 
electrospray-ionization mass spectrometry. J. Am. Chem. Soc. 1991, 113, 8534-8535. 
9. Ganem, B.; Li, Y. T.; Henion, J. D. Detection of noncovalent receptor-ligand complexes 
by mass spectrometry. J. Am. Chem. Soc. 1991, 113, 6294-6296. 
10. Ganem, B.; Li, Y. T. Henion, J. D. Observation of noncovalent enzyme-substrate and 
enzyme-product complexes by ion-spray mass spectrometry. J. Am. Chem. Soc. 1991, 
113, 7818-7819. 
11. Armentrout, P. B.; Beauchamp, J. L. Cobalt carbene ion: reactions of Co+ with C2H4, 
cyclo-C3H6, and cyclo-C2H4O. J. Chem. Phys. 1981, 74, 2819-2826. 
12. Ervin, K. M.; Armentrout, P. B. Translational energy dependence of Ar+ + XY = ArX+ + 
Y (XY=H2,D2,HD) from thermal to 30 eV c.m. J. Chem. Phys. 1985, 83, 166-189. 
13. Weber, M. E.; Elkind, J. L.; Armentrout, P. B. Kinetic energy dependence of Al+ + O2              
AlO+ + O. J. Chem. Phys. 1986, 84, 1521-1529. 
14. Aristov, N.; Armentrout, P. B. Collision-induced dissociation of vanadium monoxide ion. 
J. Chem. Phys. 1986, 90, 5135-5140. 
15. Hales, D. A.; Lian, L.; Armentrout, P. B. Collision-induced dissociation of Nb+n (n=2-
11): bond energies and dissociation pathways. Int. J. Mass Spectrom. Ion Processes 1990, 
102, 269-301. 
16. Schultz, R. H.; Crellin, K. C.; Armentrout, P. B. Sequential bond energies of Fe(CO)x+ 
(x=1-5): systematic effects on collision-induced dissociation measurements. J. Am. 
Chem. Soc. 1991, 113, 8590-8601. 
17. Rodgers, M. T.; Ervin, K. M.; Armentrout, P. B. Statistical modeling of collision-induced 
dissociation thresholds. J. Chem. Phys. 1997, 106, 4499-4508. 
18. Rodgers, M. T.; Armentrout, P. B. Statistical modeling of competitive threshold 
collision-induced dissociation. J. Chem. Phys. 1998, 109, 1787-1800. 
19. Rodgers, M. T.; Armentrout, P. B. Noncovalent metal-ligand bond energies as studied by 
threshold collision-induced dissociation. Mass Spec Rev 2000, 19, 215-247. 
20. Daniel, J. M.; Friess, S. D.; Rajagopala, S.; Wendt, S.; Zenobi, R. Quantitative 
determination of noncovalent binding interactions using soft ionization mass 
spectrometry. Int. J. Mass Spectrom. 2002, 216, 1-27. 
21. Colorado, A.; Brodbelt, J. An Empirical Approach to Estimation of Critical Energies by 
Using a Quadrupole Ion Trap, J Am Soc Mass Spectrom 1996, 7, 1116-1125. 
 88
 22. Graul, S. T.; Squires, R. R. Gas-Phase Acidities Derived from Threshold Energies for 
Activated Reactions, J. Am. Chem. Soc. 1990, 112, 2517-2529. 
23. Sunderlin, L. S.; Wang, D.; Squires, R. R. Bond Strengths in First-Row-Metal Carbonyl 
Anions, J. Am. Chem. Soc. 1993, 115, 12060-12070. 
24. Anderson, S. G.; Blades, A. T.; Klassen, J.; Kebarle, P. Determination of ion-ligand bond 
energies and ion fragmentation energies of electrospray-produced ions by collision-
induced dissociation threshold measurements, Int. J. Mass Spectrom Ion Processes 1995, 
141, 217-228. 
25. Klassen, J. S.; Anderson, S. G.; Blades, A. T.; Kebarle, P. Reaction enthalpies for M+L = 
M+ + L, where M+ = Na+ and K+ and L = acetamide, N-methylacetamide, N,N-
dimethylacetamide, glycine, and glyvylglycine, from determinations of the collision-
induced dissociation thresholds, J. Phys. Chem. 1996, 100, 14218-14227. 
26. Kebarle, P. Gas phase ion thermochemistry based on ion-equilibria. From the ionosphere 
to the reactive centers of enzymes, Int. J. Mass Spectrom. 2000, 200, 313-330. 
27. Nielsen, S. B.; Masella, M.; Kebarle, P. Competitive gas-phase solvation of alkali metal 
ions by water and methanol, J. Phys. Chem. A 1999, 103, 9891-9898. 
28. Peschke, M.; Blades, A. T.; Kebarle, P. Binding energies for doubly-charged ions M2+ = 
Mg2+, Ca2+ and Zn2+ for n = 1 to 7 from gas phase equilibria determinations and 
theoretical calculations J. Am. Chem. Soc., 2000, 122, 10440-10449. 
29. Reid, C. J. Breakdown diagrams for low-mass cation from angle-resolved mass 
spectrometric measurements, Organic Mass Spectrometry 1991, 26, 402-409. 
30. Martinez, R. I.; Ganguli, B. Kinetics and mechanism of the collision-activated 
dissociation of the acetone cation, J Am Soc Mass Spectrom 1992, 3, 427-444. 
31. Rogalewicz, F.; Hoppilliard, Y.; Ohanessian, G. Fragmentation mechanisms of α-amino 
acids protonated under electrospray ionization: a collisional activation and ab initio 
theoretical study, Int. J. Mass Spectrom. 2000, 195/196, 565-590. 
32. Vazquez, S.; Truscott, R. J. W.; O’Hair, R. A. J.; Weimann, A.; Sheil, M. M. A study of 
kynurenine fragmentation using electrospray tandem mass spectrometry, J Am Soc Mass 
Spectrom 2001, 12, 786-794. 
33. Butcher, C. P. G.; Dyson, P. J.; Johnson, B. F. G.; Langridge-Smith, P. R. R.; McIndoe, J. 
S.; Whyte, C. On the use of breakdown graphs combined with energy-dependent mass 
spectrometry to provide a complete picture of fragmentation processess, Rapid Commun. 
Mass Spectrom. 2002, 16, 1595-1598. 
34. Harrison, A. G. Energy-resolved mass spectrometry: a comparison of quadrupole cell and 
cone-voltage collision-induced dissociation, Rapid Commun. Mass Spectrom. 1999, 13, 
1663-1670. 
35. Harrison, A. G.; Csizmadia, I. G.; Tang, T. H.; Tu, Y. P. Reaction competition in the 
fragmentation of protonated dipeptides, J. Mass Spectrom. 2000, 35, 683-688. 
36. Chass, G. A.; Marai, C. N. J.; Harrison, A. G.; Csizmadia, I. G. Fragmentation reactions 
of a2 ions derived from deprotonated dipeptides – a synergy between experiment and 
theory, J. Phys. Chem. A 2002, 106, 9695-9704. 
37. Martinez, R. I.; Instrument-independent MS/MS database for xqq instruments: a kinetics-
based measurement protocol J Res. Natl. Inst. Std. Technol. (U.S.) 1989, 94, 281- 304. 
38. McLafferty, F. W.; Turecek, F. Interpretation of Mass Spectra, 4th ed.; University 
Science Books: CA, 1993; p 115. 
 89
 39. Ham, B. M.; Cole, R. B. Determination of Bond Dissociation Energies Using 
Electrospray Tandem Mass Spectrometry and a Novel Derived Effective Reaction Path 
Length Approach (manuscript accepted by Analytical Chemistry). 
40. Srivastava, M. S. Methods of Multivariate Statistics, 1st ed.; John Wiley & Sons, Inc.: 
New York, 2002; p 365. 
41. Ham, B. M.; Jacob, J. T.; Keese, M. M.; Cole, R. B. Identification, quantification and 
comparison of major non-polar lipids in normal and dry eye tear lipidomes by 
electrospray tandem mass spectrometry. J. Mass Spectrom. 2004, 39, 1321-1336. 
42. Gaussian 98, Revision A.3, M. J. Frisch, G. W. Trucks, H. B. Schlegel, G. E. Scuseria, 
M. A. Robb, J. R. Cheeseman, V. G. Zakrzewski, J. A. Montgomery, Jr., R. E. Stratmann, 
J. C. Burant, S. Dapprich, J. M. Millam, A. D. Daniels, K. N. Kudin, M. C. Strain, O. 
Farkas, J. Tomasi, V. Barone, M. Cossi, R. Cammi, B. Mennucci, C. Pomelli, C. Adamo, 
S. Clifford, J. Ochterski, G. A. Petersson, P. Y. Ayala, Q. Cui, K. Morokuma, D. K. 
Malick, A. D. Rabuck, K. Raghavachari, J. B. Foresman, J. Cioslowski, J. V. Ortiz, B. B. 
Stefanov, G. Liu, A. Liashenko, P. Piskorz, I. Komaromi, R. Gomperts, R. L. Martin, D. 
J. Fox, T. Keith, M. A. Al-Laham, C. Y. Peng, A. Nanayakkara, C. Gonzalez, M. 
Challacombe, P. M. W. Gill, B. Johnson, W. Chen, M. W. Wong, J. L. Andres, C. 
Gonzalez, M. Head-Gordon, E. S. Replogle, and J. A. Pople, Gaussian, Inc., Pittsburgh 
PA, 1998. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 90
 CHAPTER V:  IDENTIFICATION, QUANTITATION AND COMPARISON OF MAJOR 
NON-POLAR LIPIDS IN NORMAL AND DRY EYE TEAR LIPIDOMES BY ES-MS-MS 
 
5.1 Introduction 
Millions of humans are afflicted with keratoconjunctivitis sicca (KCS, also known as 
“dry eye”), which can be associated with aging, disease, smoke, surgery, or any form of irritation 
of the eye.  The National Eye Institute’s (NEI) definition of dry eye states that KCS is a disorder 
of the ocular tear film layer usually caused by a tear deficiency, or excessive evaporation of the 
aqueous layer, resulting in damage to the ocular surface and symptoms of discomfort(1). Some 
forms of dry eye may be physiologically related, perhaps from the breakdown of the eye tear 
layer, or to hormones, as demonstrated in a hormone replacement study by Schaumberg, et.al.(1).  
In two separate demographic studies, it has been estimated that 11% of Europeans (Copenhagen 
criteria), between the ages of 30 and 60 years suffer from dry eye symptoms(2), and that 14.6% of 
Americans over the age of 65 years (approximately 4.3 million people) also suffer from dry eye 
symptoms(3).  Although their symptoms are similar, the underlying causes are often unknown and 
no practical method for evaluating the composition of tears from such patients exists.  
Therapeutical approaches for the treatment of dry eye include application of artificial tear drops 
for wetting and lubrication(4,5), corticosteroids (anti-inflammatory agents), anti-biotics and 
immunosuppresants such as cyclosporin(6).  The widely used dry eye drops consist of various 
solutions containing electrolytes, organic additives, etc., but are primarily composed of water 
(97-99%)(4). 
The structure of the ocular tear film is generally divided into three layers: the innermost 
corneal layer, an intermediate aqueous-mucin layer(7,8), and an outermost lipid layer(9).  One of 
the functions of the outer lipid layer is to retard the evaporation of the inner aqueous layer.  The 
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 lipids are supplied to the tear film through the meibomian gland.  The chemical composition of 
the human meibomian gland liquid secretions is a complex mixture of cholesterol and wax 
esters, triglycerides, free fatty acids, diesters, free cholesterol, hydrocarbons, and polar lipids(10-
14), with water composing 98-98.5%(4).  Some forms of dry eye may be related to the breakdown 
of the eye tear layer. 
Electrospray(15-17) tandem mass spectrometry (ES-MS/MS) is a powerful analytical tool 
for compound identification(18-20).  In this paper, we use this method to develop a standard lipid 
component profile of normal tears and identify specific component differences in the tears from a 
dry eye model.  Through the development of this technology to provide specific information 
concerning the lipid profile of a healthy person’s tear, it may be possible to identify a defective 
lipid profile, something which has been suggested to be a major contributor to the dry eye 
syndrome(21).  The mass spectrometric analysis of acylglycerides, which are comprised of mono-, 
di-, and triglycerides, has been reported using various approaches such as derivative gas 
chromatography-electron ionization mass spectrometry GC-EI-MS(22-24), positive chemical 
ionization(22), negative chemical ionization(25-27) (NCI) of chloride adducts, ES-MS/MS(28,29) 
including ES-MS/MS of ammonium adducts(30,31), MALDI-TOF(32,33), fast atom bombardment 
(FAB)(34), atmospheric pressure chemical ionization (APCI) mass spectrometry(30,35), and APCI 
liquid chromatography/mass spectrometry(36-38) (LC/MS).  Quantifying triglycerides using ratios 
of diacylglyceride fragment ions vs parent ions and fragmentation schemes has been reported for 
single-stage APCI-MS experiments(39-42). Saturated acylglycerides do not readily form 
protonated molecules, even in acidified solutions, so alkali metal salt (Na+), and ammonium 
acetate (NH4+), have been used as additives in chloroform:methanol for both ES, and APCI 
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 LC/MS.  It has also been reported(36) that APCI LC/MS is not sensitive enough to detect even 
moderately low amounts (about 2.5 mg/mL) of monoacylglycerides under standard solutions. 
In our mass spectrometry work involving the identification of lipid fractions in tear 
samples, Li+ was chosen as the alkali metal for adduct formation for both the non-polar lipids 
such as the acylglycerides and wax esters that, to our knowledge, have not appeared in the 
literature, and for the more polar phosphorylated lipids, which have previously been reported(43).  
The specific use of lithium adducts has been reported for FAB-MS-MS, and ES-MS studies of 
oligosaccharides(44,45), for the ES ionization and structural determination of 
triacylglycerides(29,46), for ionization of aryl 1,2-diols by fast atom bombardment(34), and for FAB 
ionization and structural identification of fatty acids(47).  In this paper, we present a detailed 
description of the major fragments produced from ES-MS/MS studies employing collisionally 
induced dissociation (CID) of lithium adducts of monoacylglycerides, and 1,2- and 1,3-
diacylglycerides, which can produce informative product ion spectra for the identification of 
complex biological extracts. 
 
5.2 Experimental 
5.2.1 Instrumentation 
Mass spectra were obtained using a triple quadrupole mass spectrometer (Micromass, 
Inc., Manchester, UK, model Quattro II) equipped with an electrospray interface operating at 
typical flow rates of 2-4 µL/min.  Nitrogen was used as both nebulizing and drying gas.  Argon 
was used as collision gas during collision induced dissociation (CID) experiments, at collision 
cell pressures of approximately 3.0 x 10-4 mBar (measured external to the cell).  The typical 
“cone” voltage setting was 40 V, and the ES capillary voltage was held at 2.5 to 3.5 kV.  For 
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 quantification of the lipids, internal standards having similar structures to the lipids 
(monopentadecanoin, dipentadecanoin, triheptadecanoin, and palmityl behenate) were employed 
to minimize differences in ionization efficiencies(53).  MassLynx software (Micromass) was used 
to acquire, process, and store mass spectral data. 
 
5.2.2 Rabbit Dry Eye Model  
The rabbit dry eye model was created in female New Zealand white rabbits by two 
sequential surgical procedures. First, the main lacrimal gland was removed from the 
experimental eye; the contralateral eye was used as the control. Approximately 2 weeks later, the 
accessory lacrimal gland and nictitating membrane were removed from the experimental eye. 
Tear breakup time (TBUT, measured by slit lamp with a Tearscopetm) was measured daily. When 
the TBUT of the surgical eye was half or less that of the control eye, the surgical eye was 
considered to be ‘dry’. Baseline tears (representing tears produced under non-irritating 
conditions) were collected daily from the normal and surgically induced dry eyes using 5 µL 
silanated microcapillary pipettes.48–50 The usual volume obtained from a normal eye was 3 µL 
each, whereas only 1 µL was typically obtained from a dry eye. The tear samples were 
immediately placed in Eppendorf tubes and preserved by storage at –70 °C.  The non-polar lipid 
fractions were extracted from tear samples with a simple chloroform solvent modification 
procedure51,52 and reconstituted in 9 : 1 methanol–chloroform solutions containing 2 mM LiCl.43
 
5.2.3 A Note on Stereochemistry of Acylglycerides 
All vicinal diacylglycerides in this report have unknown stereochemistries at the chiral 
carbon.  Differentiation between 1,2-diglycerides and 2,3-diglycerides is not possible, and for 
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 convenience these are all designated as 1,2-diglycerides in the text.  Similarly, 3-position 
monoglycerides are not distinguishable from 1- position monoglycerides, and the 1-position is 
used to describe both.  Moreover, 1,3-diglycerides cannot be distinguished from their enantomers 
and the 1-position is arbitrarily assigned to the largest alkyl chain. 
 
5.3 Results and Discussion 
It was observed that, in the positive mode, mass spectral signal intensities of the lithiated 
adduct species (upon addition of 2 mM LiCl) were more reproducible than those of the 
corresponding protonated lipid molecules, or mass analysis of the deprotonated lipid species in 
the negative mode.  Upon decomposition, the lithium adducts were also observed to form 
product ions that were characteristic of the lipid being analyzed, as will be described below. 
Comparison of ES-MS spectra for normal human tear and normal rabbit tear, obtained in 
our laboratory, have shown close similarities where the total chloroform extractables from 
normal rabbit tears match quite closely those from human tears. This suggests that the rabbit 
tears are quite close in composition to human tears, which would allow extrapolation of findings 
from one species to the other.  Secondly, it was noted that there was not a readily observable 
difference in major components when comparing normal tears with dry eye tear total chloroform 
extractables, though changes in the fatty acid fragments of the non-polar, and polar lipids have 
been reported by Sullivan, et. al.(54-57) for people suffering from dry eye due to an androgen 
deficiency caused by Sjogren’s syndrome, menopause, and aging. 
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 5.3.1 MS of Lipid Standards 
5.3.1.1 Product Ion Spectra 
Figure 5.1a is the product ion spectrum of the lithiated adduct of triheptadecanoin.  The 
characteristic informative peaks include the C17:0 acylium ion at m/z 253 [C17H33O]+, the 
lithium adduct of heptadecanoic acid at m/z 277 [C17H34O2Li]+, the neutral loss of heptadecanoic 
acid, then the neutral loss of a C17:1 alpha-beta unsaturated fatty acid, to give the m/z 317 
product ion [MLi - C17H34O2 - C17H32O2]+, the parent ion minus lithiated heptadecanoate at m/z 
579 [MLi – C17H33O2Li]+, and the parent ion minus the neutral loss of heptadecanoic acid at m/z 
585 [MLi – C17H34O2]+.  The m/z 579 product ion from the neutral loss of a catonized fatty 
acetate, from triglycerides, is observed in ES tandem mass spectrometry studies with ammonium 
adducts(36), but the product ions of m/z 317 and m/z 585, which both involve the neutral loss of a 
fatty acid, have not.  Hsu et al.(46) also reported the neutral loss of fatty acids from lithiated 
triglycerides using a triple quadrupole with an electrospray interface.  The spectrum also contains 
hydrocarbon fragment ions at m/z 43, m/z 57, m/z 71, and m/z 85 which are derived from σ-
bond cleavage of the fatty acid hydrocarbon chains.  Also included in the lower mass region is 
the product ion at m/z 99 which is the lithium adduct of the glycerol backbone, and an ion at m/z 
81 derived from water loss from this glycerol backbone. 
The product ion spectrum of 1,3-dipentadecanoin, Figure 5.1b, also contains the 
hydrocarbon fragment ions, and a peak at m/z 63 for two water losses from the glycerol 
backbone, in addition to m/z 99 and m/z 81 from glycerol.  In the m/z 200 to m/z 350 region 
there are two major fragment peaks which characterize this diglyceride, i.e., lithiated 
pentadecanoic acid at m/z 249 [C15H30O2Li]+, and the m/z 323 fragment ion that has undergone 
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 Figure 5.1.  Positive mode ES-MS/MS product ion spectra of the lithium adducts of the internal 
acylglyceride standards used for identification and quantification of extracted lipids [MLi]+, with 
peak assignments of major informative fragment ions for: (a) triheptadecanoin m/z 855, (b) 1,3-
dipentadecanoin m/z 547, (c) “up-front” CID-MS-MS experiment using precursor (m/z 323) 
fragment ions formed from “up-front” dissociation of the 1,3-dipentadecanoin standard (m/z 
547) [M + Li]+.  The product ion peak at m/z 299 (inset) indicates the minor pathway of a step-
wise initial “in-source” loss of ketene, followed by LiOH, in addition to production of m/z 299 
from the loss of the lithium fatty acetate from m/z 547. Positive mode ES-MS/MS product ion 
spectra of: (d) monopentadecanoin m/z 323, and (e) palmityl behenate m/z 571.  
 
 
neutral loss of C15:0 fatty acyl chain as a ketene [MLi – C15H28O]+.  Also observed are peaks at 
m/z 289 from the consecutive neutral losses of H2O followed by C15:1 alpha-beta unsaturated 
fatty acid [MLi – H2O – C15H28O2]+.  The order of this consecutive process was ascertained by a 
precursor scan of m/z 289 that showed peaks at m/z 547 for the lithiated parent ion, and m/z 529 
representing loss of H2O from the m/z 547 parent.  Notably the peak that would correspond to 
initial C15H28O2 loss at m/z 307 was not observed, thus indicating a two-step process with H2O 
loss being the first step.  Fig. 5.1b also shows peaks at m/z 299 formed from the neutral loss of 
C15:0 lithium fatty acetate [MLi - C15H29O2Li]+, and at m/z 305 for the neutral loss of C15:0 
fatty acid [MLi – C15H30O2]+.  The loss of NH4OH, then ketene, has been observed and reported 
by APCI LC/MS(36), which would be analogous to the pathway leading to m/z 299 if the process 
occurs in two steps, involving initial loss of C:15 fatty ketene, followed by loss of LiOH; 
alternatively it could be formed through neutral loss of C15:0 lithium fatty acetate.  To 
distinguish which fragment pathway was responsible for the m/z 299 product ion, an experiment 
was performed where the loss of the C:15 fatty ketene from the m/z 547 precursor was produced 
in the source using high cone voltage (i.e. “in-source” or “up-front” collision induced 
dissociation, CID).  M/z 323 was then isolated with the first quadrupole, subjected to CID in the 
central hexapole, and the product ions scanned by the third quadrupole for the loss of LiOH at 
m/z 299.  Figure 5.1c illustrates the results of the experiment where a small peak was observed at 
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 m/z 299 indicating that this fragmentation pathway can occur, i.e., the loss of a fatty ketene 
followed by loss of LiOH, but it is much less favored than the direct neutral loss of the C:15 
lithium fatty acetate from the m/z 547 precursor.  Finally, to the best of our knowledge, the 
second product ion observed at m/z 323 (Fig. 5.1b) through the loss of ketene, resulting in a 
lithium adduct of monoacylglycerol has not been reported. 
Figure 5.1d is the product ion spectrum from the collision induced dissociation of 
lithiated monopentadecanoin.  Three peaks characteristic of the fragmentation of lithiated 
monoglycerides are observed in the lower molecular weight region.  The major ion at m/z 99 is 
the glycerol backbone derived from the neutral loss of the C15:0 fatty ketene from the parent ion 
[MLi – C15H28O]+.  The next two ion peaks at m/z 81 and m/z 63 are the subsequent loss of one, 
and then two H2O molecules from the glycerol backbone as was observed for the tri- and 
diglycerides.  Figure 5.1e is the product ion spectrum of the lithium adduct of palmityl behenate, 
a representative fatty acid/fatty alcohol wax ester.  In the low mass region, only the hydrocarbon 
fragments are observed at m/z 43, m/z 57, m/z 71, m/z 83 (one unsaturation), and m/z 85.  In the 
m/z 350 region there is one predominant peak appearing at m/z 347.  This represents the neutral 
loss of the carbon chain of the fatty alcohol [MLi – C16H32]+, leaving the lithium adduct of the 
fatty acid portion of the wax ester at m/z 347 [C22H44O2Li]+. 
 
5.3.1.2 Lipid Fragmentation Pathways 
Figures 5.2, 5.3, and 5.4 are diagrams illustrating the major fragment ions produced from 
CID of the lithium adducts of the acylglycerides triheptadecanoin, 1,3-dipentadecanoin, and 
monopentadecanoin, respectively. Mu, et. al.(36), and Holcapek, et. al.(37), each have reported 
different types of fragmentation pathways for the CID of CI-generated diglycerides employing 
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 ammonium adducts(36), or protonated, diglycerides with 3 or more double bonds(37). To determine 
whether a different product ion spectrum would be obtained for the two types of substitution 
(1,2- versus 1,3-), and whether a distinction could be made between the two substituents on a 
1,2-diglyceride, a 1-stearin-2-palmitin diglyceride standard was analyzed by tandem mass 
spectrometry as the lithium adduct.  Recall that in the product ion spectrum of the 1,3-
dipentadecanoin standard (Figure 5.1b), the predominant ion was the m/z 323 peak from the loss 
of C15:0 fatty acyl chain as a ketene from the parent ion [MLi – C15H28O]+, followed by the peak 
at m/z 299 for the neutral loss of C15:0 lithium fatty acetate [MLi – C15H29O2Li]+.  In Fig. 5.5a, 
the product ion spectrum of the lithium adduct of the 1,2-diglyceride, the predominant product 
ions are m/z 313 and m/z 341.  The m/z 313 product ion is derived from the loss of C18:0 
lithium fatty acetate, which is in the 1- position, [MLi – C18H35O2Li]+.  The second major 
product ion at m/z 341 is derived from the loss of C16:0 lithium fatty acetate, which is in the 2-
position, [MLi – C16H31O2Li]+.  The greater intensity of the m/z 313 peak versus m/z 341 
indicates that lithium fatty acetate loss occurs with greater facility from the 1-position relative to 
the analogous loss from the 2-position.  Thus, when two non-identical fatty acyl substituents are 
present on a 1,2- diglyceride, the higher intensity monoacyl fragment has lost the substituent that 
was formerly at the 1-position.  This behavior is identical to the type of selective loss of the fatty 
acid from the 1-position being greater than the analogous loss from the 2-position observed with 
the phosphorylated lipids(43).  To verify the positional selectivity of this lithium fatty acetate loss, 
the lithium adduct of 1-palmitin-2-stearin diglyceride was subjected to CID under similar 
conditions.  The product ion spectrum showed that the predominant neutral loss was that of 
C16:0 lithium fatty acetate, from the 1-position.  This behavior indicates that the principal factor 
in determining the preferred neutral loss of a lithium fatty acetate is the position (i.e, 1-position is 
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 favored over the 2-position), rather than chain length. The spectrum (Fig. 5.5a) also contains a 
low intensity peak at m/z 365 for the loss of the 2-position C16:0 fatty acyl chain as a ketene 
[MLi - C16H30O]+, and a very minor peak at m/z 337 for the loss of the 1-position C18:0 fatty  
 
 
Figure 5.2.  Major fragment ions produced from the collisionally induced dissociation of 
triheptadecanoin m/z 855 [MLi]+: the C17:0 acylium ion at m/z 253 [C17H33O]+, the lithium 
adduct of heptadecanoic acid at m/z 277 [C17H34O2Li]+, the neutral loss of heptadecanoic acid, 
then the neutral loss of a C17:1 alpha-beta unsaturated fatty acid, to give the m/z 317 product ion 
[MLi - C17H34O2 - C17H32O2]+, the parent ion minus lithiated heptadecanoate at m/z 579 [MLi – 
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 C17H33O2Li]+, and the parent ion minus the neutral loss of heptadecanoic acid at m/z 585 [MLi – 
C17H34O2]+. 
 
Figure 5.3.  Major fragment ions produced from the collisionally induced dissociation of 1,3-
dipentadecanoin m/z 547 [MLi]+: the parent ion peak minus the neutral loss of C15:0 fatty acyl 
chain as ketene at m/z 323 [MLi – C15H28O]+, the neutral loss of C15:0 lithium fatty acetate at 
m/z 299 [MLi – C15H29O2Li]+ (major path), or the loss of C15:0 fatty acyl chain as ketene from 
the parent ion followed by LiOH at m/z 299 [MLi - C15H28O - LiOH]+ (minor path), the neutral 
loss of C15:0 fatty acid at m/z 305 [MLi - C15H30O2]+, the consecutive losses of H2O followed by 
C15:1 alpha-beta unsaturated fatty acid at m/z 289 [MLi - H2O - C15H28O2]+, and the lithiated 
fatty acid ion, pentadecanoic acid, at m/z 249 [C15H30O2Li]+. 
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Figure 5.4.  Major fragment ions produced from the collisionally induced dissociation of 
monopentadecanoin m/z 323 [MLi]+: the major ion at m/z 99 is the glycerol backbone derived 
from the neutral loss of the C15:0 fatty acyl chain as a ketene from the parent ion [MLi – 
C15H28O]+, and the m/z 81 and m/z 63 are the subsequent losses of one, and then two H2O 
molecules from the lithiated glycerol backbone. 
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 acyl chain as a ketene [MLi - C18H34O]+.  This behavior contrasts with that of a 1,3- diglyceride 
in that the latter shows significant ketene loss from the 1-, or 3-position as being responsible for 
the predominant product ions, whereas neutral losses of lithium fatty acetates are only minor.  As 
a further control, the asymmetric 1,3-diglyceride 1-palmitin-3-stearin was analyzed under similar 
CID conditions.  The resultant product ion spectrum confirmed that neutral losses of the fatty 
acyl chains as ketenes are the favored product ion pathways for 1,3-diglycerides, and peaks 
representing losses of each of the two fatty acid substituents were observed.  Notably, for the 
asymmetric 1,3-diglyceride, loss of the longer C18:0 fatty acyl chain as a ketene was the slightly 
favored product ion as compared to the loss of the shorter C16:0 fatty acyl chain as a ketene, 
suggesting that for the asymmetric 1,3-diglyceride, a longer chain length can subtly increase the 
propensity for ketene loss.   Also identified in the Fig. 5.5a spectrum are peaks for the neutral 
loss of C16:0 fatty acid at m/z 347 [MLi - C16H32O2]+, the neutral loss of the C18:0 fatty acid at 
m/z 319 [MLi - C18H36O2]+, and the lithium adducts of stearic acid at m/z 291 [C18H36O2Li]+, and 
palmitic acid at m/z 263 [C16H32O2Li]+. 
Figure 5.5b is a diagram illustrating the major fragment ions produced from the collision 
induced dissociation of the lithium adduct of the 1-stearin-2-palmitin diglyceride standard. 
Figure 5.6 illustrates four proposed fragmentation pathways for the collisionally induced 
dissociation of the lithium adduct of 1-stearin-2-palmitin diglyceride.  The top two processes 
(Fig. 5.6a and 5.6b) illustrate the major pathways producing product ions through the neutral loss 
of a lithium fatty acetate.  The bottom two processes (Fig. 5.6c and 5.6d) are minor pathways 
each producing product ions through the neutral loss of a fatty ketene, followed by the loss of 
LiOH. Both processes result in the same m/z product ion with 5-membered ring formation to  
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Figure 5.5.  (a) Product ion spectrum of 1-stearin-2-palmitin standard at m/z 603.  The greater 
intensity of the m/z 313 vs. m/z 341 allows the identification of the 1- position of the 1,2-
diglyceride. (b) Major fragment ions produced from the collisionally induced dissociation of 1-
stearin-2-palmitin diacylglycerol m/z 603 [MLi]+: the m/z 313 ion from the neutral loss of C18:0 
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 lithium fatty acetate (1- position), [MLi – C18H35O2Li]+, the ion at m/z 341 from the neutral loss 
of C16:0 lithium fatty acetate (2- position), [MLi – C16H31O2Li]+, the m/z 365 ion from the loss 
of the C16:0 fatty acyl chain as ketene [MLi - C16H30O]+, the neutral loss of C16:0 fatty acid at 
m/z 347 [MLi - C16H32O2]+, the neutral loss of the C18:0 fatty acid at m/z 319 [MLi - 
C18H36O2]+, the lithium adducts of stearic acid  at m/z 291 [C18H36O2Li]+, the lithium adduct of 
palmitic acid at m/z 263 [C16H32O2Li]+, and protonated stearic and palmitic acids at m/z 285 
[C18H36O2H]+, and m/z 257 [C16H32O2H]+, respectively. 
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Figure 5.6.  Proposed fragmentation pathways for the collisionally induced dissociation of the 
lithium adduct of 1-stearin-2-palmitin diglyceride involving the fatty acid substituent and loss of 
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 LiOH.  In the major fragment pathway process (top set (a) and (b)), there is the neutral loss of 
lithium fatty acetate (1- position or 2- position) forming the product ion.  In the minor fragment 
pathway (bottom set (c) and (d)), the initial step is the loss of the ketene of either the 1- position 
or the 2- position fatty acid substituent, followed by the loss of LiOH forming the product ion. 
 
 
make the most stable structure.  The 1,3-diacylglycerides would have analogous pathways for the 
two-step neutral loss of a fatty acyl chain as a ketene, followed by the loss of LiOH.  However, 
the neutral loss of a lithium fatty acetate for the 1,3- would be slightly more complicated, 
involving a hydroxyl shift to form the final stable 5-membered ring product ion (e.g., see m/z 
299 in Fig. 5.3). 
 
5.3.1.3 Distinguishing Asymmetric 1,2-diglycerides, and 1,2- from 1,3-diglycerides 
Figure 5.7 presents a general scheme that can be used in the identification of diglycerides 
under low-energy (e.g., up to 100 eV ELAB) collision conditions.  The top part of panel (a) 
illustrates the usage of product ion intensities for determining substituent location within an 
asymmetric 1,2-diglyceride.  First of all, a characteristic of the 1,2-diglycerides vs. the 1,3- is 
that the predominant product ions are those formed via losses of lithium fatty acetates. 
Furthermore, it has been observed that the R1 substituent in the 1-position of the 1,2-diglyceride 
shows a greater loss of the neutral lithium fatty acetate compared to the R2 substituent in the 2-
position, when both are initially present.  The product ion pathways leading to losses of R1 and 
R2 fatty acyl ketenes (Fig 5.7a, bottom half) are minor decomposition routes. In contrast to this 
behavior, as shown in the top half of Fig. 5.7b, for decompositions of lithiated 1,3-diglycerides 
the neutral losses of both the R1 and the R3 substituents as fatty acyl ketenes are observed to be 
the major product ions formed.  Finally, the bottom part of panel (b) illustrates that the 1,3- 
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Figure 5.7.  General scheme for distinguishing asymmetric 1,2-diglycerides, and 1,2-
diglycerides from 1,3-diglycerides based upon MS/MS decompositions of lithium adducts. (a) 
Illustrates the usage of product ion abundances for determining substituent location within an 
Neutral loss of H2O followed by neutral loss of  R1 (left) or 
R3 (right) as alpha-beta unsaturated fatty acids, discernable 
 
-α, β unsat. Fatty 
-
(b) 
(a) 
Neutral loss of R1 or R3 as fatty acyl ketenes, the most 
Loss of R1 and R2 fatty acyl ketene product ions are 
Loss of R1 substituent as lithium fatty acetate greater than loss of R2 
substituent as lithium fatty acetate. These are the predominant product 
>
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 asymmetric 1,2-diglyceride.  Loss of R1 substituent as lithium fatty acetate is greater than the R2 
loss.  Indicative of 1,2-diglycerides is that neutral losses of lithium fatty acetates are the 
predominant product ions. Bottom half of panel (a) shows that losses of fatty acyl ketenes are 
minor product ions. Top half of panel (b) illustrates that the neutral losses of the R1 or the R3 
substituent as fatty acyl ketenes are observed for the 1,3-diglyceride isomer, and these are the 
major product ions.  Bottom part of panel (b) illustrates that the 1,3-diglyceride has a 
fragmentation pathway which results in the neutral loss of H2O with subsequent loss of an alpha-
beta unsaturated fatty acid.  This fragmentation pathway is not observed for the 1,2-diglycerides. 
 
 
diglyceride has a fragment pathway which results in a consecutive neutral loss of H2O followed 
by neutral loss of an alpha-beta unsaturated fatty acid (this order was established by inspection of 
precursor scans of the ions shown at the bottom of Fig. 5.7b).  The latter fragmentation pathway 
is not observed in the 1,2-diglycerides. 
 
5.3.2 MS of Rabbit Tear Lipids 
Figure 5.8 contains the mass spectra of normal eye rabbit tears, panel (a), and dry eye 
model rabbit tears, panel (b), extracted lipid lithium adducts.  The spectra also contain lithium 
adduct peaks of four internal standards that were used to quantify the extracted lipids which are 
identified in Figure 5.8 by “IS”.  Three major envelopes are observed consisting of 
monoglycerides, diglycerides, and triglycerides.  
 
5.3.2.1 Identification of Monoglycerides 
The m/z 300 to m/z 500 region contains three major peaks at m/z 337, m/z 365, and m/z 
421.  The first two have been identified as monoglycerides with empirical formulas of 
CnH2nO4Li+, having the single substituent of C16:0 for the m/z 337 peak, identified as 
 
 109
 (a) 
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Figure 5.8. Typical single stage MS positive mode ES scans of the lithium adducts of extracted 
compounds, including the spiked internal standards (IS) of: (a) normal rabbit tear extract, and (b) 
dry eye rabbit model tear extract.  The internal standards include: 3.65x10-5 mg/µL 
monopentadecanoin at m/z 323, 4.35x10-5 mg/µL dipentadecanoin at m/z 547, 4.8x10-5 mg/µL 
palmityl behenate at m/z 571, and 5.2x10-5 mg/µL triheptadecanoin at m/z 855. 
 
 
monopalmitin glyceride, and C18:0 for the m/z 365 peak, identified as monostearin glyceride 
(the m/z 421 has been identified as a lithium adduct of an isoprene acetal).  Figure 5.9a is the 
product ion spectrum of the m/z 365 compound in the normal rabbit tear extract.  Analogous to 
the product ion spectrum of monopentadecanoin, the spectrum contains the glycerol backbone 
lithium adduct at m/z 99 derived from the neutral loss of C18:0 stearyl fatty ketene from the 
parent ion [MLi – C18H34O]+, and ions at m/z 81 and m/z 63 derived from the further loss of one, 
and then two water molecules from the glycerol backbone.  
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5.3.2.2 Identification of Diglycerides 
The m/z 500 to m/z 800 region of the spectra contains three major peaks at m/z 575, m/z 
603, and m/z 631. The m/z 575, m/z 603, and m/z 631 peaks have been identified as diglycerides 
with empirical formulas of CnH2n-2O5Li+, where n = 35, 37, and 39, respectively. 
 
5.3.2.2.1 m/z 575 
The m/z 575 compound, as a diglyceride, has two possible fatty acid configurations.  The 
product ion spectrum of m/z 575, Fig. 5.9b, allows assignment of at least two isomeric 
components having fatty acid compositions of dipalmitoyl, and stearin + myristin.  For the 
dipalmitoyl glyceride, the spectrum contains informative peaks at m/z 337 for the loss of C16:0 
fatty acyl chain as a ketene from the parent ion [MLi – C16H30O]+, at m/z 263 for the lithium 
adduct of palmitic acid [C16H32O2Li]+, at m/z 319 for the neutral loss of C16:0 fatty acid [MLi - 
C16H32O2]+, at m/z 313 for the neutral loss of C16:0 lithium fatty acetate [MLi – C16H31O2Li]+, 
and at m/z 303 for the neutral loss of H2O followed by consecutive loss of C16:1 alpha-beta 
unsaturated fatty acid [MLi-H2O-C16H30O2]+.  According to the identification scheme illustrated 
in Fig. 5.7, the observation of the m/z 303 peak confirms the presence of the 1,3-dipalmitoyl 
isomer, however, a minor presence of the 1,2-dipalmitoyl isomer cannot be ruled out 
(conversely, the absence of m/z 303 could be used to rule out the 1,3- isomer).  Secondly, the 
identification scheme illustrated in Fig. 5.7 suggests that the greater intensity of the m/z 337 
product ion (from the C16:0 fatty acyl ketene loss), as compared to the m/z 313 product ion 
(from C16:0 lithium fatty acetate loss), indicates a 1,3-dipalmitoyl isomer. Concerning the 
stearin, myristin diacylglyceride, the spectrum contains peaks that allow identification of both 
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 fatty acid substituents, including: a product ion peak at m/z 235 for C14:0 lithiated fatty acid 
[C14H28O2Li]+, at m/z 347 for the neutral loss of C14:0 fatty acid [MLi – C14H28O2]+, and at m/z 
291 for both C18:0 lithiated fatty acid [C18H36O2Li]+ and for the neutral loss of C18:0 fatty acid 
[MLi – C18H36O2]+ (also m/z 291). Peaks at m/z 309 for the loss of C18:0 fatty acyl chain as 
ketene [MLi – C18H34O]+, and at m/z 365 for the loss of C14:0 fatty acyl chain as ketene [MLi – 
C14H26O]+, are observed in similar intensities, and more predominant than those of the 
corresponding lithium fatty acetate losses, which is illustrative of the 1,3-isomer.  However, the 
spectrum does contain peaks corresponding to these lithium fatty acetate losses at m/z 285 ([MLi 
– C18H35O2Li]+ ), and at m/z 341 ([MLi -C14H27O2Li]+). Because the latter peaks are found in 
higher abundances than one would expect from a case where only the 1,3-diglyceride was 
present, it is likely that the 1,2-isomer exists as a minor component. The intensity of the m/z 341 
ion for the neutral loss of the C14:0 lithium fatty acetate is slightly greater than the m/z 285 ion 
for the neutral loss of the C18:0 lithium fatty acetate suggesting that the 1,2-isomer consists 
largely of 1-myristin,2-stearin. Finally, a peak at m/z 275 is observed for the neutral loss of H2O 
followed by consecutive loss of C18:1 alpha-beta unsaturated fatty acid [MLi-H2O-C18H34O2]+, 
also indicative of the 1,3-isomer. Thus, the parent ion contains one C14:0 fatty acid in the 3-
position, while the C18:0 fatty acid is in the 1-position allowing the assignment of 1-stearin,3-
myristin diglyceride.  The spectrum also contains the low molecular weight hydrocarbon ions 
m/z 43, m/z 57, m/z 71, and m/z 85, plus the m/z 99, m/z 81, and m/z 63 ions from the lithiated 
glycerol backbone. The m/z 575 precursor ion was thus identified as a mixture of lithiated 1,3-
dipalmitin (major component), and of 1,3-stearin-myristin and 1-myristin,2-stearin (minor 
components)  diglyceride isomers. 
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 5.3.2.2.2 m/z 603 
Similar characterization is found with the m/z 603 parent ion (Figure 5.9 panel (c)).  A major 
product ion appears at m/z 365 produced from the neutral loss of a C16:0 fatty acyl chain as a 
ketene from the parent [MLi – C16H30O]+.  A peak with slightly greater intensity is observed at 
m/z 337 from the 1-position loss of the C18:0 fatty acyl chain as a ketene [MLi – C18H34O]+.  
According to the identification scheme in Figure 5.7, the observance of the loss of these two 
different fatty acid ketenes as the predominant product ions provides evidence that this 
diglyceride is present as the 1,3- isomer.  Moreover, the intensities of the peaks at m/z 263 for 
the lithiated fatty acid ion hexadecanoic [C16H32O2Li]+ and m/z 291 from the lithiated fatty acid 
ion octadecanoic [C18H36O2Li]+ are also similar in intensity, which further indicates that the 
compound is composed primarily of the 1,3-isomer.  Characteristic peaks for the 1,3-isomer are 
also observed at m/z 303 for the consecutive neutral losses of H2O, followed by loss of C18:1 
alpha-beta unsaturated fatty acid [MLi-H2O-C18H34O2]+, and at m/z 331 for the neutral losses of 
H2O and C16:1 alpha-beta unsaturated fatty acid [MLi-H2O-C16H30O2]+.  Also observed are 
lower intensity (minor) peaks at m/z 313 from the neutral loss of C18:0 lithium fatty acetate 
[MLi – C18H35O2Li]+, and at m/z 341 from the neutral loss C16:0 lithium fatty acetate [MLi – 
C16H31O2Li]+.  Also present in lower intensities are peaks at m/z 319 for the neutral loss of 
octadecanoic acid [MLi - C18H36O2]+, and at m/z 347 for the neutral loss of hexadecanoic acid 
[MLi - C16H32O2]+.  The hydrocarbon ions at m/z 43, 57, 71, and 85 are present, as are the 
glycerol backbone ions at m/z 99, 81 and 63.  The product ion at m/z 585 is due to the loss of 
water from the parent ion [MLi - H2O]+.  The above evidence indicates that the m/z 603 parent 
ion primarily consists of the 1-stearin,3-palmitin isomer. 
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Figure 5.9.  Positive mode ES tandem mass spectra illustrating informative fragment ions used 
for identification of: (a) the m/z 365 lipid lithium adduct, identified as monostearyl glyceride, (b) 
the m/z 575 lipid lithium adduct, identified as 1,3-dipalmitin diglyceride being the major 
component, with a minor 1-stearin,3-myristin constituent, and a minor 1-myristin,2-stearin 
constituent, (c) the m/z 603 lithium adduct identified as 1-stearyl,3-palmityl diglyceride, and (d) 
the m/z 631 lithium adduct identified as 1,3-distearin acylglyceride. 
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 5.3.2.2.3 m/z 631 
Finally, for the spectrum of the m/z 631 compound in Figure 5.9d a product ion at m/z 
365 is observed for the neutral loss of C18:0 fatty acyl chain as a ketene [MLi – C18H34O]+, and 
the ion at m/z 331 from the consecutive neutral losses of H2O and C18:1 alpha-beta unsaturated 
fatty acid [MLi-H2O-C18H34O2]+ that is indicative of a 1,3-diglyceride, is also observed.  The 
spectrum also contains the lithium adduct of stearic acid at m/z 291 [C18H36O2Li]+, and peaks at 
m/z 341 for the neutral loss of C18:0 lithium fatty acetate [MLi-C18H35O2Li]+, as well as at m/z 
347, representing the neutral loss of the C18:0 fatty acid [MLi-C18H36O2]+.  The spectrum is also 
characterized by the low molecular weight product ions from carbon-carbon bond dissociation, 
and the product ions for the glycerol backbone, and subsequent one and two water losses.  The 
structure is thus assigned as the 1,3-distearin diglyceride, but the presence of a minor amount of 
the 1,2- isomer cannot be ruled out. 
 
5.3.2.3 Identification of Triglycerides 
The m/z 800 to m/z 1100 range consists of triesters of the empirical formula CnH2n-
4O6Li+.  Figure 5.10a shows an expanded mass axis illustrating the m/z 850 to m/z 970 region.  
As can be seen by the relative peak intensity of the internal standard triheptadecanoin (m/z 855), 
the triesters are present in relatively low concentrations.  Peaks in this area, such as the m/z 863, 
the m/z 877, the m/z 905, m/z 961, etc., were analyzed by MS/MS and were found to be singly 
charged Li+-bound mixed dimers primarily comprised of species from the 500 to 800 Da region 
noncovalently bound with species in the 300 to 500 Da region.  The product ion spectrum of the 
m/z 897 peak, Figure 5.10b contains ions that are consistent with the characterization of 
triglycerides, such as the m/z 267 peak for the C18:0 acylium ion [C18H35O]+, the lithium adduct 
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 of octadecanoic acid at m/z 291 [C18H36O2Li]+, the parent ion minus lithiated arachidinoate at 
m/z 579 [MLi – C20H39O2Li]+, the parent ion minus the neutral loss of arachidinoic acid at m/z 
585 [MLi – C20H40O2]+, the parent ion minus lithiated octadecanoate at m/z 607 [MLi - 
C18H35O2Li]+, and the parent ion minus neutral loss of octadecanoic acid at m/z 613 [MLi - 
C18H36O2Li]+.  A low intensity peak is observed at m/z 641 from the loss of palmitic acid [MLi – 
C16H32O2]+.  The absence of more of the ions of the fatty acids is probably due to the low 
concentration levels being measured.  The spectrum also contains lower molecular weight ions 
from the fragmentation of the fatty acids through carbon-carbon bond cleavage.  The peak at m/z 
897 is thus assigned as the lithium adduct of a mixture of two triglyceride isomers with the 
predominant one being trioctadecanoin, and the minor being 1-arachidin,2-stearin,3-palmitin. 
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Figure 5.10 (a) Expanded mass axis of the triester spectral region (m/z 850 to m/z 970) of 
normal tear extract lithium adducts illustrating the occurrence of mixed dimers, and low 
concentrations of triacylglycerols present in the extract.  (b) Product ion spectrum with peak 
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 assignments of informative product ions of the m/z 897 precursor identified as an isomeric 
mixture of tristearin and 1-arachidin,2-stearin,3-palmitin. 
 
 
5.3.2.4 Wax Ester Analysis 
Also included in the extract is a peak at m/z 571 from the spiking addition of palmityl 
behenate, a fatty acid/fatty alcohol wax ester standard (see Figure 5.1e for structure).  The wax 
ester was found to have a low ionization efficiency compared to the other components in the tear 
extract.  This was expected, as the ionization efficiency for lipids with ammonium acetate 
showed greater response as the polarity of the lipid increased(28) (increase in number of alcohol 
groups, one for diglyceride, two for monoglyceride, etc.), while the product ions were only of the 
protonated species from the initial loss of NH3.  This trend was also observed with an equimolar 
mixture of lipid standards, where the monoglycerides exhibited the greatest response, followed 
by the diglycerides, with the triglycerides showing the weakest response, though the product ions 
were mostly lithiated, with some appearing as fragment ions (e.g., acylium).  Some of the 
experiments yielded good responses for the palmityl behenate wax ester standard, and peaks in 
the region expected for wax esters (m/z 500 to m/z 700) were analyzed by tandem mass 
spectrometry, but these peaks were not found to correspond to wax esters.  The major 
components of the non-polar tear lipids have been reported in the past literature as wax esters(10-
14), such as the C27 alcohol/C15 fatty acid wax ester which would have a lithiated mass at m/z 
625.  None of the simple, fatty alcohol/fatty acid wax esters(58) were observed in any of the 
extracts reported in this study.  Previous work in our lab (unpublished results) showed that the 
optimum response for lithiated phosphorylated lipids was at approximately 10 mM LiCl.  A new 
ionization-internal standard solution was used which contained 10 mM LiCl, instead of the 2 
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 mM LiCl solution which had been used in all previous experiments.  While the individual wax 
ester standard gave an excellent response when run with 10 mM LiCl, poor responses were still 
achieved when it was present with other lipids in a mixture, suggesting that the low response for 
the wax ester standard was due to suppression from the acylglycerides.  However, a search for 
the simple fatty alcohol/fatty acid wax esters, such as the C27 alcohol/C15 fatty acid wax ester 
(lithium adduct mass at m/z 625), resulted in the conclusion that the wax esters are probably not 
detectable by this method, as they are likely present below the method’s limit of detection for 
wax esters (i.e., 1.4 x 10-5 mg/µL, S/N = 3) established for the spiked palmityl behenate internal 
standard. This means that under the method’s conditions for ES of the lithium adducts, the wax 
and cholesterol esters are not being observed. Other separation methods performed in our lab 
such as TLC indicated that the wax and cholesterol esters are indeed present, but the current ES-
MS method suppresses their response. 
 
 5.3.2.5 Quantification of the Tear Lipids 
To estimate the concentration of the lipids in the extract, standards were chosen which 
were predicted to have ionization efficiencies very similar to those of the extracted lipids.  For 
the m/z 20 to m/z 500 region, monopentadecanoin was used with a lithium adduct mass of m/z 
323, for the m/z 500 to m/z 800 region, dipentadecanoin was used with a lithium adduct mass of 
m/z 547, for the m/z 800 to m/z 1100 region, triheptadecanoin was used with a lithium adduct 
mass of m/z 855; for the wax esters, palmityl behenate was used with a lithium adduct mass of 
m/z 571.  Figure 5.8a is the spectrum of the lithium adducts of normal tear lipid extract where the 
locations of the internal standards are marked with “IS”.  The concentrations of the four internal 
standards were chosen to be in the same approximate range as the extracted lipids, namely 
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 3.65x10-5 mg/µL monopentadecanoin, 4.35x10-5 mg/µL dipentadecanoin, 5.2x10-5 mg/µL 
triheptadecanoin, and 4.8x10-5 mg/µL palmityl behenate, all in 50:50 chloroform/methanol with 
2 mM LiCl.  To quantify the terpenoids, the response factor of the diacylglyceride 
dipentadecanoin was used due to the expected similarity in ionization efficiency (one alcohol 
group) for the two.   
Table 5.1 shows a comparison of quantitative results of the normal and dry eye tear lipid 
extracts.  The total lipid extract value for the normal eye is 7.3 ± 0.7 µg µl-1, while the dry eye 
total lipid extract average result was determined to be 14.0 ± 2.1 µg µl-1.  This indicates that the 
total lipid content in dry eye tears is much greater, approximately double, as compared to what is 
observed in normal eye tears.  This might be explained by the fact that the dry eye may have less 
aqueous content in the tear layer compared to normal eyes, resulting in a higher concentration of 
lipids per microliter of tears. In particular, the glyceryl isoprene acetals appear to have increased 
in concentration the most (approximately three-fold relative to the normal eye). The relatively 
large standard errors of the means (see Table 5.1) indicate variation in lipid composition from 
sample to sample. The general overall pattern for the two lipid extracts is similar when 
comparing each compound’s percentage of the total extract.  
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Compound Identification Li+ Adduct 
(m/z) 
Normal Eyea 
(mg/µL) 
Dry Eyeb 
(mg/µL) 
Percent Increase 
(%) 
Free glycerol 99 9.6x10-4 ± 2.3x10-4 1.5x10-3 ± 2.7x10-4 56 
Glyceryl-isoprene acetal 153 6.8x10-4 ± 2.7x10-4 1.7x10-3 ± 8.5x10-4 150 
Glyceryl-isoprene acetal 287 7.5x10-4 ± 2.9x10-4 1.8x10-3 ± 9.2x10-4 140 
Monopalmitin 337 7.4x10-4 ± 1.6x10-4 1.1x10-3 ± 2.0x10-4 49 
Monostearin 365 1.6x10-3 ± 3.4x10-4 2.5x10-3 ± 2.5x10-4 56 
Glyceryl-isoprene acetal 421 1.2x10-3 ± 3.7x10-4 2.9x10-3 ± 1.6x10-3 142 
1,3-dipalmitin (major) 
1-stearin,3-myristin (minor) 
1-myristin,2-stearin (minor) 
575 1.4x10-4 ± 3.1x10-5 2.1x10-4 ± 2.3x10-5 50 
1-stearin,3-palmitin (major) 603 5.2x10-4 ± 9.5x10-5 7.3x10-4 ± 2.7x10-5 40 
1,3-distearin (major) 631 5.1x10-4 ± 9.0x10-5 7.2x10-4 ± 1.3x10-5 41 
Tristearin (major) c
1-arachidin,2-stearin, 
3-palmitin (minor) 
897 1.3x10-4 ± 5.5x10-5 1.8x10-4 ± 9.9x10-5 38 
TOTAL  7.3x10-3 ± 7.1x10-4 1.4x10-2 ± 2.1x10-3 92 
 
aAverages and standard errors of the mean reported for normal eye results were derived from 
four different sets of composite rabbit tear samples, where each composite set was analyzed 
separately.  Tear composite volumes were 12 µL, 12 µL, 7 µL, and 7 µL. 
bDry eye results are the average and standard error of the mean of two different composite sets 
which were analyzed individually.  Tear composite volumes were 6 µL, and 7 µL. 
cReported value for the triglyceride tristearin is substantially above the method’s limit of 
detection for triglycerides (i.e., 5.8 x 10-6 mg/µL).   
 
Table 5.1.  Comparison of Quantitative Results of Normal and Dry Eye Tear Lipid Extracts. 
 
 
5.4 Conclusions 
Tandem mass spectrometry experiments on the major components of the total chloroform 
extracts identified that these compounds were more polar than the simple “fatty acid esterified to 
a fatty alcohol” type of wax ester, which is what has been previously reported to make up the 
majority of the non-polar lipids.  Empirical formulas were derived which can be used to calculate 
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 the number of oxygens, and double bonds, for the species in three mass regions which primarily 
indicate lipids.  The first region (m/z 20 to m/z 500) consists of free glycerol, three glyceryl-
terpene acetals, and monoacylglycerols with empirical formulas of CnH2nO4Li+.  The m/z 500 to 
m/z 800 region consists of diacylglycerols with empirical formulas of CnH2n-2O5Li+, and the m/z 
800 to m/z 1100 region is comprised of triacylglycerols with empirical formulas of CnH2n-4O6Li+. 
The work reported here using lithium adducts, combined with electrospray tandem mass 
spectrometry (ES-MS-MS), for the analysis of complicated biological extracts has shown a 
marked improvement over past approaches of TLC, HPLC-MS, derivative GC-MS, etc., that 
have been used to characterize the tear film lipids. New, informative product ion spectra are 
presented for lithiated monoacyl, 1,2- and 1,3-diacyl, and triacylglyceride standards.  Newly 
proposed structures and fragment pathways for the major product ions are presented for the 1,2- 
and 1,3-diglycerides, and for the monoglyceride. The mass spectra of the lithium adducts of the 
acylglycerides contain detailed and informative product ions that were successfully used to 
identify the acylglycerides, and the terpenoid type compounds that were observed to be present 
in the tear extracts.  Through the use of ES-MS/MS, the normal and dry eye rabbit tear extracted 
lipids were found to be primarily comprised of acylglycerides that exhibited high responses in 
ES, whereas the wax and cholesterol esters were not detected, presumably due to ionization 
suppression. Also, with this approach, separation such as HPLC, TLC, SPE, etc., was not 
essential due to separation by mass.  Finally, all extracted compounds that are subsequently 
ionized and measured by the mass spectrometer can be quantified, and analyzed by tandem mass 
spectrometry to identify their molecular structures.  
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 CHAPTER VI :  MALDI-TOF MS OF PHOSPHORYLATED LIPIDS IN BIOLOGICAL 
FLUIDS USING IMMOBILIZED METAL AFFINITY CHROMATOGRAPHY AND A SOLID 
IONIC CRYSTAL MATRIX 
 
6.1 INTRODUCTION 
Lipids are important biomolecules that are found in all living species.  These include non-
polar lipids such as the acylglycerols, and the more polar phosphorylated lipids.  Of the non-
polar lipids, triacylglycerols are thought to be a storage form of carbon in the cells1, while 
diacylglycerols are of special importance for their role as physiological activators of protein 
kinase C (PKC)2,3.  Of the polar lipids, those containing phosphoryl head groups, such as the 
phosphatidylcholines (PC), the phosphatidylethanolamines (PE), and the phosphatidylserines 
(PS) (see Fig. 1 for structures), constitute the bilayer components of biological membranes, 
determine the physical properties of these membranes, and directly participate in membrane 
protein regulation and function.  Other types of phosphorylated lipids are the sphingomyelins and 
the glycosphingolipids which have been reported to be involved in different biological processes 
such as growth and morphogenesis of cells4.  Thus, analysis of this special class of biomolecules 
has been of great interest to medical researchers, biologists, and chemists. 
Recent analyses of phospholipids have employed HPLC5, MEKC5,6, CE-ES-MS7, ES-
MS-MS8-15, and to a lesser extent MALDI-FTICR16, and MALDI-TOF17-21.  The mass 
spectrometric analyses of nonvolatile lipids has been reviewed by Murphy, et al.22, and it is 
pointed out that the advent of soft ionization techniques such as ES-MS and MALDI-MS, has 
obviated the need for derivatization of lipids.  Biological samples are complex mixtures of a 
wide variety of compounds that can have a negative influence on the ability to identify and 
quantify lipids by mass spectrometry; effects include signal suppression, and interferences from 
isomeric and isobaric compounds. 
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 In this paper, a MALDI-TOF MS study of the phosphorylated lipids of normal human 
eye tear is reported using a novel solid ionic crystal MALDI matrix comprised of para-
nitroaniline and butyric acid. MALDI-TOF has become an important tool for the characterization 
of complex biological extracts due to its high sensitivity, high resolution, and limited 
fragmentation of the compounds of interest. Front-end isolation of the phosphorylated lipids was 
achieved using immobilized metal affinity chromatography (IMAC). The chemical composition 
of the human meibomian gland liquid secretions (tear) has previously been characterized by 
HPLC23, P-NMR24, TLC25, and fatty acid fragment profiles have been generated by HPLC-MS26.  
The newly developed methods reported in this paper enable the detection of very low-level 
phosphorylated lipids in tear samples, and have the potential for use for phosphorylated lipid 
determinations in other complex biological samples. 
 
6.2 EXPERIMENTAL SECTION 
6.2.1 Extraction of non-Polar and Polar Lipids 
The non-polar and polar lipid fractions were extracted from tear samples with a simple 
modified chloroform-water partitioning procedure27,28.  The aqueous phase contained the tear 
proteins, while the chloroform phase held the lipids.  
 
6.2.2 Synthesis of Solid Ionic Crystal MALDI Matrix 
Scheme 6.1 is a reaction scheme showing the synthesis of the solid ionic crystal matrix 
for MALDI. 250 mg of 4-nitroaniline and 333 µL of butyric acid were added to 9.05 mL of 
methanol with vortex mixing. After one minute, solvent was removed by rotovap. Upon removal 
of the methanol, yellow, slightly oily, pungent crystals were formed. The MALDI matrix used 
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 for further studies consisted of 20 mg of the solid ionic crystal 4-nitroaniline/butyric acid 
dissolved in 1 mL of ethanol. 
 
 
 
Scheme 6.1. Synthesis of MALDI ionic crystal matrix. 
 
6.2.3 MALDI-TOF MS Analysis 
   MALDI-TOF mass spectra were acquired using an Applied Biosystems Voyager Elite r-
ToF with Delayed Extraction (Applied Biosystems, Inc., Framingham, MA).  An applied 
extraction voltage of 20 kV was typically employed. Delayed extraction mode was used for all 
acquisitions with a 175 ns delay time setting.  The laser was operated just above the threshold 
energy required to obtain desorption/ionization. Each phospholipid mass spectrum constitutes an 
average of 150 to 200 traces.  For sample plate spotting, 3 µL of phospholipid solution was 
mixed with 3 µL of matrix and then deposited onto the MALDI plate and allowed to air dry. 
All spectra were calibrated using a two-point calibration employing protonated lyso PC, 
at m/z 496.34, and protonated DMPC at m/z 678.51.  Phospholipids in the biological samples are 
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 identified according to their MALDI-TOF MS spectral molecular weights derived from either 
protonated molecules, sodiated molecules, and/or PSD product ions. 
 
6.3 RESULTS AND DISCUSSION  
6.3.1 Characterization and Optimization of the Ionic Crystal MALDI matrix 
Experiments were performed in order to characterize and optimize the MALDI matrix for 
the mass spectral analysis of the phosphorylated lipids extracted from tear samples.  In general, 
prompt fragmentation involving cleavage at the head group of phosphorylated lipids is a 
common problem when analyzing biological lipid extracts by MALDI.  Difficulties pertaining to 
the ability to obtain quantitative29 and spatial30 information also arise when using solid MALDI 
matrixes.  Inhomogeneous deposits of the analyte within the matrix and non-uniformities in the 
matrix layer cause variations in responses due to so-called “hot” or “sweet” spots versus the 
areas that produce lower-level signals.  In general, a rather complex relationship exists between 
the MALDI spectral signal intensity and the amount of the measured analyte present in the 
spot.31 A recent study by Rujoi et al.32, reported the use of para-nitroaniline as a matrix for the 
study of the neutral phospholipids phosphatidylcholine and sphingomyelin in lens tissue, where 
the obtained [M + H]+, [M + Na]+, and [M + K]+ signals appeared in greater sensitivities as 
compared to the 2,5-dihydroxybenzoic acid (DHB) matrix often used for phosphorylated lipids.  
Recently reported by Mank et al.29 is the use of ionic liquid matrixes which have improved shot-
to-shot reproducibility of signal intensities over traditional solid matrixes.  This should enable 
more accurate quantitative analysis by MALDI.  Also reported is a reduction in fragmentation 
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Figure 6.1. Structures of the main phosphorylated lipids included in this study. The left side lists 
the neutral, polar, zwitterionic phosphorylated lipids. The right side lists the anionic 
phosphorylated lipids as their neutral sodium adducts. 
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induced by the MALDI ionization technique when using the ionic liquid matrixes.  Three 
examples of ionic liquid matrixes used by Mank et al.29 are illustrated in Figure 6.2: (a) 2,5-
dihydroxybenzoic acid butylamine, (b) alpha-cyano-4-hydroxycinnamic acid butylamine, and (c) 
3,5-dimethoxy-4-hydroxycinnamic acid triethylamine.  The ionic liquid matrixes are formed 
through combining the appropriate viscous liquid amines with the crystal MALDI matrix, after 
having dissolved both in methanol.  The methanol and free amine are subsequently removed, 
thus producing the ionic pair which is then mixed with a small amount of ethanol to reduce the 
viscosity of the liquid matrix. 
In the present study, para-nitroaniline was reacted with butyric acid as shown in Scheme 
6.1. This mixture contrasts with those in Fig. 6.2 in that an ionic liquid was not produced. Rather, 
upon analyte mixing and drying, a solid ionic crystal is formed that acts as a powerful gas-phase 
proton donor and enhances phosphorylated lipid response. Because the final matrix preparation 
is crystalline, it shows deposition (spotting) behavior similar to other widely used solid MALDI 
matrixes such as sinapinic acid, DHB, or α-CHCA.  Furthermore, difficult applications, such as 
depositing the matrix upon tissue or other surfaces for MALDI analyses revealing two-
dimensional spatial distributions, will be more likely to succeed when a solid ionic crystal matrix 
is used in preference to an ionic liquid matrix.  Finally, acidification of the analyte environment 
should not be severe with the solid ionic crystal matrix (where butyric acid is largely ion-paired 
with a p-nitroaniline), in contrast to the acidic MALDI matrixes DHB or α-CHCA.  
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Figure 6.2. Ionic liquid matrixes used for improved shot-to-shot reproducibility, and a reduction 
in fragmentation induced by MALDI. (a) 2,5-dihydroxybenzoic acid butylamine, (b) alpha-
cyano-4-hydroxycinnamic acid butylamine, and (c) 3,5-dimethoxy-4-hydroxycinnamic acid 
triethylamine.     
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 6.3.2 Zwitterionic Phospholipid MALDI Matrix Comparison.  
For the optimization of the MALDI matrix for phosphorylated lipid analyses, six matrix 
preparations were evaluated in a comparison of the PNA-butyric acid matrix (with and without 
TFA) to 4 standard matrix preparations. The six matrixes consisted of (1) 20 mg/mL DHB 
dissolved in 1:1 MeOH:CHCl3, (2) 10 mg/mL DHB + 10 mg/mL α-CHCA + 0.1% TFA 
dissolved in 2:1 CHCl3:MeOH, (3) 20 mg/mL PNA dissolved in EtOH, (4) 20 mg/mL PNA + 
0.1% TFA dissolved in EtOH, (5) 20 mg/mL PNA-butyric acid ionic crystals dissolved in EtOH, 
and (6) 20 mg/mL PNA-butyric acid ionic crystals + 0.1% TFA dissolved in EtOH. TFA was 
included in certain preparations to either aid in analyte protonation, or to enhance the dissolution 
of the lipids in the matrix17. 
Table 6.1 shows the zwitterionic phosphorylated lipids’ major molecular ions observed in 
the MALDI spectra for the six different matrixes; Figure 6.1 illustrates the structures of the 
phosphorylated lipids used in this study. The left side of Figure 6.1 lists the neutral, polar 
zwitterionic phosphorylated lipids. The right side of Figure 6.1 shows the anionic phosphorylated 
lipids as their neutral sodium salts.  In Table 6.1, the most striking feature found was that the 
PNA-butyric acid matrix and the PNA-butyric acid plus TFA matrix both produce the protonated 
form of PE as the predominant molecular ion.  This is illustrated in Figure 6.3 which compares 
the MALDI spectra of PE using the six separate matrixes obtained at a laser fluence just above 
the threshold energy for appearance. For the DHB matrix, Fig. 6.3a, the major molecular ion 
peak is the sodium adduct [PE+Na]+ at m/z 714, while the protonated molecule [PE+H]+ at m/z 
692 is of considerably lower abundance in the spectrum. Also observed in the spectrum are 
major ions produced through neutral head group losses at m/z 537 [PE+H-C3H10NO4P]+, at m/z  
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αCHCA/DHB 
0.1% TFA 
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PE [PE+Na]+
[PE-HG]+
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[PE-HG]+
Very Low 
Signal 
[PE+H]+
[PE-HG]+
[PE+H]+ [PE+H]+
[PE-HG]+
Lyso PC [PC+H]+
[PC+Na]+
[PC+H]+ [PC+H]+ [PC+H]+ [PC+H]+ [PC+H]+
SM [SM+H]+
 
[SM+Na]+
[SM+H]+ [SM+H]+ [SM+H]+ [SM+H]+ [SM+H]+
PC [PC+H]+ [PC+H]+ [PC+H]+ [PC+H]+ [PC+H]+ [PC+H]+
PAF [PAF+H]+ [PAF+H]+ [PAF+H]+ [PAF+H]+ [PAF+H]+ [PAF+H]+
 
Table 6.1. Comparative Study of the Zwitterionic Phosphorylated Lipids’ Major Spectral 
Molecular Ions Observed for the Six Different MALDI Matrixes. 
 
 
 
551 [PE+H-C2H8NO4P]+, and at m/z 565 which is probably produced through post source decay 
(the peak is wide and the isotopes are not resolved). The 1:1 DHB:α-CHCA plus TFA matrix, 
Fig. 6.3b, produces the sodium adduct as the major MI, but there is significant head group loss 
leading to m/z 551. The protonated molecule, [PE+H]+, is only a very minor peak at m/z 692. 
The PNA matrix, Fig. 6.3c, did not produce any appreciable positive mode molecular ions at 
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Figure 6.3. Comparison of the six MALDI matrixes for the analysis of 
phosphatidylethanolamine in positive ion mode. (a) DHB matrix showing predominant sodium 
adduct peak [PE+Na]+ at m/z 714, and minor [PE+H]+ at m/z 692. (b) α-CHCA/DHB plus TFA 
matrix with sodium adduct at m/z 714, but significant head group loss at m/z 551 observed, and a 
minor [PE+H]+ peak at m/z 692. (c) PNA matrix shows no appreciable signals for sodium 
adducts or protonated molecules. (d) PNA plus TFA producing [PE+H]+ at m/z 692, but major 
peaks for neutral losses of head group components at m/z 551, and m/z 605 are also observed.  
(e) PNA-butyric acid solid ionic crystal matrix producing predominantly the [PE+H]+ ion at m/z 
692 with only very minor amounts of the sodium adduct at m/z 714, and few fragment ions. (f) 
PNA-butyric acid plus TFA matrix producing the [PE+H]+ ion at m/z 692 as a major spectral 
peak, but also significant headgroup loss ions at m/z 551 and m/z 565. 
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the expected m/z values of sodium or proton adducts. The PNA plus TFA matrix, Fig. 6.3d, did 
produce the protonated molecule [PE+H]+ at m/z 692, but also major peaks for neutral losses of 
head group components at m/z 551, and m/z 605.  In general, the inclusion of TFA was observed 
to promote fragmentation in the form of the loss of neutral head group components.  The newly 
synthesized solid ionic crystal PNA-butyric acid matrix (Fig. 6.3e) and the PNA-butyric acid 
plus TFA matrix (Fig. 6.3f) were observed to produce protonated molecules as the major spectral 
peaks, with only very minor amounts of sodium adducts. However, the presence of TFA was 
again observed to induce significant fragmentation of the protonated molecule in the form of 
head group (neutral) loss at m/z 551 (Fig. 6.3f). 
The observance of the protonated molecule, MH+, as the major species in the mass 
spectrum helps to simplify spectral interpretation and can help enhance the fragmentation 
efficiency in tandem mass spectrometry experiments33. As illustrated in Table 6.1, the 
phosphatidylcholine head group containing lipids such as lyso PC, PC, PAF, and sphingomyelin 
all yield protonated molecules as the predominant molecular ion for the six matrixes studied.  
However, the solid ionic crystal PNA-butyric acid matrix allows formation of the strongest 
[lipid+H]+ peak, and is the least conducive to head group loss. 
Figure 6.4a is a MALDI-TOF spectrum of the para-nitroaniline/butyric acid matrix 
preparation illustrating the low molecular weight portion of the m/z range. The predominant 
spectral PNA-related ions include: m/z 108 [PNA+H-HNO]+ and m/z 109  
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Figure 6.4. (a) MALDI-TOF mass spectrum of the para-nitroaniline/butyric acid matrix 
preparation illustrating the low mass region of the mass spectrum and showing background peaks 
originating from the matrix. (b) MALDI-TOF mass spectrum of a two-component mixture of 
lyso PC and DMPC standards showing protonated lyso PC at m/z 496, and protonated DMPC at 
m/z 678, using the PNA-butyric acid matrix. 
 
 
[PNA+H-NO]+ (both requiring rearrangement), m/z 122 [PNA+H-NH3]+, m/z 139 [PNA+H]+, 
and m/z 229 [2PNA+H-H2NO2]+ (actually produced through a reaction between two PNA 
molecules). Figure 6.4b is a MALDI-TOF spectrum of a two-component standard using the 
PNA-butyric acid matrix which includes the low molecular weight range of the spectrum. The 
standard consists of lyso PC and DMPC. As can be seen in Fig. 6.4b there is no interference of 
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 the matrix peaks with the lipid analytes. An approximate limit of detection was determined to be 
1 x 10-6 M DMPC (~300 pg on sample target) using the novel solid ionic crystal as the MALDI 
matrix. 
 
6.3.3 Anionic Phospholipid MALDI Matrix Comparison 
Table 6.2 shows the anionic phosphorylated lipids’ major molecular ions observed in 
MALDI mass spectra for the six different matrixes (see right side of Fig. 6.1 for structures). Row 
1 of Table 6.2 shows the results for MALDI-TOF MS analysis of six matrixes with the lipid 
standard phosphatidylglycerol (PG) which is anionic and often present as a sodium salt.  The 
DHB:α-CHCA plus TFA matrix was found to produce the [PG+2Na-H]+ molecular ion as the 
predominant peak, while the other five were observed to produce the sodium adduct [PG+Na]+ 
as the predominant molecular ion.  For the PNA plus TFA matrix, the addition of TFA was 
found to promote prompt head group loss from both [PG+2Na-H]+ and [PG+Na]+.  Figure 6.5a is 
the MALDI-TOF spectrum of PG using the PNA-butyric acid matrix showing the sodium adduct 
[PG+Na]+ at m/z 771, and [PG+2Na-H]+ at m/z 793.  The phosphatidylserine lipid was also 
observed to suffer high degrees of head group loss with the addition of TFA as shown in Table 
6.2, row 2. For the DHB:α-CHCA plus TFA matrix, PS exhibited facile prompt head group loss, 
and [PS+Na]+ at m/z 784 was observed to be a very minor spectral ion. Head group loss for PS 
leading to m/z 577 [PS-C3H7NO6PNa]+ as a major spectral ion was observed for the PNA plus 
TFA matrix and for the PNA-butyric acid plus TFA matrix.  Figure 6.5b is the MALDI-TOF 
spectrum of PS using the PNA-butyric acid matrix showing [PS+Na]+ at m/z 784, and 
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 Lipid DHB 50/50 
αCHCA/DHB 
0.1% TFA 
PNA PNA 
0.1% TFA 
PNA + 
Butyric Acid 
PNA + 
Butyric Acid 
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 [PG+2Na-H]+
[PG-HG] 
[PG+2Na-H]+
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[PG+2Na-H]+
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[PG-HG]+
[PG+Na]+
[PG+2Na-H]+
[PG+Na]+
PS [PS+Na]+
 [PS+2Na-H]+
[PS-HG]+ [PS+Na]+ [PS+Na]+
[PS-HG]+
[PS+Na]+  [PS-HG]+
 
PA [PA+Na]+ 
[PA+2Na-H]+
[PA+2Na-H]+ Very Low 
Signal 
[PA+2Na-H]+
 [PA+Na]+
[PA+Na]+
[PA+2Na-H]+
Very Low 
Signal 
PI [PI+Na]+
 [PI+2Na-H]+
[PI+2Na-H]+
 [PI+Na]+
[PI+Na]+
 [PI+2Na-H]+
[PI+Na]+
 [PI+2Na-H]+
[PI+Na]+
[PI+2Na-H]+
[PI+Na]+
 [PI+2Na-H]+
 
Table 6.2. Comparative Study of the Anionic Phosphorylated Lipids’ Major Spectral Molecular 
Ions Observed for the Six Different MALDI Matrixes (for abbreviations, see text. HG = head 
group). 
 
[PS+2Na-H]+ at m/z 806.  Notably, the phosphatidic acid (PA) lipid standard, Table 6.2, row 3, 
did not respond well when mixed with either the PNA matrix or the PNA-butyric acid plus TFA 
matrix. For PA in the PNA-butyric acid matrix (Fig. 6.5c), the predominant ion peak was 
observed to be the [PA+Na]+ ion at m/z 697 which is in contrast to the DHB:α-CHCA plus TFA 
matrix and the PNA plus TFA matrix where the predominant ion is [PA+2Na-H]+ (m/z 719). 
With the novel solid ionic crystal matrix (PNA-butyric acid), PG and PA are found 
predominantly as the sodium adducts [Phospholipid+Na]+, and not as [Phospholipid+2Na-H]+.  
This suggests that the butyric acid additive in the PNA matrix is acting as a protonating agent 
during MALDI analysis, displacing one of the sodium ions. This behavior is similar to that 
observed for PE (Table 6.1, row 1) where the predominant molecular ion is [PE+H]+ (Fig. 6.3e), 
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 whereas the sodium adduct [PE+Na]+ is observed as the predominant molecular ion with the 
DHB matrix (Fig. 6.3a) and the DHB:α-CHCA plus TFA matrix (Fig. 6.3b).  
Other non-polar lipids that do not contain phosphate in the head group were also tested 
with the new matrix. These consisted of cholesteryl stearate, monopentadecanoin, 1-palmitin-2-
stearin diacylglycerol, 1-palmitoyl-3-stearoyl diacylglycerol, triheptadecanoin, and the wax ester 
palmityl behenate. Observed in the MALDI-TOF spectra (not shown) for all of these non-polar 
lipids were sodium adducts as the predominant molecular ion peak, with minor potassium 
adducts.  
As compared to traditional MALDI matrixes such as DHB for the study of 
phosphorylated lipids, one may summarize that the PNA-butyric acid solid ionic crystal offers: 
(1) reliable appearance of only the protonated molecules of lipids containing phosphatidylcholine 
head groups such as lyso PC, PC, and PAF; (2) reliable appearance of only the sodium adduct 
species for anionic phospholipids such as PG, PA, and PS; and (3) the ability to simultaneously 
detect all of the phosphorylated lipids represented in Figure 6.2 (including PE) in the positive 
mode of MALDI-MS. These three points can greatly simplify determinations of phosphorylated 
lipids present in complex biological samples and extracts. 
 
6.3.4 PSD Fragmentation Study of Phosphatidylserine 
Post source decay (PSD) analysis was performed on the phosphorylated lipid standards to 
study the decompositions of [Phospholipid+H]+ for the neutral, polar zwitterionic phospholipids, 
and both the [Phospholipid+Na]+ and [Phospholipid+2Na-H]+ peaks for the anionic 
phospholipids. Figure 6.6a is the PSD spectrum of the sodium adduct of phosphatidylserine 
[PS+Na]+ at m/z 784. 
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Figure 6.5. (a) MALDI-TOF mass spectra acquired using the PNA-butyric acid matrix: (a) PG 
showing [PG+Na]+ at m/z 771, and [PG+2Na-H]+ at m/z 793, (b) PS displaying [PS+Na]+ at m/z 
784, and [PS+2Na-H]+ at m/z 806, and (c) PA showing [PA+Na]+ at m/z 697, and [PA+2Na-H]+ 
at m/z 719.     
 Figure 6.6b is the PSD spectrum of [PS+2Na-H]+ at m/z 806.  As can be seen in the two figures, 
the two molecular ions of PS have the same fragmentation pathways producing loss of head 
group fragments, but the favored pathways appear to be quite different. The phosphatidylserine 
lipid undergoes three forms of head group neutral loss under PSD conditions. The three product 
ion structures representing m/z 697, m/z 599, and m/z 577 are illustrated in Fig. 6.6a.  As has 
been previously reported by Al-Saad et al19, m/z 577 represents a six-membered ring product ion 
where the sodium was lost with the head group. The m/z 599 product ion is assigned as the 
sodium adduct of an alkene.  The fragmentation pathway leading to the m/z 577 product ion is 
clearly favored over the m/z 599 product ion (Fig. 6.6a).  The m/z 577 product ion involves the 
neutral loss of the sodium in the head group, while the production of the m/z 599 product ion 
results in the sodium staying adducted to the acylglycerol portion of the lipid.  This indicates that 
for each molecular ion that contains two sodium atoms, one of the sodium ions is clearly 
associated with the negatively charged oxygen in the phosphoryl group.  Secondly, the 
predominant m/z 208 product ion in Fig. 6.6a, which is comprised of the neutral head group 
sodium adduct, is similar to the fragmentation pathway forming m/z 577, except that a proton is 
transferred to the head group, so charge is retained on the latter. This further indicates that the 
predominant form of the precursor is the singly-sodiated molecule where the sodium is adducted 
to the phosphoryl head group, and not the acylglycerol portion of the lipid. For [PS+2Na-H]+ the 
only predominant product ion is m/z 719 (Fig. 6.6b), which is formed through the neutral loss of 
C3H5O2N (87 Da). This indicates, as observed by Al-Saad et al.19, that [PS+2Na-H]+ is more 
stable than [PS+Na]+. In fact, this is well known because charge on Na+ is less mobile than on H+ 
33. Figure 6.6b also contains structures of the different neutral molecules involved in head group 
losses. 
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Figure 6.6. PSD spectra of: (a) phosphatidylserine [PS+NA]+ precursor ion at m/z 784, and (b) 
phosphatidylserine [PS+2Na-H]+ precursor ion at m/z 806. 
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 6.3.5 PSD Fragmentation Study of Phosphatidic Acid 
Head group loss pathways similar to those observed for phosphatidylserine were also 
observed in the PSD spectrum of phosphatidic acid, as illustrated in Figure 6.7a. In the spectrum 
there is the six-membered ring formation for the neutral loss of the sodium-containing head 
group at m/z 577 [M+Na-PO4H2Na]+, and the alkene product ion formed through neutral head 
group loss at m/z 599 [M+Na-PO4H3]+.  Also observed in Fig. 6.7a are product ion peaks arising 
from neutral loss of the C16:0 fatty acid substituent at m/z 441 [M+Na-C16H32O2]+, neutral loss 
of C18:0 sodium fatty acetate at m/z 391 [M+Na-C18H35O2Na]+, and a sodium adduct of the 
phosphoric acid head group at m/z 121 [H3PO4Na]+.  Figure 6.7b is the PSD spectrum of 
[PA+2Na-H]+. The two predominant peaks are formed through neutral loss of the fatty acid 
substituents, and can be used for identification purposes when coupled with the PSD spectrum of 
[PA+Na]+ which gives head group information. 
 
6.3.6 PSD Fragmentation Study of Lyso PC and DMPC 
Figure 6.8a is the PSD spectrum of protonated lyso 1-palmitoyl choline (lyso-PC) at m/z 
496.  The predominant product ion in the spectrum is the expected peak  
representing the protonated phosphatidylcholine head group at m/z 184. However, there are three 
other peaks of interest in the spectrum. 
The m/z 313 peak is derived from the neutral loss of the phosphatidylcholine head group 
from the m/z 496 precursor [M+H-C5H14NO4P]+, and the m/z 258 peak from the neutral loss of a 
fatty acyl chain as a ketene [M+H-C16H30O]+.  The observance of these two peaks can aid in the 
identification of the lyso phosphatidylcholine lipid.  The third peak at m/z 104 is the head group  
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Figure 6.7. PSD spectra of: (a) phosphatidic acid [PA+NA]+ precursor ion at m/z 697, (b) 
phosphatidic acid [PA+2Na-H]+ precursor ion at m/z 719. 
 
 
fragment ion C5H14NO+, whose structure is illustrated in Fig. 6.8a.  Figure 6.8b is the PSD 
spectrum of protonated dimyristyl phosphatidylcholine (DMPC) at m/z 678.  In this spectrum 
there is also the m/z 184 product ion for the charged phosphatidylcholine head group that has 
previously been reported by Al-Saad, et al.34, and a m/z 495 product ion derived from neutral 
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 loss of the PC head group [M+H-C14H14NO4P]+.  For fatty acid substituent identification, there is 
the product ion at m/z 450 derived from the neutral loss of the C14:0 fatty acid [M+H-
C14H28O2]+, and a product ion at m/z 468 from the neutral loss of a C14:0 fatty acyl chain as a 
ketene [M+H-C14H26O]+. At m/z 86 in the spectrum there is a PC head group product ion whose 
structure is illustrated in Fig. 6.8b.  
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Figure 6.8. PSD spectra of: (a) lyso 1-palmitoyl choline (lyso-PC) [LysoPC+H]+ precursor ion at 
m/z 496, and (b) dimyristyl phosphatidylcholine (DMPC) [DMPC+H]+ precursor ion at m/z 678. 
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 6.3.7 PSD Fragmentation Study of Phosphatidylglycerol 
Figure 6.9a is the PSD spectrum of the sodium adduct of 1-palmitoyl-2-oleoyl-sn-
glycero-3-[phospho-rac-(1-glycerol)] (sodium salt) (POPG) at m/z 771.  In the spectrum, there 
are three predominant product ion peaks which involve the phospho-glycerol head group. At m/z 
599, there is a minor peak for the neutral loss of the phospho-glycerol head group, and at m/z 
577 there is the more predominant product ion peak for neutral loss of the phospho-glycerol head 
group (with sodium). The intensity of the m/z 577 peak being greater than the m/z 599 peak 
suggests that the departure of the neutral head group (with sodium) is the more favored 
fragmentation pathway, as was also observed in the PSD of PS (Fig. 6.6a). The most 
predominant product ion peak in the spectrum is the m/z 195 peak, i.e. the sodium adduct of the 
phospho-glycerol head group whose structure is illustrated in Fig. 6.9a.  A minor peak is also 
observed at m/z 415 representing a two-step loss of a head group fragment (neutral loss of 74 Da, 
see Fig. 6.9b m/z 719 structure) in conjunction with neutral loss of the C18:1 fatty acid 
substituent [M+Na-C3H6O2-C18H34O2]+, giving some structural information for the 
phosphorylated lipid. Fig. 6.9b is the PSD spectrum of [PG+2Na-H]+ at m/z 793. This spectrum 
contains information concerning both the phospho-glycerol head group, and the two fatty acid 
substituents. M/z 719, m/z 217, and m/z 199 all involve the phospho-glycerol head group, and 
the associated structures are represented in the spectrum. The two fatty acid substituents are 
identified in the spectrum through two separate fragmentation pathways. There is a product ion 
formed as a result of neutral loss of the C18:1 fatty acid at m/z 511 [M-H+2Na-C18H34O2]+, and a 
product ion formed upon neutral loss of the C16:0 fatty acid at m/z 537 [M-H+2Na-C16H32O2]+. 
There are also two product ion peaks at m/z 437, and m/z 463, representing the combined neutral 
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Figure 6.9. PSD spectra of: (a) 1-palmitoyl-2-oleoyl-sn-glycero-3-[phospho-rac-(1-glycerol)] 
(POPG) [POPG+Na]+ precursor ion at m/z 771, and (b) [POPG+2Na-H]+ precursor ion at m/z 
793. 
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 losses of a head group fragment and a fatty acid for the C18:1 and the C16:0 fatty acid 
substituents, respectively. 
 
6.3.8 IMAC Cleanup and Preconcentration of Phosphorylated Lipids 
A modified Millipore phosphopeptide enrichment method using ZipTipMC (Millipore 
Inc., Bedford, MA) pipette tips containing an immobilized metal ion affinity chromatography 
(IMAC) media (iminodiacetic acid, IDA resin) was used to enrich the phosphorylated lipids. The 
suggested method from the manufacturer was followed except for two key solutions: the binding 
solution was changed from 0.1% acetic acid (aqueous) to 0.1% acetic acid in 1:1 
methanol:acetonitrile, and the elution solution was changed from 0.3 N ammonium hydroxide 
(aqueous) to 0.3 N ammonium hydroxide in 1:1 methanol:acetonitrile.  The immobilized metal 
ion affinity chromatography (IMAC) media was found to be soluble in chloroform, therefore, 
care must be taken to remove all chloroform from the extracted lipids before application of the 
ZipTipMC.  
Figure 6.10 is a MALDI-TOF MS spectrum illustrating the recovery of a 4-component 
lipid standard mixture comprised of lyso phosphatidylcholine at m/z 496, dimyristyl 
phosphatidylcholine at m/z 678, dipalmitoyl phosphatidylethanolamine at m/z 692, and 
sphingomyelin at m/z 731, each detected in protonated form using the modified IMAC ZipTipMC 
method.  The modified IMAC ZipTipMC method presented in this study has thus been 
demonstrated to be applicable to the isolation and cleanup of phosphorylated lipids in addition to 
the manufacturer’s intended use for the isolation and cleanup of phosphorylated peptides. 
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Figure 6.10. Recovery of a four-component phosphorylated lipid standard mixture using the 
IMAC ZipTipMC. Protonated lyso phosphatidylcholine at m/z 496, protonated dimyristyl 
phosphatidylcholine at m/z 678, protonated dipalmitoyl phosphatidylethanolamine at m/z 692, 
and protonated sphingomyelin at m/z 731. 
 
 
6.3.9 MALDI-TOF MS Analysis of Human Tear Film Lipid Layer 
A normal eye tear sample was extracted, using the modified extraction procedure above, 
forming a chloroform phase containing lipids, and an aqueous phase containing proteins. The 
chloroform phase was evaporated, and the phosphorylated lipids were isolated using the IMAC 
ZipTipMC method. Figure 6.11a is a MALDI-TOF spectrum of the tear total chloroform 
extractables collected without the use of the IMAC ZipTipMC cleanup method. Figure 6.11b is 
the same extract with the use of the IMAC ZipTipMC cleanup prior to spectral collection. In Fig. 
6.11a, the major peaks observed have been previously identified in our laboratory35 as sodium 
adducts of monopalmitin acylglycerol at m/z 353 (not shown), monostearin acylglycerol at m/z 
381 (not shown), a glyceryl-isoprene acetal at m/z 437, 1,3-dipalmitin diacylglycerol at m/z 591, 
1-stearin,3-palmitin diacylglycerol at m/z 619, and 1,3-distearin diacylglycerol at m/z 647. As 
has been observed previously in our laboratory with electrospray, the phosphorylated lipids 
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Figure 6.11. MALDI-TOF mass spectra of the tear total chloroform extractables collected: (a) 
without the use of the IMAC ZipTipMC cleanup method, and (b) with the use of the IMAC 
ZipTipMC cleanup prior to spectral acquisition. 
 
 
 
 
 
 
 
 are present in tear extracts in very low concentrations compared to the acylglycerols, and can 
experience a substantial amount, or even complete, signal suppression in positive mode 
electrospray. Figure 6.11a illustrates that signal suppression of the phosphorylated lipids in the 
tear extract, due to the acylglycerols also present, is again occurring with the use of MALDI. By 
applying the IMAC ZipTipMC isolation and cleanup procedure to the phosphorylated lipids, 
removal of the acylglycerols has been achieved and the phosphorylated lipids are now 
observable in Fig. 6.11b. In the ZipTipMC extract cleanup spectrum of Fig. 6.11b, m/z 659 is 
postulated to be the sodium adduct of a pyrophosphate sphingomyelin with a molecular formula 
of C24H50N2O13P2Na, m/z 678 is protonated 1,2- (rac) dimyristoyl phosphocholine, and m/z 719 
and 747 are also postulated to be protonated pyrophosphate sphingomyelins with molecular 
formulas of C31H65N2O12P2, and C33H69N2O12P2, respectively. There are also even numbered ions 
at m/z 430 and 530 indicating an odd number of nitrogens in those unidentified compounds. 
   
6.4 CONCLUSIONS 
  Biological extracts, such as the tear film lipid layer presented in this study, are typically 
complex, multi-component mixtures. Separation schemes are usually employed to isolate the 
compounds of interest to simplify the mass spectra, and to lower the limits of detection. The 
novel solid ionic crystal MALDI matrix reported in this paper combines lipid detection 
enhancement through the use of para-nitroaniline as the matrix’s ultraviolet light absorber with 
the powerful protonating additive butyric acid. Mass spectrum complexity is reduced and 
interpretation is simplified due to the phosphorylated lipids of interest existing primarily as 
[M+H]+ ions for the neutral, polar zwitterionic phosphatidylcholine head group containing 
species lyso PC, PC, SM, and PAF. Further simplification is obtained because one need only 
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 monitor the mass spectrum for sodium adducts of the anionic phosphorylated lipids such as PG, 
PA, and PS. Finally, all of the phosphorylated lipids represented in this study can be measured 
simultaneously in the positive mode, including PE. It has also been demonstrated that the new 
ionic crystal matrix gives PSD spectra that can be used for head group identification, and fatty 
acid substituent characterization for both the nitrogen-containing phosphorylated lipids and those 
devoid of nitrogen. 
A new extraction, isolation, and cleanup procedure has also been reported for the 
phosphorylated lipids using immobilized metal ion affinity chromatography (IMAC) media 
ZipTipMC. It was shown that the ZipTipMC procedure is highly specific for recovery of the 
phosphorylated lipids. The ZipTipMC procedure has been successfully applied to a complex 
biological tear film lipid layer extract by removing the signal suppressing acylglycerols, thus 
allowing the determination of very low levels of phosphorylated lipids. 
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 CHAPTER VII:  IDENTIFICATION AND COMPARISON OF THE POLAR 
PHOSPHORYLATED LIPIDS IN NORMAL AND DRY EYE RABBIT TEARS BY MALDI-
TOF MASS SPECTROMETRY 
 
7.1 Introduction 
The ocular tear fluid is a dynamic and complex mixture of water, salts, mucins, and 
diverse biomolecules including proteins, enzymes, and lipids, whose components interact with 
one another to maintain the health and clarity of the cornea and ocular surface. The tear film acts 
as a lubricant during blinking, and protects the cells of the ocular surface from damaging debris 
and pathogens. Additionally, the tears transport oxygen and nutrients to the cells of the cornea 
and conjunctiva. Irregularities in the tear film can cause a number of ocular problems, including 
dry eye. The National Eye Institute defines dry eye syndrome as “a disorder of the tear film due 
to tear deficiency or excessive evaporation that causes damage to the interpalpebral ocular 
surface and is associated with symptoms of discomfort.”1 Approximately 10 to 14 million people 
in the United States alone have some form of dry eye.  
 The development of dry eye syndrome is associated with a number of physiological and 
environmental conditions, including aging,2 hormonal imbalance,3 disease,4 surgery,5,6 smoke, 
wind, heat, and/or low humidity.1,7,8 However, the ability to classify dry eye patients within 
specific etiological categories, except for those caused by a specific disease states such as 
Sjögren's syndrome,4 is difficult because the exact effect of the various causative conditions on 
the compositional structure of the tear film is unknown. 
The normal tear fluid, which is approximately 7 µL in volume in both rabbits and 
humans, continuously bathes the corneal and conjunctival surface of the eye. The structure of the 
tear fluid is generally divided into three layers: the innermost epithelial-glycocalyx layer, an 
intermediate aqueous-mucin layer,9,10 and an outermost lipid layer.11 The components of the tear 
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 film are supplied by a number of ocular tissues. The innermost glycocalyx layer is secreted by 
the stratified squamous cells of the conjunctiva and cornea. Its primary functions are to protect 
the ocular surface cells from bacterial binding and smooth out any small surface irregularities. 
The aqueous-mucin layer, composed of mucins, proteins, and electrolytes, is secreted by the 
main and accessory lacrimal glands and the conjunctival goblet cells. The various proteins found 
in the aqueous layer perform a myriad of functions vital to maintaining the health of the ocular 
surface, regulating surface cell function, and maintaining the tear film structure.12 The outer lipid 
layer is secreted by the meibomian glands, which are located in the eyelids; its main function is 
to retard the evaporation of the aqueous layer.13,14 Because the cells of the ocular surface 
function within a narrow range of pH, osmolarity, and ionic compositions, it is vital that the tears 
maintain the appropriate concentrations of constituents in each of the three layers. Alterations of 
the composition of the tear film can result in development of dry eye syndrome and, ultimately, 
deleterious effects on vision. 
The instability of the outer lipid layer of the tear film, due to changes in the polar lipid 
concentration, has been identified as a potential factor in the development of dry eye 
syndrome.15,16 Previous investigations into molecular changes in tear film structure have been 
hampered by the need to pool tears to make up a sample quantity large enough to allow detection 
by analytical methods such as one- or two-dimensional electrophoresis.17,18,19 Another problem is 
the requirement that the tear components be derivatized before they are subjected to gas 
chromatography (GC), mass spectrometry (MS), or both.20,21 The chemical composition of the 
human meibomian gland liquid secretions has been characterized by high pressure liquid 
chromatography (HPLC),22 pico-nuclear magnetic resonance (p-NMR),23 and thin-layer 
chromatography (TLC),24 and fatty acid fragment profiles have been obtained by HPLC-MS.25 
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 During the past several years, the analysis of phospholipids in general has been reported by 
HPLC26 and micellar electrokinetic chromatography (MEKC),26,27 capillary electrophoresis-
electrospray-mass spectrometry (CE-ES-MS),28 electrospray tandem mass spectrometry (ES-
MS/MS),29-36 and to a lesser extent matrix-assisted laser desorption/ionization-Fourier-transform 
ion cyclotron resonance (MALDI-FTICR)37 and MALDI-time-of-flight (TOF) MS.38-42 Indeed 
However, with the advent of soft ionization techniques such as ES-MS and MALDI-MS, the 
derivatization of volatile lipids is no longer essential.43 In this paper, we report a MALDI-TOF 
MS study of the phosphorylated lipids of normal and dry eye tears using an immobilized metal 
ion affinity chromatography (IMAC) ZipTipMC (Millipore, Bedford, MA) clean-up method 
coupled with a newly synthesized solid ionic crystal MALDI matrix to detect nanogram to 
picogram quantities of phosphorylated lipids in small volume tear samples. Comparison of the 
types and relative quantities of the polar phospholipids in normal and dry eye rabbit tears should 
provide insight into the effect of polar lipid changes on the stability of the tear film. 
 
7.2 Experimental 
7.2.1 Animals 
Six female New Zealand white rabbits (7-8 lbs body weight) purchased from Harlan 
(Indianapolis, IN) were used. All animal studies were conducted in accordance with the ARVO 
Statement on the Use of Animals in Ophthalmic and Vision Research. 
 
7.2.2 Rabbit Tear Samples 
The rabbit dry eye model was created in female New Zealand white rabbits by two 
sequential surgical procedures. First, the main lacrimal gland was removed from the 
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 experimental eye; the contralateral eye was used as the normal control. Approximately 2 weeks 
later, the accessory lacrimal gland and nictitating membrane were removed from the 
experimental eye. Tear breakup time (TBUT) was measured daily by slit lamp with a Tearscope 
(Keeler Instruments, Broomall, PA). When the TBUT of the surgical eye was half or less that of 
the control eye, the surgical eye was considered to be dry. Baseline tears (representing tears 
produced under non-irritating conditions) were collected daily from the normal and surgically 
induced dry eyes using 5-µL silanized microcapillary pipettes.24 The tear samples were 
immediately placed in Eppendorf tubes and stored at –70ºC. 
 
7.2.3 Chemicals  
Lyso 1-palmitoyl choline, dimyristoyl phosphatidylcholine, 1,2-dipalmitoyl-sn-glycero-3-
phosphoethanolamine, 1-palmitoyl-2-hydroxy-sn-glycero-3-phosphocholine, and sphingomyelin 
were purchased as standards (Avanti Polar Lipids, Alabaster, AL). Methanol and chloroform 
solvents of HPLC/spectroscopy grade were purchased from EM Science (Darmstadt, Germany). 
All other chemicals were of analytical-reagent grade. All standards and chemicals were used as 
received without further purification. Distilled and deionized (dd) water (18 MΩ, Milli-Q Water 
Purification System; Millipore Inc., Bedford, MA) was used throughout standard and sample 
preparations.  
 
7.2.4 Extraction of Non-Polar and Polar Lipids 
The non-polar and polar lipid fractions were extracted from tear samples with a simple 
two-phase (chloroform, water) extraction technique; the resulting aqueous phase contained the 
tear proteins and the chloroform phase contained the lipids.44,45 Briefly, 1 week of tears collected 
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 from one eye was diluted to 300 µL with dd water. The aqueous tear solution was then extracted 
three times with 500 µL of chloroform. The chloroform extracts were combined and evaporated 
to near dryness. At least three weeks of samples per eye were analyzed using the Zip-Tip 
MALDI-TOF method described below. 
 To extract the phosphorylated lipids from the lacrimal glands, the gland was blended with 
100 mL of chloroform. The extract was filtered and the volume of the solution was reduced to 
approximately 20 mL using low heat and a gentle stream of nitrogen. Aliquots were diluted 1:10 
with matrix solution (see MALDI-TOF MS below) and spotted directly onto the MALDI target 
for analysis. At least three aliquots per sample type were analyzed by MALDI-TOF. 
 
7.2.5 Zip-Tip Cleanup and Pre-concentration of Polar Lipids  
A modified phosphopeptide enrichment method, previously developed in this laboratory 
(Ham et al., accepted for publication), using ZipTipMC pipette tips containing an IMAC medium 
(iminodiacetic acid, IDA resin) was used to concentrate the phosphorylated lipids. The suggested 
method from the manufacturer (Millipore) was followed except for two key solutions: the 
binding solution was changed from 0.1% acetic acid to 0.1% acetic acid in 1:1 
methanol:acetonitrile, and the elution solution was changed from 0.3 N ammonium hydroxide to 
0.3 N ammonium hydroxide in 1:1 methanol:acetonitrile. The IMAC medium was found to be 
soluble in chloroform; therefore, care was taken to remove all chloroform from the extracted 
lipids before application of the ZipTipMC. The lipids were reconstituted in 5 :l of the Zip-Tip 
binding solution, aspirated through the Zip-tip matrix for binding, washed, and eluted with 3:l of 
elution solution. 
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 7.2.6 MALDI-TOF MS  
MALDI-TOF mass spectra were acquired using an Applied Biosystems Voyager Elite 
MALDI-rTOF mass spectrometer with delayed extraction (Applied Biosystems, Inc., 
Framingham, MA). A UV light, 337 nm emission wavelength, nitrogen laser was used for 
irradiation. A typical spectrum was collected at an extraction voltage of 20 kV. Delayed 
extraction mode was used for all acquisitions with a 175 ns delay. The laser power was adjusted 
to a level just above the threshold for signal appearance to minimize head group loss. Each 
phospholipid mass spectrum was collected by averaging data from 250 laser shots. For sample 
plate spotting, 3 µL of ZipTipMC- eluted phospholipids was mixed with 3 µL of matrix and then 
deposited onto the MALDI plate and allowed to air dry. The MALDI matrix used in all studies 
consisted of a recently developed solid ionic crystal matrix of 20 mg of paranitroaniline (PNA) 
and butyric acid in a 1:2 molar ratio dissolved in ethanol (Ham et al., accepted for publication). 
All spectra were collected using a two-point calibration of protonated 
lysophosphatidylcholine at a mass/charge ratio (m/z) of 496.34, and protonated dimyristoyl 
phosphatidylcholine (DMPC) at m/z 678.51. Phospholipids in the biological samples were 
assigned according to their molecular weights derived from either the monoisotopic protonated 
molecules, monoisotopic sodium adducts, and/or post source decay (PSD) product ions in 
MALDI-TOF mass spectra. 
 
7.3 Results and Discussion 
7.3.1 Rabbit Eyes and Tear Samples 
All of the rabbit eyes remained healthy throughout the study period; the corneas and 
conjunctivas of both the normal and dry eyes were healthy and showed no epithelial staining. 
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 The experimental dry eyes had TBUTs approximately one-third those of the corresponding 
contralateral control eyes. The usual tear volume obtained from a single normal eye was 3 µL, 
whereas only 1 µL was typically obtained from a dry eye. 
  
7.3.2 MALDI-TOF MS Analysis of Tear Phospholipids 
By inducing dry eye in only one eye of each rabbit, we were able to compare lipid 
expression in dry eye and normal tear samples from the same animal, thereby reducing or 
eliminating the effect of physiological variation from rabbit to rabbit. Samples of normal and dry 
eye tears were extracted with chloroform following the modified extraction method outlined 
above. The lipid-containing chloroform phase was recovered and evaporated, and the 
phosphorylated lipids were isolated using the IMAC ZipTipMC method; proteins were largely left 
behind in the aqueous phase. All presented mass spectra were acquired after extraction and 
ZipTipMC cleanup. 
Figure 7.1 a and b are representative of normal and dry eye tear mass spectra obtained by 
our method. In general, the normal eye tear spectra showed six major peaks (m/z 494, 522, 550, 
577, 610, 638) and seven minor peaks (m/z 637, 642, 659, 678, 695, 866, 936). The dry eye tear 
spectra showed 10 major (m/z 494, 522, 550, 577, 605, 621, 637, 659, 610, 642) and four minor 
(m/z 678, 695, 828, 886) peaks assignable within their mass spectra. Five of the major peaks 
(m/z 494, 522, 550, 577, 610) and two of the minor peaks (m/z 678, 695) were the same for both  
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Figure 7.1.  Representative MALDI-TOF spectra of (A) normal eye tear and (B) dry eye tear 
phosphorylated lipids. Important series include (1) C14:1-2:0 PAF (m/z 494), C16:1-2:0 PAF 
(m/z 522), and C18:1-2:0 PAF (m/z 550) in the normal tears, and (2) m/z 577, 605, 621, 637, and 
659 in the dry eye tears. The second series consists of SMs, which may play a role in the dry eye 
response.  
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 types of tears. The m/z 494, 522, and 550 species in the tear mass spectra did not have reliable 
post source decay (PSD) spectra for their specific identification. However, it is reasonable that 
they are phosphorylated and contain one nitrogen. For the m/z 494 species, possible assignments, 
based upon molecular weight alone, could be (1) a C14:1-2:0 PAF with molecular formula of 
C24H48NO7P or (2) a C16:1 Lyso-PC with a molecular formula of C24H48NO7P. The m/z 522 and 
550 species appear to be related to the m/z 494 species by the successive addition of two carbon 
atoms of chain length (-CH2CH2-). Figure 7.2 illustrates assigned structures of some of the main 
phosphorylated lipids observed in the tear extracts. 
Next, as illustrated in Figure 7.3(a), we found a series of peaks which included m/z 577, 
605, 621, 637, and 659. The five compounds exhibited affinities to the IMAC ZipTipMC resin, 
indicating they are phosphorylated lipids, and the odd numbered m/z values pointed to an even 
number of nitrogen atoms (e.g., 2) in each of the compounds. Additionally, the PSD spectra of 
the m/z 577, 605, and 621 species indicated an m/z 184 head group. These three findings support 
the hypothesis that the five compounds are related to sphingomyelin (SM). A similar series of 
m/z 605, 621, 637, 643 and 659 species has also been observed in a C18:1 sphingomyelin 
standard as impurity, Figure 7.3(b). From the sphingomyelin standard, PSD was also performed 
on the m/z 605 species, Figure 7.4. The spectral informative peaks include the 
phosphatidylcholine head group at m/z 184, a pyrophosphate phosphatidylcholine head group at 
m/z 280, neutral loss of the long chain substituent at m/z 335 [M+H-C17H34O2]+, and loss of the 
epoxide oxygen at m/z 589 [M+H-O]+. From the derived molecular weights and PSD spectra, 
tentative assignments of these compounds, based upon sphingomyelin structures, can be made 
(Figure 7.5). The m/z 605, 621, and 637 species are proposed to be related structures where the 
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Figure 7.2. Assigned structures of the major phosphorylated lipids observed in the tear extracts.  
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Figure 7.3. MALDI-TOF mass spectra of (a) dry eye tear extract lipids. (b) sphingomyelin 
standard. 
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  m/z 605 is a protonated oxidized pyrophosphate sphingomyelin related compound with a 
molecular formula of C24H50N2O11P2 likely resulting from epoxidation of the unsaturation on the 
long chain substituent. The m/z 621 species represents a further oxidized form of the same 
molecule resulting in peroxide formation with a molecular formula of C24H50N2O12P2.  The m/z 
637 species is a further oxidized form of m/z 605 likely resulting from formation of an epoxide 
of the m/z 621 species, with a molecular formula of C24H50N2O13P2. Finally, the m/z 659 species 
is the sodium adduct of the m/z 637 species with a molecular formula of C24H50N2O13P2Na. 
For the m/z 610 and 638 species found within the tear spectra, PSD spectra were obtained 
that indicate a relationship between the two (Figure 7.6). However, despite having a molecular 
weight equal to an oxidized form of phosphatidylcholine, the species are unassigned since no 
m/z 184 peak was evident. The m/z 642 species differs from the m/z 610 species by 32 Daltons, 
suggesting an oxidized state of m/z 610. The M/z 678 species has been identified as C14:0-14:0 
PC based off of its molecular weight and the PSD spectrum which illustrates the m/z 184 product 
ion indicative of a phosphatidylcholine head group containing species (see Figure 7.7a). The 
PSD spectrum of the m/z 828 species indicates that it may be a phosphatidyl serine due to a 
diagnostic peak at m/z 741 (see Figure 7.7b). The m/z 695, 866, 886, and 936 species are 
currently unidentified. 
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Figure 7.4. Post source decay (PSD) of m/z 605 species in the Sphingomyelin standard.  
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Figure 7.5. Proposed structures of pyrophosphate sphingomyelin. 
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Figure 7.6. PSD spectrum of species found within the MALDI-TOF MS of tears. (a) PSD 
spectrum of m/z 610 species. (b) PSD spectrum of m/z 638 species. 
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Figure 7.7. PSD spectrum of species found within the MALDI-TOF mass spectra of tears. (a) 
PSD spectrum of m/z 678 species. (b) PSD spectrum of m/z 828 species. 
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 Table 7.1 lists the phosphorylated lipid species observed in the tear extracts and their 
relative abundances in normal versus dry eye tears. The major peak assignments corresponded to 
types of platelet activating factor (PAF) and pyrophosphate sphingomyelin (SM)-related 
compounds with minor peaks corresponding to phosphatidylcholine (PC) and phosphatidylserine 
(PS). 
Major differences in the normal and dry eye tear mass spectra were found in the peaks 
corresponding to SM and PS molecules. Two major SM peaks not found in the normal tears were 
present in the dry eye tears and two minor SM peaks found in the normal tears were major peaks 
in the dry eye tears. A minor peaks corresponding to PS was identifiable in the dry eye tears but 
was not seen in the normal tears. Additionally, a minor peak in the normal eye tears possibly 
corresponding to an oxidized form the PC molecule was seen as a major peak in dry eye tears, 
and two of the minor, unidentifiable peaks in the normal eye tears were not present in the mass 
spectra of dry eye tears. 
 
7.3.3 MALDI-TOF MS Analysis of Extracted Lacrimal Glands 
Figure 7.8 is a representative MALDI-TOF MS spectrum of the extracted lipids from the 
main lacrimal glands of the rabbits. The predominant set of phosphorylated lipids, which is 
located in the region between m/z 700 and m/z 850, consists mainly of PCs, with some PEs. 
Table 7.2 lists the major peaks observed in the lacrimal gland extracts and their assignments. In 
addition to PC and PE molecules, peaks corresponding to PAF (m/z 496) and SM (m/z 577) were 
found. No peaks corresponding to PS were identified.  
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 Lipid in Tear Extract 
Molecular Ion 
(MI) 
Normal 
Eye* 
Dry 
Eye* 
C14:1-2:0 PAF C24H48NO7P (?) [M+H]+, m/z 494 major major 
M/z 522  [M+H]+ major major 
M/z 550  [M+H]+  major major 
Pyrophosphate SM C22H46N2O11P2 [M+H]+, m/z 577  major major 
Pyrophosphate SM C24H50N2O11P2  [M+H]+, m/z 605  major 
Pyrophosphate SM C24H50N2O12P2  [M+H]+, m/z 621  major 
Pyrophosphate SM C24H50N2O13P2  [M+H]+, m/z 637 minor major 
Pyrophosphate SM C24H50N2O13P2Na [M+Na]+, m/z 659 minor major 
M/z 610 [M+H]+ major major 
M/z 638 [M+H]+ major  
M/z 642 [M+H]+ minor major 
C14:0-14:0 PC (DMPC) [M+H]+, m/z 678 minor minor 
M/z 695 [M+H]+ minor minor 
16:0-20:4 PS C42H73NO10PNa [M+2Na-H]+, m/z 828  minor 
M/z 866 [M+H]+ minor  
M/z 886 [M+2Na-H]
+
  minor 
M/z 936 [M+H]+ minor  
 
*The assignment of a major or minor presence is qualitative and is derived from the relative 
intensity abundance of the peak in the mass spectra. 
 
 
TABLE 7.1. Phospholipids Peaks in MALDI-TOF Mass Spectra of Normal and Dry Eye Rabbit 
Tears. 
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Figure 7.8. MALDI-TOF spectrum of lacrimal gland phosphorylated lipids. 
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Spectral 
Peak 
Compound Assignment Spectral 
Peak 
Compound 
Assignment 
M/z 413 2-N species with PC head-group, possibly SM related M/z 756  
16:0-18:3 PC 
or 16:1-18:2 
PC 
M/z 429 2-N species (m/z 413 oxidized) PC head-group, SM related M/z 758  16:0-18:2 PC 
M/z 496 C14:0-2:0 PAF M/z 760  16:0-18:1 PC 
M/z 511 Unidentified M/z 762  16:0-18:0 PC 
M/z 512  1-N species with PC head-group  M/z 770 18:0-20:3 PE 
M/z 518  1-N species with PC head-group M/z 772 18:0-20:2 PE 
M/z 577   M/z 774 18:0-20:1 PE 
M/z 610  16:0-5:1 oxidized PC C29H56NO10P  M/z 780 16:1-20:4 PC 
M/z 642  16:0-5:1 oxidized PC C29H56NO12P M/z 782  16:0-20:4 PC 
M/z 706  14:0-16:0 PC M/z 786  18:0-18:2 PC 
M/z 720 16:0-18:0 PE M/z 788  18:0-18:1 PC 
M/z 734  14:0-18:0 PC   
M/z 744 18:0-18:2 PE M/z 810 18:0-20:4 PC 
M/z 746 18:0-18:1 PE   
 
 
 
TABLE 7.2. Assignment of MALDI-TOF Mass Spectra Peaks from Rabbit Main Lacrimal 
Gland 
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 Current tear film models suggest that a chemically stable, lamellar layer of polar 
phospholipids lies anterior to the aqueous fluid and binds the non-polar meibomian oil to the 
aqueous layer. The presence of this polar phospholipid interface is thought to be critical to the 
spreading of the non-polar lipid film over the aqueous layer. Shine and McCulley16 found that 
specific changes in the content of the polar phospholipid interface correlate directly to the 
presence of dry eye in patients with chronic blepharitis.  
The majority of the phospholipids are supplied to the tear film through the meibomian 
glands, which are located in the eyelid. The chemical composition of the human meibomian 
gland secretions is a complex mixture of cholesterol and wax esters, triacylglycerols, free fatty 
acids, diesters, free cholesterol, hydrocarbons, and polar lipids.20,46-49 The polar lipids found in 
the meibomian gland secretion contain 70% phospholipids and 30% sphingolipids, and the 
phospholipid portion consists of 38% PC, 18% PE, 7% SM, and 39% unknowns.20 Polar lipids 
make up approximately 6-16% of the compounds found in the liquid phase of the tear film.20,22,49 
Based on these data, the percentages of phosphorylated lipids in the lipid phase of the tear film 
would be 1.6-4% PC, 0.8-2% PE, and < 1% SM. Analysis of the rabbit meibomian gland cells 
and secretions has shown the polar lipid content to be similar to that of humans, with PC, PE, 
SM, and PS making up the majority of the phospholipids.23,50  
 Although the meibomian gland supplies the majority of the lipids to the tear film, the 
lacrimal gland also provides some lipids, as well as the majority of tear proteins. An early study 
performed by Stuchell et al. (Stuchell RN, et al. IOVS 1984;25:ARVO Abstract, p. 320, #2) 
reported that the lipid composition of lacrimal gland secretions consisted of 55.0% glycolipids, 
44.1% other neutral lipids, and 0.9% phospholipids. However, the types of phospholipids were 
not reported. In our study, we found that rabbit lacrimal glands had significant amounts of the 
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 same polar phospholipids found in the human tear fluid, although the degree to which these 
phospholipids are excreted into the tears is unknown.  
In addition to the meibomian and main and accessory lacrimal glands, the rabbit has a 
harderian gland that has been shown to contribute to the tear film components. The harderian 
gland lies in the nasal region of the orbit with its secretions flowing through ducts within the 
nictitating membrane. Analysis of the harderian gland has shown that tear proteins and lipids are 
produced within the gland, although the degree to which these molecules are actively secreted is 
unknown.21,51,52 In our dry eye model, both the main and accessory lacrimal glands were 
removed and the ducts from the harderian gland were severed and cauterized. Only the 
meibomian glands remained intact to supply lipids to the tear film.  
 The total chloroform extract of the tear layer constitutes a complex mixture of biological 
compounds that includes non-polar and polar lipids and some lipoproteins. The polar lipid 
components make up a very small fraction of the total extract, rendering their analyses difficult 
by mass spectrometry alone. Combining the use of the IMAC ZipTipMC with the optimized solid 
ionic crystal MALDI matrix para-nitroaniline/butyric acid allowed the identification and 
comparison of the lipoprotein and phosphorylated lipid components of normal versus dry eye 
rabbit tears.  
 Some similarities in the polar phospholipids were found in the normal and dry eye rabbit 
tears. For example, three compositions of PAF, a tear lipoprotein component known to be 
involved in the human lipid-mediated inflammatory response and such specific ocular conditions 
as allergic conjunctivitis53 and contact lens induced acute red eye (CLARE),54 were expressed to 
a similar degree in both the normal and dry eye rabbit tears. The three types of PAF lipids 
differed from one another in terms of two carbon atoms of chain length (–CH2CH2–). The similar 
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 degree of expression of the three PAFs indicates that the inflammatory response was not 
activated in our dry eye model.  
Additionally, however, some significant differences in the polar phospholipids were 
found in the normal and dry eye rabbit tears using our novel analytical method. The types and 
concentrations of SM molecules were significantly increased in the dry eye tears compared with 
the normal tears. The normal rabbit tears showed the presence of three types of SM, with one 
major type present in significantly higher concentrations than the other two. The dry eye tears 
showed the same three SMs as the normal tears and two additional SMs, all in significantly high 
concentrations. Sphingomyelins are zwitterionic phospholipids which have been suggested to 
play a significant role in maintaining the interfacial layer between the aqueous and oil layers of 
the tear film. The polar head groups of zwitterionic and neutral phospholipids are known to align 
themselves head-to-tail, creating an interfacial layer between meibomian oil non-polar lipids and 
aqueous tears that is chemically stable and resistant to mechanical rupture.11,50 A decrease in the 
percentage of SMs in the tear film was correlated with the presence of dry eye in patients with 
chronic blepharitis, although the different SM species within the tear film were not identified.16 
The presence of different SM species in the dry eye tears may indicate a compensation 
mechanism provided by the meibomian glands to stabilize the tear film in the absence of lacrimal 
and harderian gland secretions.  
Previous work has shown that PE is present in human tears and may play a significant 
role as a zwitterionic phospholipid in the maintenance of tear stability.16 PE was not found in 
either the normal or dry eye rabbit tears examined. However, PS, a precursor in PE synthesis in 
mammalian cells, was found in significant quantities in the dry eye tears. PS is an anionic 
phospholipid and, as such, aids in the spreading of the meibomian oil film within the lipid 
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 interfacial layer through the mutual repulsion of negative charges. 
Our analytical method not only allowed the assignment of the types of polar 
phospholipids present in the tear film, but also allowed assignment of specific molecular 
compositions within the phospholipid groups. Comparative analysis of polar phospholipids in 
rabbit tears from normal and dry eyes points to the importance of SM and PS in stabilizing the 
tear film in the rabbit dry eye model.  
 
7.4 Conclusions 
The combination of ZipTipMC chromatography and the solid ionic crystal matrix for 
MALDI enabled the detection and assignment of phosphorylated lipids in the tears. Specific 
differences between polar phospholipid levels in normal and dry eye tears were observable with 
this methodology. The appearance of various SM and PS species only in the dry eye tears may 
provide markers for this disease state in the future.  
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 CHAPTER VIII :IDENTIFICATION AND COMPARISON OF RABBIT TEAR 
PROTEINS OF NORMAL VERSUS A DRY EYE MODEL BY MALDI-TOF MS 
 
8.1 Introduction 
The eye is a complex, sensitive component of the human body that has obvious 
importance, thus extensive study has been conducted on the eye, and particularly the protein 
components that make up the eye(1-13), for well over at least seventy years for modern testing, and 
since antiquity for other. The eye structure is divided into three layers, the innermost corneal 
layer, an intermediate aqueous-mucin(14,15) layer, and an outer most lipid layer(16).  One of the 
functions of the outer lipid layer is to retard the evaporation of the inner aqueous layer through 
the functionality of the non-polar and polar lipids.  The lipids are supplied to the tear film 
through the meibomian gland.  The proteins are supplied to the aqueous portion of the tear layer 
by the main (orbital) lacrimal gland(17).  Exhaustive studies have been performed on human and 
rabbit tear, and less extensive for dog tear(18) and rat tear(19), for protein quantification and 
identification, and also for protein expression studies concerning physiological changes that have 
resulted in the symptoms of dry eye.  These types of studies have been accomplished through 
many standard techniques including 1-D(20) and 2-D(21) gel electrophoresis, capillary 
electrophoresis(22), HPLC(23,24), immunochemistry(25-27), chip-based micro-fluidic techniques(28), 
and thin layer chromatography(29).  Today’s proteomic approaches to protein characterization and 
identification, through the use of mass spectrometric techniques, have contributed to the 
information in the study of tear proteins.  Some of the mass spectrometric methods used have 
been gas chromatography-mass spectrometry(29), high-pressure liquid 
chromatography/electrospray ionization mass spectrometry(30), and matrix assisted laser 
desorption ionization-time of flight mass spectrometry(31,32).  Capillary 
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 electrophoresis/electrospray ionization-mass spectrometry has also been applied to the analysis 
of proteins in whole human blood(33). 
Protein profiles, identification, and quantitation have been reported on both normal tear 
protein content, and protein content for dry eye syndrome, for both human and rabbit. Reported 
total protein concentrations for rabbit include 12.6 µg/µl in unstimulated tears(34), and 40.0 ± 5.3 
µg/µl in lacrimal gland fluid at flow rates < 2 µl/min(35).  For normal human tear, a few examples 
of total reported protein concentrations include 8.1 µg/µl in stimulated tears and 22.7 µg/µl in 
unstimulated tears(36), 8 ± 2.25 g/l from gentle stimulation(11), and from 6.05 ± 1.58 mg/ml to 
11.48 ± 2.32 mg/ml (difference depending on which method was used for calculation, as 
expressed by the authors) for tears collected by yawn reflex(37).  Human tear contains numerous 
proteins including serum-based proteins such as IgA and IgG, antibacteriolytic components such 
as lysozyme, transferrin, albumin, lipocalin, and many more.  Indeed, Fung, et al(32), recently 
reported the identification of approximately 500 proteins in normal human basal tear fluid.  
Rabbit tear contains many of the same types of proteins as are contained in human tear.  
Boonstra, et al(26), reported the identification of transferrin in rabbit tear, but no lactoferrin, thus 
indicating that rabbit tear may be substantially different from human tear.  Recently, Zhou et 
al(30), reported the finding of lactoferrin in rabbit tear, demonstrating the differences that may 
arise from techniques and methods used.  Nonetheless, there are many similarities in the types of 
protein contained in both. 
In the past 25 years, many advances in diagnosis, causes, and treatments of the dry eye 
condition have been made(38).  Many are afflicted with the condition Keratoconjunctivitis sicca 
(KCS, also known as “dry eye”), which can be associated with aging, disease, smoke, surgery, or 
any form of irritation of the eye.  The National Eye Institute’s (NEI) definition of dry eye states 
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 that KCS is a disorder of the ocular tear film layer usually caused by a tear deficiency, or 
excessive evaporation of the aqueous layer, resulting in damage of the ocular surface and 
symptoms of discomfort(39). Some forms of dry eye may be physiologically related, perhaps from 
the breakdown of the eye tear layer, or to hormones, as demonstrated in a hormone replacement 
study by Schaumberg, et.al.(40), or to Sjogren syndrom(41).  In human dry eye studies, the 
analytical evaluation of the dry eye condition is performed through the collection of tear samples 
from individuals who are afflicted with one of the underlying causes of dry eye, and then 
performing various wet chemistry and instrumental methods for compositions, tear breakup, etc. 
Studies are also performed on rabbits where the rabbit has been externally given the dry eye 
condition, and samples are taken and analyzed.  The rabbit dry model has been produced through 
sensory denervation of the lacrimal gland(17,42), and through corneal wounding(43). In this study, 
the rabbit dry eye model was produced through the removal first of the main lacrimal gland from 
one of the rabbit’s eyes, while the other eye is kept normal as a control.  Then, after 
approximately two weeks, the accessory lacrimal gland and nictitating membrane are removed 
from the same eye without the lacrimal gland.  Tear samples were subsequently taken and 
analyzed for protein content. 
 
8.2 EXPERIMENTAL 
8.2.1 Rabbit tear samples 
Baseline tears (representing tears produced under non-irritating conditions used in normal 
protection and lubrication functions) were collected from normal and surgically induced dry eyes 
of New Zealand white rabbits using 5 µL silanated microcapillary pipettes(24,37).  A usual volume 
obtained from normal eye is 5 µL, whereas only 2 µL are typically obtained from a dry eye 
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 subject.  Tear samples were immediately placed into Eppendorf tubes, and preserved by storage 
at –70 oC.  The rabbit dry eye tear model is created through two surgical procedures.  First, the 
main lacrimal gland is removed from one of the rabbit’s eyes, while the other eye is kept normal 
as a control, and the rabbit is then allowed to heal.  After approximately two weeks, the 
accessory lacrimal gland and nictitating membrane are removed from the same eye without the 
lacrimal gland.  The tear breakup time (TBUT, measured by slit lamp and Tearscope) of the eye 
is then measured and followed.  The TBUT of the surgical eye must be at least half of the control 
eye to be considered as “dry”.  The polar and non-polar lipid fractions were extracted from tear 
samples with a simple chloroform solvent modification procedure(44,45), and the proteins were 
recovered from the aqueous phase of the extraction. 
 
8.2.2 In-gel reduction, alkylation, digestion, and extraction of peptides 
The protein bands that were analyzed by MALDI-TOF mass spectrometry were in-gel 
digested using an in-lab procedure.  The bands of interest are excised from the gel with a scalpel.  
The bands are chopped into cubes (1 x 1 mm), and placed into separate 1.5 mL Eppendorf tubes.  
The chopped bands are then washed with 100 – 150 µL of DD water, three times, with five min. 
soakings.  Between each wash, the cubes are centrifuged, and the washing removed.  The gels 
are then dehydrated by the addition of 100 µL of acetonitrile.  After approximately 15 minutes, 
the gels become white and stick together indicating dehydration.  The acetonitrile is removed, 
and the gels are dried in an eppendorf Vacufuge Concentrator 5301 (Brinkman Instruments, 
Inc.).  Reduction is then performed by swelling the gels in 50 µL of a freshly prepared solution 
containing 10 mM of DTT in a 100 mM NH4HCO3 buffer solution.  The gels are then incubated 
for 60 minutes at 56 oC.  After incubation, the gels are centrifuged and the liquid is removed.  
The gels are again dehydrated in 100 µL of acetonitrile.  The acetonitrile is removed and 
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 alkylation is performed by the addition of 50 µL of freshly prepared 55 mM iodoacetamide in 
100 mM NH4HCO3 buffer.  The gels are allowed to react, in the dark, for 45 minutes at room 
temperature.  The gels are then centrifuged, and the liquid is removed.  The gels are then washed 
with 100 µL of 100 mM NH4HCO3.  100 µL of acetonitrile is added, and the solution is vortexed 
for 20 minutes.  The gels are then centrifuged, the liquid is removed, and dried in the Vacufuge 
Concentrator.  The gels are rehydrated with 10-20 µL of a freshly prepared solution of 50 mM 
NH4HCO3, 5 mM CaCL2, and 12 ng/µL trypsin.  The gels are digested for 40 min. at 4 oC, then 
overnight at 37 oC.  The digestion solution is collected, and the gels are incubated for 15 min. in 
30 µL 20 mM NH4HCO3 at 37 oC, the supernatent is collected, then gels are incubated 3 times 
for 15 min. in 30 µL of a 60% acetonitrile, 5% formic acid solution.  The supernatents are pooled 
and the volume is reduced to 3 – 10 µL in the Vacufuge Concentrator.  For MALDI-TOF mass 
spectrometry analysis, the peptides are desalted using ZipTipC18 (Millipore, Bredford, MA).  A 
basic manufacturer method is followed where 1 µL of 0.1% TFA is added to the sample. The 
ZipTip is wetted with 2 x 10 µL of 50% acetonitrile, and equilabrated with 3 x 10 µL of 0.1% 
TFA.  The sample is loaded and dispensed for 10 cycles, washed with 3 x 10 µL of 0.1% TFA, 
and then eluted with 1 to 4 µL of 50% acetonitrile, 0.1% TFA, into a 0.5 mL eppendorf tube by 
drawing and expelling the elution solution 10 times. 
 
8.2.3 MALDI-TOF MS and MALDI-PSD-TOF MS 
MALDI-TOF mass spectra and MALDI-PSD-TOF mass spectra were collected using a 
Applied Biosystems Voyager Elite BioSpectrometry Research Station with Delayed Extraction 
Technology, version 5.1 series software (Applied Biosystems, Inc., Framingham, MA).  A 337 
nm nitrogen laser is used.  For peptide analysis, α-cyano-4-hydroxycinnamic acid (α-CHCA) as 
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 a saturated solution in 50:50 H2O:ACN with 0.1% TFA was used by a dry dropplet spotting 
method.  For protein analysis, 3,5-dimethoxy-4-hydroxycinnamic acid (sinapinic acid) as a 
saturated solution in 30:70 ACN:H2O with 0.1% TFA was used.  
 
8.3 RESULTS AND DISCUSSION  
8.3.1 1D gel electrophoresis 
The extracted proteins from the normal-control eye rabbit tear, and the dry eye model 
rabbit tear, were separated for approximate molecular weight determination using a Mini-
PROTEAN Electrophoresis module assembly obtained from Bio-Rad Laboratories, Inc. 
(Hercules, CA). Figure 8.1 shows the results of the electrophoresis for the low molecular weight 
standard, the normal-control eye rabbit tear, and the dry eye model rabbit tear, where well over 
40 distinct bands are observed.  The separation was performed by following the manufacturer’s 
guidelines.  Basically, this entails using a 1 mm thick gel with a 12% acrylamide composition.  5 
µL of a LMW std and dye mixture was loaded onto the gel along with 10 µL of sample and dye 
mixtures at dilutions where the second sample well contained one half the concentration of the 
initial sample loading for comparative purposes (as discussed and illustrated in Figure 8.1).  The 
separation is performed at a constant voltage of 200V.  After the electrophoresis separation is 
complete, the gel is fixed in a solution of 50% methanol (v/v) and 5% acetic acid (v/v). The gel 
is then rinsed and stained in a solution of 50% methanol (v/v) 5% acetic acid (v/v) and 0.1% blue 
R250 (w/v).  After staining, the gel is rinsed and de-stained in a solution of 5% methanol (v/v) 
and 5% acetic acid (v/v).  For storage, the gel is kept in a fresh solution of 5% methanol (v/v) 
and 5% acetic acid (v/v).  The LMW standard was used to calculate the approximate molecular  
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Figure 8.1. 1D SDS-PAGE results of normal eye tear versus dry eye tear. 
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Figure 8.2. Calibration plot used for the molecular weight determinations constructed from the 
LMW standard’s Rf values.  
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 Molecular 
Weight 
Protein ID from Literature and Mass Spectrometry 
 
Difference in 
Protein Expression 
(Da) in Dry Eyes 
Compared to 
Normal 
10,200 Lipophilin  Increased 
10456 Lipophilin CL2* Not Available 
11,300 ß-2 microglobulin Equal 
14,113 Apolipoprotein A-1** Not Available 
14,254 Cystatin Increased 
14,390 Lysozyme Variable 
14,559 Unidentified Increased 
16,399 Lipophilin Variable 
17,310 Lipocalin (Tear specific pre-albumin) Increased 
18,500 Platelet-activating growth factor Equal 
20,500 Unidentified Equal 
25,307 T-cell-specific surface glycoprotein CD28 precursor*** Not Available 
30,300 Apolipoprotein D monomer Variable 
30,740 Channel protein 1 ** Not Available 
37,500 Unidentified Equal 
51,165 Lacrimal lipase** Not Available 
55,721 Cytochrome P450 2C14** Not Available 
56,808 Protein disulfide isomerase precursor (PDI)*** Not Available 
68,915 Serum albumin precursor*** Not Available 
 
*Identification determined by MALDI-TOF PSD analysis which did not allow for quantitative comparison. 
Identification determined by ES-MS-MS analysis which did not allow for quantitative comparison. 
arison. 
LDI-TOF MS and ES-MS-MS with 
entative Assignments. 
**
***Identification determined by MALDI-TOF fingerprint analysis which did not allow for quantitative comp
1Related to voltage dependent anion-selective channel protein. 
 
Table 8.1. Protein Peaks Found in Rabbit Tear by MA
T
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 weights of the extracted rabbit tear proteins.  Figure 8.2 is the calibration plot used for the 
.3.2 Tear total protein 
al tear protein was determined by the Bradford Assay method (Sigma-
Aldrich
.3.3 MALDI-TOF MS of Tear Protein 
been numerous amounts of incremental optimizations 
in samp
molecular weight determinations constructed from the LMW standard’s Rf values.  Table 8.1 
lists the protein assignments for some of the major bands observed for the extracted proteins. 
 
8
Quantitation of tot
, St. Louis, MO). The protein, in solution, is complexed with the dye Brilliant Blue G 
which causes a shift in the dye’s maximum absorption from 465 nm to 595 nm. The absorption 
amount is directly proportional to protein concentration in a linear working range of 1-1.4 
mg/mL.  Figure 8.3 is a calibration curve showing the linear working range used to quantitate the 
proteins in both the normal, and the dry eye model tear fluid. Table 8.2 is a tabulation of total 
tear protein comparative results for normal versus dry eye tear for seven different rabbits. Also 
included in the table is a 21µL composite sample of normal eye tear total protein.  
 
8
In the recent literature, there have 
le pretreatment prior to MALDI-TOF MS analysis reported.  These include the addition 
of monobasic ammonium phosphate as a matrix enhancement, and post-crystallization washing 
with dibasic ammonium citrate, both resulting in suppressing the formation of metal adducts and 
matrix clusters(46). There has also been the reporting of wax coating MALDI plates prior to 
sample spotting as a way of improving response(47) in peptide analysis. In the present study of 
tear proteins, we have evaluated these optimization steps and incorporated certain aspects of  
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igure 8.3. Calibration curve for protein quantitation. F
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Table 8.2. Concentration of protein in normal and dry eye tear 
   
Sample ID Control Eye 
(mg/mL) 
Dry Model Eye 
(mg/mL) 
   
SJ-71 (06-01-04) 1.69 3.24 
SJ-72 (06-01-04) 4.42 3.45 
omp. 
SJ-73 (06-01-04) 6.95 7.94 
SJ-75 (10-09-03) 3.33 aNA 
SJ-75 (06-01-04) 7.58 5.44 
SJ-76 (10-13-03) aNA 3.23 
SJ-76 (06-01-04) 4.70 1.43 
SJ73-SJ76 21µL C 3.70 NA 
   
Average 4.62 4.12 
Std Dev 2.05 2.26 
 
aNA: not analyzed. 
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 them into the collection of the presently reported results. Wax coating of the Voyager MALDI 
lates was observed to decrease the chemical noise in MALDI-TOF spectra, and increase the 
de.  
llecting the spectrum in linear 
mode. 
 
p
resolution of the peaks, for the analysis of peptides. The most dramatic effect though of applying 
the wax coating to the Voyager MALDI plates was observed for protein analysis in linear mo
Figure 8.4a is the MALDI-TOF spectrum for lysozyme with an uncoated plate, and Fig. 8.4b is 
the MALDI linear mode spectrum of lysozyme collected using a wax coated plate. The S/N ratio 
increased from 7:1 to 65:1 with the application of the wax coating. A decrease in dimerization is 
also observed at m/z 28.8 kDa. This same affect was observed with carbonic anhydrase  (Figure 
8.5a uncoated plate, Fig. 8.5b coated plate) where the S/N ratio increased from 12:1 to 135:1. 
Figure 8.6a is the MALDI-TOF spectrum for an uncoated plate analysis of BSA (+2 at 33216 Da 
and +1 at 66431 Da) giving a S/N ratio of 10:1 for the 33 kDa peak, and 15:1 for the 66 kDa 
peak. Figure 8.6b is the same BSA standard collected using a wax coated plate resulting in a S/N 
ratio of 39:1 for the 33 kDa peak, and 158:1 for the 66 kDa peak. 
A study was performed comparing the tear protein of normal eye tear to the dry eye tear 
model by depositing a 50:1 ratio of tear (neat) with matrix, and co
Figure 8.7 shows the enhancement effect observed for the tear protein spectrum when 
employing the wax coated Voyager MALDI plates. Figure 8.7a was collected using an uncoated 
plate. Figure 8.7b is the MALDI-TOF spectrum collected using the wax coated Voyager plate, 
illustrating a clear enhancement in the MALDI-TOF MS spectrum of the tear proteins.  Because 
the tear samples contain a considerable amount of salts, the matrix/sample plate spots were 
washed with a 10 mM diammonium citrate H2O solution, which was observed to also enhance 
the response of the proteins. 
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Figure 8.4 (a) MALDI-TOF spectrum of a lysozyme (14376 Da) standard collected using a 
standard, non-coated Voyager plate with a S/N ratio of 7:1. (b) Lysozyme protein standard 
spectrum collected using a wax coated plate with a S/N ratio of 65:1. A decrease in dimerization 
is observed at m/z 28.8 kDa. 
 
 
2500 9000 15500 22000 28500 35000
Mass (m/z)
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
%
 In
te
ns
ity
100 
 
14377
7162 28885 
 
2500 9000 15500 22000 28500 35000
Mass (m/z)
0 
10 
20 
30 
 
 
60 
70 
80 
90 
100 
nt
en
si
ty
 
(a) 
40
50
%
 I
14351
7183 
28785 
(b) 
 196
  
 
 
 
 
 
 
 
Figure 8.5. (a) MALDI-TOF spectrum of carbonic anhydrase (29024 Da) standard collected 
using a non-coated plate with a S/N ratio of 12:1.  (b) Carbonic anhydrase protein standard 
spectrum collected using a wax coated plate with S/N ratio of 135:1. 
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Figure 8.6. (a) MALDI-TOF spectrum of BSA (33216 Da and 66431 Da) standard collected 
using a non-coated plate. The S/N ratio for the 33 kDa peak is 10:1 and S/N ratio for 66 kDa 
peak is 15:1.  (b) BSA spectrum collected using wax coated plate. The S/N ratio for the 33 kDa 
peak is 39:1 and S/N ratio for 66 kDa peak is 158:1.   
 
 
 
 
 
2500 18000 33500 49000 64500 80000
Mass (m/z)
0 
10 
20 
30 
40 
50 
60 
70 
80 
90 
100 
ty
 
%
 In
te
ns
i
66571 33110
 
2500 18000 33500 49000 64500 80000
Mass (m/z)
0 
10 
40 
50 
60 
70 
80 
90 
100 
te
ns
ity
 
20 
30 
66717 
33453
(a) 
(b) 
%
 In
 198
 Figures 8.8a and 8.8b are the first comparative spectra of rabbit tear fluid proteins from a 
ye of the rabbit. Of interest in these two spectra is the observance of a decrease in the 14,390 Da 
rotein, a decrease in the 16,454 Da protein, and an increase in the 10,151 Da protein for Fig 
8.8b, th
rabbit that has been given the dry eye condition. Figure 8.8a is the MALDI-TOF mass spectrum 
of the left, normal eye of the rabbit. Figure 8.8b is the mass spectrum of the right, dry eye model 
e
p
e dry eye model. From Table 1 it appears that a likely candidate for the assignment of the 
14,390 Da protein may be lysozyme. The 16,454 Da protein may be lipophilin, and the 10,151 
Da protein is probably the lipophilin protein. The 11,300 Da protein found in both the normal 
and the dry eye extracts is assigned as a ß-2 microglobulin protein. Figure 8.9 is the post source 
decay (PSD) spectrum of an m/z 1756 peptide obtained from band 1 in the 1D SDS-PAGE gel. It 
has been identified as the lipophilin CL2 protein at 10,456 Da. The 1D SDS-PAGE result of the 
tear proteins illustrated in Figure 8.1 shows that the majority of the proteins are the lower 
molecular weight proteins ranging from approximately 10 kDa to 25 kDa (bands 1 through 4), 
followed by the transferrins of bands 10 and 11. These low molecular weight proteins appear to 
be comprised of many lipid-binding proteins such as the lipophilins, the apolipoproteins, and the 
lipocalins, and also the globulins, cystatin and lysozyme. Therefore, it would be expected that 
readily observable changes in the protein expressions would primarily involve these low 
molecular weight species. Furthermore, previous work done in our lab has shown that the major 
lipids in the tear film are mono and diacylglycerols(48), while other known tear lipids such as 
cholesterol, the wax esters, and the phosphorylated lipids, are in much lower abundances. It 
would seem likely then that the lipid binding proteins in the tear film are the fatty acid chain type 
binding proteins, for example the human tear lipocalin member tear prealbumin is found in vitro 
to bind retinol and fatty acids, but not cholesterol, while tear fluid apoD does bind cholesterol 
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Figure 8.7. Comparison of tear protein MALDI-TOF MS spectral response enhancement using a 
wax coated Voyager plate. (a) Tear protein spectrum collected using an un-coated plate. (b) Tear 
protein spectrum collected using a wax coated plate. 
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 and the phosphorylated lipids(49) (apoD possibly bands 6 and 8 which are in low abundances).   
A second set of spectra are presented in Figure 8.10 comparing the MALDI-TOF MS 
protein analysis of the rabbit normal eye versus the dry eye model. The normal eye spectrum in 
Fig. 8.10a shows a very large abundance of an m/z 17,408 protein which would probably 
represent tear lipocalin, represented by the the predominant band #2 in Figure 1. Notably, in the 
dry eye model spectrum of Fig. 8.10b, this protein is absent, but a new protein at m/z 29,002 
(unidentified) is now observed. Tear lipocalin is thought to play a major role in tear stability, 
being solely bound to the lipids, thus providing an anchoring effect between the tear film lipid 
layer and the tear aqueous region.  m/z 30,370 Da apolipoprotein D monomer as compared to the 
dry eye.  Secondly, the dry eye spectrum appears to have added the m/z 17,330 Da lipocalin 
protein, thirdly, the m/z 11,370 Da ß-2 microglobulin protein appears to have decreased in the 
dry eye spectrum, and fourthly, the 16,392 Da lipophilin protein has increased in the dry eye 
spectrum. The next normal versus dry eye model is illustrated in Figure 8.11, where the normal 
eye spectrum is Fig. 8.11a, and the dry eye model spectrum is Fig. 8.11b. Four differences are 
observed between the spectra. First, the normal eye spectrum appears to have a more abundant 
11 kDa protein expressed. In the dry eye 11b spectrum, the m/z 10 kDa, the m/z 16 kDa, and the 
m/z 17 kDa protein are observed to be more greatly expressed. In Figure 8.12, the dry eye 
spectrum in (b) shows an elevation of the m/z 14 kDa protein compared to the normal eye 
spectrum in Fig. 8.12a.  In both Figures 8.13 and 8.14, the dry eye model spectra show an 
increase in the 10 kDa protein (lipophilin), and the 17 kDa (lipocalin) protein. 
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Figure 8.8. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear 
proteins. The bottom dry eye MS spectrum shows an increase in the 10 kDa lipophilin protein, 
nd a decrease in both the 14 kDa lysozyme protein, and the 16 kDa lipophilin protein. 
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el, identified as the lipophilin CL2 protein at 10,456 Da. 
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Figure 8.9. PSD spectrum of an m/z 1756 peptide obtained from band 1 in the 1D SDS-PAGE 
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Figure 8.10. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear 
proteins. The top normal eye spectrum contains a strong peak at 17 kDa which is probably 
pocalin. The bottom dry eye tear protein spectrum shows a predominant peak at 29 kDa of an 
unidentified protein. 
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 (a) 
 
 
igure 8.11. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear 
proteins. The bottom dry eye MS spectrum shows an increase in the 17 kDa lipocalin protein, an 
crease in the 16 kDa lipophilin protein and a decrease in both the 11 kDa ß-2 microglobulin 
protein, and the 30 kDa apoD protein. 
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 8.3.4 ES Triple Quadrupole MS/MS of Digested Peptides 
As a further aid in the identification of the tear proteins, Electrospray Triple Quadrupole 
tandem mass spectrometry was performed on the most abundant peptides from an in-solution 
digestion of the tear proteins. The lipid fraction was first removed from the tear fluid following 
the above modified extraction method. The aqueous tear protein extract was then cleaned using a 
ProteoPrep  Protein Precipitation Kit (Sigma, Saint Louis, Missouri) to isolate the proteins and 
wash off the tear salts. In-solution digestion was then performed on the proteins, and the 
resulting peptides were infused into the electrospray source using a syringe pump. Figure 8.15a 
is a single stage spectrum of the normal eye peptides. Figure 8.15b is a single stage spectrum of 
the dry eye peptides. The most abundant peptides were subjected to collision induced 
dissociation, and the resultant product ion spectra were searched using Protein Prospector for 
possible protein identification. Figure 8.16 is a product ion spectrum from the collision induced 
dissociation of the m/z 661 (+3) peptide. The important product ions include the y1-NH3 peak at 
m/z 158, the y3  peak at m/z 187, the a2 peak at m/z 251, the y16-NH3  at m/z 843, the y8-NH3 
peak at m/z 895, and the a12 peak at m/z 1240. The protein was identified as the T-cell receptor 
alpha chain V region RL-5 precursor with a molecular weight of 14,856 Da. 
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Figure 8.12. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear 
proteins. The bottom dry eye MS spectrum shows an increase in the 14 kDa apolipoprotein. 
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Figure 8.13. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear 
proteins. The bottom dry eye MS spectrum shows an increase in both the 10 kDa lipophilin 
protein, and the 17 kDa lipocalin protein. 
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Figure 8.14. MALDI-TOF MS spectra of (a) normal eye tear proteins, and (b) dry eye tear 
proteins. The bottom dry eye MS spectrum shows an increase in both the 10 kDa lipophilin 
protein, and the 17 kDa lipocalin protein. 
 
 
 
 
 
 209
  
 
 
 
 
Figure 8.15. (a) Single stage spectrum of the normal eye peptides. (b) Single stage spectrum of 
 
 
 
 
 
 
 
 
 
 
 
the dry eye peptides. 
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Figure 8.16. Ms/ms spectrum of the m/z 661.3 peptide. 
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 8.4 Conclusion 
ing of MALDI plates significantly enhances the response of proteins in linear 
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.5 REFERENCES 
emp, M. A. The preocular tear film and dry eye syndromes. International 
ophthalmology Clinics, Vol. 13, No. 1, Little, Brown and Company, Boston, 1973, 29-46. 
  
gy  
3. 
Am. J. Ophthalmol., 1981; 92: 559-567. 
ye Res, 1982; 2: 301-308. 
ory IgM in tears of IgA defecient individuals. Cur Eye Res, 1990; 9: 997-
Wax coat
time-of-flight analysis.  Tears contain a considerable amount of salts that can be 
effectively removed through spot washing with an aqueous solution of ammonium citrate, thus 
reducing the salt suppression effects of the untreated biological sample.  Tear protein 
quantitation and 1D SDS-PAGE gel analysis of the normal versus the dry eye model tears did not 
show a significant difference. The MALDI-TOF MS linear mode analysis of the intact tear 
proteins indicated that expression differences exist primarily in the low molecular weight range 
of the lipid binding proteins. Substantial differences in the observed abundances of lipophilin 
(m/z 10.2 kDa), lysozyme (14.4 kDa), and lipocalin (m/z 17.3 kDa), in normal versus dry eye 
tear protein MALDI-TOF MS spectra could indicate a diseased state, and may have an 
application in diagnosis of the dry eye condition. 
 
8
1. Holly, F. J., and L
2. Ellison, Solon A.; Jacobson, Mark; Levine, Michael J. Lacrimal and salivary proteins.  
Immunol. Eye, Workshop 3: Immunol. Aspects Ocul. Dis.: Infect., Inflammation, Aller
(1981),  Meeting Date 1980, 205-19.  
Frey, W. H., DeSota-Johnson, D. Hoffman, C., and McCall, J. T. Effects of stimulus of the 
chemical composition of human tears. 
4. Holly, F. J., and Hong, B. S. Biochemical and surface characteristics of human tear proteins. 
Am J Optom & Physiol Optics, 1982; 59: 43-50. 
5. Gachon, A. M., Richard, J., and Dastugue, B. Human tears: normal protein pattern and 
individual protein determinations in adults. Cur E
6. Suarez, J. C. Significance of postgamma protein fraction in tears. Ophthalmologica, Basel, 
1986; 193: 75-77. 
7. Kuizenga, A., Stolwijk, T. R., van Agtmaal, E. J., van Haeringen, N. J., and Kijlstra, A. 
Detection of secret
1005. 
 212
 8. Gachon, A. M. F. Human lacrimal gland secretes proteins belonging to the group of 
hydrophobic molecule transporters. In Lacrimal Gland, Tear Film, and Dry Eye Syndromes. 
Sullivan DA (ed). Plenum Press: New York 1994; 205. 
9. Baguet J., Claudon-Eyl, V., Sommer, F., and Chevallier, P. Normal protein and glycoprotein 
profiles of reflex tears and trace element composition of basal tears from heavy and slight 
deposits on soft contact lenses. CLAO J, 1995; 21: 114-121. 
10. Asrani, A. C., Lumsden, A. J., Kumar, R., and Laurie, G. W. Gene cloning of BM180, a 
lacrimal gland enriched basement membrane protein with a role in stimulated secretion. In 
Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. Sullivan DA, Dartt DA, Meneray 
MA (ed). Plenum Press: New York 1998; 49. 
11. Lehrer, R. I., Xu, G., Abduragimov, A., Dinh, N. N., Qu, X. D., Martin, D., and Glasgow, B. 
J. Lipophilin, a novel heterodimeric protein of human tears. FEBS Letters, 1998; 432: 163-
167. 
12. Schoenwald, R. D., Vidvauns, S., Wurster, D. E., and Barfknecht, C. F. The role of tear 
proteins in tear film stability in the dry eye patient and in the rabbit. In Lacrimal Gland, Tear 
Film, and Dry Eye Syndromes 2. Sullivan DA, Dartt DA, Meneray MA (ed). Plenum Press: 
New York 1998; 391. 
13. Boptom, V. E., Willcox, M. D. P., and Millar, T. J. Modulation of tear film protein secretion 
with phosphodiesterase inhibitors. Clin. Exp. Ophthalmol., 2000; 28: 208-211. 
14. Moore JC, Tiffany JM. Human ocular mucas. Chemical studies. Exp. Eye Res. 1981; 33: 203. 
15. Carrington SD, Hicks SJ, Corfield AP, Kaswan RL, Packer N, Bolis S, Morris CA. In 
Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. Sullivan DA, Dartt DA, Meneray 
MA (ed). Plenum Press: New York 1998; 253. 
16. McCulley JP, Shine WE. The lipid layer: the outer surface of the ocular surface tear film. 
Bioscience Reports. 2001; 21: 407. 
17. Salvatore, M. F., Pedroza, L., and Beuerman, R. W. Denervation of rabbit lacrimal gland 
increases levels of transferrin and unidentified tear proteins of 44 and 36 kDa. Curr Eye Res. 
1999; 18: 455-466. 
18. Barrera, R., Jimenez, A., Lopez, R., Mane, M. C., Rodriguez, J. F., and Molleda, J. M. 
Evaluation of total protein content in tears of dogs by polyacrylamide gel disk 
electrophoresis. Am J Vet Res 1992; 53: 454-456 
19. Kondo, Y. Studies on the biochemical marker loci detected with urine, tears, and saliva of 
rats. Exp. Anim. 1994; 43: 1-9. 
20. Berta, A. A polyacrylamide-gel electrophoresis study of human tear proteins. Graefe’s Arch 
Clin Exp Ophthalmol 1982; 219: 95-99. 
21. Joo, W., Lee, D., and Kim, C. Development of an effective sample preparation method for 
the proteome analysis of body fluids using 2-D Gel electrophoresis. Biosci. Biotechnol. 
Biochem., 2003; 67: 1574-1577. 
22. Varnell, R. J., Maitchouk, D. Y., Beuerman, R. W., Salvatore, M. F., Carlton, J. E., and 
Haag, A. M. Analysis of rabbit tear fluid using capillary electrophoresis with UV or laser-
induced fluorescence detection. J. Cap. Elec., 1997; 1: 1-6. 
23. Boonstra, A., and Kijlstra, A. Separation of human tear proteins by high performance liquid 
chromatography. Curr. Eye Res., 1984; 3: 1461-1469. 
24. Wollensak, G., Mur, E., Mayr, A., Baier, G., Gottinger, W., and Stoffler, G. Effective 
methods for the investigation of human tear film proteins and lipids. Graefe’s Arch Clin Exp 
Ophthalmol 1990; 228: 78-82. 
 213
 25. Gachon, A. M., Verrelle, P., Betail, G., and Dastugue, B. Immunological and electrophoretic 
studies of human tear proteins. Exp. Eye Res., 1979; 29: 539-553. 
26. Boonstra, A., and Kijlstra, A. The identification of transferrin, an iron-binding protein in 
rabbit tears. Exp. Eye Res., 1984; 38: 561-567. 
27. Inada, K., Baba, H., and Okamura, R. Studies of human tear proteins – 1. Analysis of tears 
from normal subjects by crossed immunoelectrophoresis. Jpn. J. Ophthalmol., 1982; 26: 314-
325. 
28. Schmut, O., Horwath-Winter, J., Zenker, A., and Trummer, G. The effect of sample 
treatment on separation profiles of tear fluid proteins: quantitative and semi-quantitative 
protein determination by an automated analysis system. Graefe’s Arch Clin Exp Ophthalmol, 
2002; 240: 900-905. 
29. Glasgow, B. J., Abduragimov, A. R., Farahbakhsh, Z. T., Faull, K. F., and Hubbell, W. L. 
Tear lipocalins bind a broad array of lipid ligands. Curr. Eye Res., 1995; 14: 363-372. 
30. Zhou, L., Beuerman, R. W., Barathi, A., and Tan, D. Analysis of rabbit tear proteins by high-
pressure liquid chromatography/electrospray ionization mass spectrometry. Rapid Commun. 
Mass Spectrum., 2003; 17: 401-412. 
31. Mulvenna, I., Stapleton, F., Hains, P. G., Cengiz, A., Tan, M., Walsh, B., and Holden, B. 
Low molecular weight analysis of tears using matrix assisted laser desorption ionization-time 
of flight mass spectrometry. Clinical and Experimental Ophthalmology, 2000; 28: 205-207. 
32. Fung, K., Morris, C., and Duncan, M. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3 
Edited by D. Sullivan et al., Kluwer Academic/Plenum Publishers, 2002, p. 601. 
33. Cao, P., and Moini, M. Analysis of peptides, proteins, protein digests, and whole human 
blood by capillary electrophoresis/electrospray ionization-mass spectrometry using an in-
capillary electrode sheathless interface. J Am Soc Mass Spectrom 1998; 9: 1081-1088. 
34. Bonavida, B., Sapse, A. T., and Sercarz, E. E. Rabbit tear proteins. I. Detection and 
quantitation of lysozyme in nonstimulated tears. Invest Ophthalmol, 1968; 7: 435. 
35. Dartt, L. A., and Botelho, S. Y. Protein in rabbit lacrimal gland fluid. Invest. Ophthalmol. 
Visual Sci., 1979; 18: 1207-1209. 
36. Dohlman, C. H., Friend, J., Kalevar, V., Yogoda, D., and Balazs, E. The glycoprotein 
(mucus) content of tears from normal and dry eye patients. Exp Eye Res 1976; 22: 359. 
37. Ng, V., Cho, P., and To, C. Tear proteins of normal young Hong Kong Chinese. Graefe’s 
Arch Clin Exp Ophthalmol, 2000; 238: 738-745. 
38. Pflugfelder, S. C., Solomon, A., and Stern, M. E. The diagnosis and management of dry eye: 
A twenty-five-year-review. Cornea, 2000; 19: 644-649. 
39. Lemp, M. A. Report of the National Eye Institute/Industry workshop on clinical trials in dry 
eyes. CLAO J, 1995; 21: 222-232. 
40. Schaumberg DA, Buring JE, Sullivan DA, Dana MR. Hormone replacement therapy and dry 
eye syndrome. JAMA. 2001; 286: 2114. 
41. Ohashi, Y., Ishida, R., Kojima, T., Goto, E., Matsumoto, Y., Watanabe, K., Ishida, N., Nakat, 
K., Takeuchi, T., and Tsubota, K. Abnormal protein profiles in tears with dry eye syndrom. 
Am. J. Ophthalmol., 2003; 136: 291-299. 
42. Nguyen, D. H., Beuerman, R. W., Meneray, M. A., and Maitchouk, D. Sensory denervation 
leads to deregulated protein synthesis in the lacrimal gland. Lacrimal Gland, Tear Film, and 
Dry Eye Syndromes 2 edited by Sullivan et al., Plenum Press, New York, 1998. 
43. Varnell, R. J., Maitchouk, D. M., Beuerman, R. W., Carlton, J. E., and Haag, A. Small-
volume analysis of rabbit tears and effects of a corneal wound on tear protein spectra. 
 214
 Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2 edited by Sullivan et al., Plenum 
Press, New York, 1998. 
44. Folch, J., Lees, M., and Stanly, G. H. S. A simple method for the isolation and purification of 
total lipids from animal tissues. J. Biol. Chem. 1957; 226: 497. 
45. Bligh, E. G., and Dyer, W. J. A rapid method of total lipid extraction and purification. Can. 
J. Biochem. Physiol. 1959; 37: 911. 
46. Smirnov, I. P.; Zhu, X.; Taylor, T.; Huang, Y.; Ross, P.; Papayanopoulos, I. A.; Martin, S. 
A.; Pappin, D. J. Suppression of -Cyano-4-hydroxycinnamic Acid Matrix Clusters and 
Reduction of Chemical Noise in MALDI-TOF Mass Spectrometry 
Anal. Chem. 2004, 76, 2958-2965.  
47. Terry, D. E., Umstot, E., and Desiderio, D. M. Optimized Sample-Processing Time and 
Peptide Recovery for the Mass Spectrometric Analysis of Protein Digests J Am Soc Mass 
Spectrom 2004, 15, 784-794. 
48. Ham, B. M.; Jacob, J. T.; Keese, M. M.; Cole, R. B. J. Mass Spectrom. 2004, 39, 1321-1336. 
49. Holzfeind, P., Merschak, P., Dieplinger, H., Bernhard, R. The Human Lacrimal Gland 
Synthesizes Apolipoprotein D mRNA in Addition to Tear Prealbumin mRNA, Both Species 
Encoding Members of the Lipocalin Superfamily Exp. Eye Res. 1995, 61, 495-500. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 215
 CHAPTER IX:  SUMMARY AND CONCLUSIONS 
Mass spectrometry has become a powerful tool for the chemist and the biochemist. For 
the disciplines of the chemist, this includes gas phase thermochemistry studies for the physical 
chemist, structural elucidation and molecular weight of organic compounds for the organic 
chemist, qualitative and quantitative analysis for the analytical chemist, and even the inorganic 
chemist for things such as particle size distributions. An increasingly important application of 
mass spectrometry has been in the fields of proteomics, lipidomics, and metabalomics.  Here, the 
biologist and biochemist have also found an accurate and precise method for composition studies 
of complex biological samples. 
Methods have been developed by affinity capillary electrophoresis (ACE), and cation 
exchange liquid chromatography (CELC), for the determination of binding strength coefficients 
for complexes formed between π-delocalized lymphangitic dyes and an anti-cancer agent 4,4-
dihydroxybenzophenone-2,4-dinitrophenylhydrazone (A007).  In vitro trials have shown that 
complexes with higher binding affinities can offer improved prospects for tumor treatment.  For 
the three tested carriers, the developed methods established that A007 non-covalent binding 
strength was greatest for methylene green, followed by methylene blue, and lastly toluidine blue.  
The developed methodology is general in nature such that it may be used to rank a wide variety 
of solution binding strengths of drug:carrier pairs. 
A new approach for calculating bond dissociation energies (BDE’s) from ES/MS-MS 
measurements has been developed.  The new method that features a “derived effective path 
length” has been applied to measure BDE’s of alkali metal adducts (Li+), and halide adducts (Cl-
), of monoacylglycerol, 1,2-diacylglycerol, and 1,3-diacylglycerol lipids.  Also studied were 
lithium-bound dimers of monoacylglycerols, 1,2-diacylglycerols, and of 1,3-diacylglycerols.  
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 BDE’s for the adducts and dimers of the lipids were measured using a triple quadrupole mass 
spectrometer with electrospray as the ionization source. Mass spectral results were compared to 
computer generated bond dissociation energies using the Becke-style 3-Parameter Density 
Functional Theory (B3LYP, using the Lee-Yang-Parr correlation functional) method, with 
excellent agreement between experimental and theoretical energy values.  The newly developed 
method is general in nature and can be used for the measurement of metal or halide ion adduct 
bond dissociation energies, covalent bond dissociation energies producing fragment ions, and for 
the measurement of bond energies of non-covalent interactions such as dimer dissociations. The 
validity of the method has been rigorously established using a triple quadrupole, but it may also 
be applied to other mass spectrometers that allow user control of the collision cell potential. 
Millions of individuals suffer from a health condition known as Keratoconjunctivitis 
sicca (KCS, also known as “dry eye”).  Studies have indicated that the lipids in the tear film 
layer, which covers the outer portion of the eye, may be directly correlated with the existence of 
dry eye syndrome.  By identifying and comparing the major, non-polar lipids in normal eye tear 
with a dry eye model, it may be possible to identify a symptom of, or a contributing factor to, dry 
eye.  Electrospray tandem mass spectrometry (ES-MS/MS) was used to identify and compare the 
non-polar lipids, detected as lithium adducts, from normal and dry eye tear samples obtained 
from rabbits. A limited number of normal human tear samples were also examined for lipid 
content, and a close resemblance to rabbit was observed. Three distinct regions were delineated 
in the ES mass spectra of the non polar lipids, m/z 20 to 500, m/z 500 to 800, and m/z 800 to 
1100. A common feature noted among identified lipid components was a glycerol backbone with 
fatty acyl substituents attached.  Product ion spectra were obtained for lithiated mono, 1,2- and 
1,3-diacyl, and triacylglyceride standards.  Newly proposed structures and fragment pathways for 
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 the major product ions are presented for the 1,2- and 1,3-diglycerides, as well as for the 
monoglyceride. New approaches to distinguish asymmetric 1,2-diglycerides, and 1,2- from 1,3-
diglycerides are proposed.  For the rabbit tear samples, the m/z 20 to 500 range contains mono-
ester diols with empirical formulas of CnH2nO4, the m/z 500 to 800 range includes diesters with 
empirical formulas of CnH2n-2O5, and the m/z 800 to 1100 range contains triesters with empirical 
formulas of CnH2n-4O6.  Also found in the extracts were three isoprene acetals (terpenoids).   
When targeting a certain class of analytes such as the phosphorylated lipids in complex 
biological extracts, interfering species can pose challenges to qualitative and quantitative 
analysis. Two aspects of lipid analysis in biological extracts were optimized in order to simplify 
the isolation and characterization of the phosphorylated lipids. A new solid ionic crystal MALDI 
matrix was synthesized which combined the lipid response enhancing UV absorber para-
nitroaniline, and the strong protonating agent butyric acid. Mass spectra of the extracts 
containing phosphorylated lipids were simplified by revealing only the protonated species of 
phosphatidylcholine (PC) head group containing lipids such as lyso PC, PC, and platelet-
activating factor (PAF) PC’s. Further spectrum simplification is obtained by the appearance of 
only the sodium adduct species for other phosphorylated lipids such as phosphatidylglycerol 
(PG), phosphatidic acid (PA), and phosphatidylserine (PS).  In addition, a new extraction, 
isolation, and cleanup procedure has been developed to prepare the phosphorylated lipids for 
MALDI-TOF analysis by the use of immobilized metal ion affinity chromatography (IMAC) 
media ZipTipMC.  The latter procedure was successfully applied to a complex biological tear film 
lipid layer extract in preparation for MALDI-TOF analysis for phospholipid characterization. 
The ocular tear fluid, like many biological fluids, is a complex mixture of biomolecules 
such as proteins, non-polar lipids, and polar phosphorylated lipids whose components interact 
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 with one another to perform an important biological function. Irregularities in the tear film can 
cause a number of ocular problems, including dry eye. Approximately 10 to 14 million people in 
the United States alone suffer from some form of dry eye.  However, without the ability to detect 
and quantify the nano- to picogram quantities of tear components, identifying the underlying 
cause of dry eye is impossible. We investigated the use of MALDI-TOF MS to identify the 
phosphorylated lipids in both normal and dry eye rabbit tears. A solid ionic crystal MALDI 
matrix comprised of para-nitroaniline and butyric acid was employed for enhanced spectral peak 
responses of the phospholipids. Additionally, a novel phosphorylated lipid isolation, pre-
concentration, and clean-up method using IMAC ZipTipMC chromatography was also used.  The 
combination of the solid ionic crystal matrix and the ZipTipMC chromatography enabled the 
detection and study of low levels of phosphorylated lipids in the complex tear fluid.   
A study of a rabbit’s tear protein expression for a dry eye rabbit model was performed to 
determine if a pattern in the expression of the proteins could be identified. The uniqueness of the 
model allows the comparison of a normal, left eye tear protein expression to a surgically induced 
dry, right eye tear protein expression.  Quantitation of the tear proteins for the dry and normal 
eye tears were not observed to change considerably with the dry eye condition. One dimensional 
mini-gel electrophoresis of the normal versus the dry eye tear proteins did not show substantial 
differences between band patterns, but was used for general identification of the major protein 
bands. Specific identification of some of the predominant proteins was obtained by tandem mass 
spectrometry which showed that the lower molecular weight lipid binding proteins 
(approximately 10 kDa to 36 kDa) comprise a considerable amount of the observed proteins, 
followed by the transferrins which have higher molecular weights ranging from 70 kDa to 85 
kDa.  Enhancement of MALDI-TOF MS linear mode analysis of intact proteins in neat tear fluid 
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 was demonstrated through the use of wax coated Voyager plates, and spot washing.  MALDI-
TOF MS analysis of the expressed tear proteins illustrated that the major differences between 
normal eye tear and dry eye tear proteins is observed for the lower molecular weight lipid 
binding proteins. 
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